ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-381038,XBP1(S) activates chaperone genes,5/48,50/10899,2.443116327530678e-6,5.969210868491012e-4,4.7007829388300395e-4,DNAJC3/LMNA/EDEM1/TPP1/TLN1,5
R-HSA-381070,IRE1alpha activates chaperones,5/48,52/10899,2.977162527925692e-6,5.969210868491012e-4,4.7007829388300395e-4,DNAJC3/LMNA/EDEM1/TPP1/TLN1,5
R-HSA-186797,Signaling by PDGF,5/48,58/10899,5.146256374365017e-6,6.878829353734572e-4,5.417111973015807e-4,COL6A1/COL3A1/FURIN/STAT6/PIK3CA,5
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,10/48,433/10899,1.4870357415931983e-5,0.0014514058200822341,0.0011429892269974283,SQSTM1/HHAT/PIM1/LMNA/VCL/FN1/PIK3CA/HGF/DKK1/TLN1,10
R-HSA-209560,NF-kB is activated and signals survival,3/48,13/10899,2.2230933813452446e-5,0.0014514058200822341,0.0011429892269974283,SQSTM1/NFKB1/IRAK1,3
R-HSA-1474228,Degradation of the extracellular matrix,6/48,140/10899,3.1771273555895734e-5,0.0014514058200822341,0.0011429892269974283,COL6A1/COL3A1/FURIN/FN1/FBN1/COL15A1,6
R-HSA-449147,Signaling by Interleukins,10/48,473/10899,3.1870192064498906e-5,0.0014514058200822341,0.0011429892269974283,CTF1/SQSTM1/PIM1/STAT6/NFKB1/FN1/PIK3CA/HGF/IRAK1/IL2RB,10
R-HSA-216083,Integrin cell surface interactions,5/48,85/10899,3.3708036655495564e-5,0.0014514058200822341,0.0011429892269974283,COL6A1/COL3A1/FN1/FBN1/ITGB5,5
R-HSA-1566948,Elastic fibre formation,4/48,44/10899,3.9499803601877874e-5,0.0014514058200822341,0.0011429892269974283,FURIN/FN1/FBN1/ITGB5,4
R-HSA-193639,p75NTR signals via NF-kB,3/48,16/10899,4.312645913620694e-5,0.0014514058200822341,0.0011429892269974283,SQSTM1/NFKB1/IRAK1,3
R-HSA-445355,Smooth Muscle Contraction,4/48,45/10899,4.321371829466678e-5,0.0014514058200822341,0.0011429892269974283,PXN/VCL/ITGB5/TLN1,4
R-HSA-1474244,Extracellular matrix organization,8/48,300/10899,4.3433590625902274e-5,0.0014514058200822341,0.0011429892269974283,COL6A1/COL3A1/FURIN/FN1/FBN1/ITGB5/COL15A1/PLOD2,8
R-HSA-381119,Unfolded Protein Response (UPR),5/48,94/10899,5.476260141531838e-5,0.0016892156282725132,0.001330265621424738,DNAJC3/LMNA/EDEM1/TPP1/TLN1,5
R-HSA-9700206,Signaling by ALK in cancer,4/48,55/10899,9.577668266552292e-5,0.002560429983258313,0.002016351214011009,SQSTM1/VCL/FN1/PIK3CA,4
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,4/48,55/10899,9.577668266552292e-5,0.002560429983258313,0.002016351214011009,SQSTM1/VCL/FN1/PIK3CA,4
R-HSA-8957275,Post-translational protein phosphorylation,5/48,108/10899,1.0620469832145467e-4,0.002661755251681458,0.002096145361607658,CCN1/DNAJC3/FN1/FBN1/TGOLN2,5
R-HSA-1442490,Collagen degradation,4/48,64/10899,1.7332489296839702e-4,0.004088428357666306,0.0032196574545213068,COL6A1/COL3A1/FURIN/COL15A1,4
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,4/48,67/10899,2.070765408219502e-4,0.004157408042639989,0.0032739792959495914,COL6A1/COL3A1/COL15A1/PLOD2,4
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,4/48,67/10899,2.070765408219502e-4,0.004157408042639989,0.0032739792959495914,LMNA/VCL/FN1/TLN1,4
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/48,125/10899,2.1131046549622664e-4,0.004157408042639989,0.0032739792959495914,CCN1/DNAJC3/FN1/FBN1/TGOLN2,5
R-HSA-3000170,Syndecan interactions,3/48,27/10899,2.1771962318064783e-4,0.004157408042639989,0.0032739792959495914,COL3A1/FN1/ITGB5,3
R-HSA-114608,Platelet degranulation ,5/48,129/10899,2.44745245847956e-4,0.004461038344774107,0.003513089653319943,VCL/FN1/FLNA/HGF/TLN1,5
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,5/48,134/10899,2.920386556863853e-4,0.005002680416880475,0.003939635451014944,VCL/FN1/FLNA/HGF/TLN1,5
R-HSA-8874081,MET activates PTK2 signaling,3/48,30/10899,2.994122942771357e-4,0.005002680416880475,0.003939635451014944,COL3A1/FN1/HGF,3
R-HSA-3000178,ECM proteoglycans,4/48,76/10899,3.3670783237054776e-4,0.005400793631223586,0.004253151566785867,COL6A1/COL3A1/FN1/ITGB5,4
R-HSA-6806834,Signaling by MET,4/48,79/10899,3.9052889574192005e-4,0.006023157199711921,0.004743265940185263,COL3A1/FN1/PIK3CA/HGF,4
R-HSA-73887,Death Receptor Signalling,5/48,146/10899,4.337936468630243e-4,0.006442638977484176,0.0050736099048306945,SQSTM1/TRAF1/NFKB1/AKAP13/IRAK1,5
R-HSA-6802957,Oncogenic MAPK signaling,4/48,84/10899,4.935043509962298e-4,0.007067687312481719,0.005565838545070261,LMNA/VCL/FN1/TLN1,4
R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,3/48,36/10899,5.168811226755107e-4,0.007147218282513096,0.00562846957541391,VCL/FN1/TLN1,3
R-HSA-2129379,Molecules associated with elastic fibres,3/48,37/10899,5.607538760681619e-4,0.007495410143444431,0.005902672379664862,FN1/FBN1/ITGB5,3
R-HSA-1474290,Collagen formation,4/48,90/10899,6.410346482631959e-4,0.00829209335334005,0.006530064328657344,COL6A1/COL3A1/COL15A1/PLOD2,4
R-HSA-5674135,MAP2K and MAPK activation,3/48,40/10899,7.064570571973655e-4,0.008852789998004486,0.0069716156960266335,VCL/FN1/TLN1,3
R-HSA-8875878,MET promotes cell motility,3/48,41/10899,7.598810165154542e-4,0.009233705685536277,0.007271588674789036,COL3A1/FN1/HGF,3
R-HSA-193704,p75 NTR receptor-mediated signalling,4/48,97/10899,8.498854424981995e-4,0.010016933215109389,0.007888384209299952,SQSTM1/NFKB1/AKAP13/IRAK1,4
R-HSA-9656223,Signaling by RAF1 mutants,3/48,43/10899,8.742959165307447e-4,0.010016933215109389,0.007888384209299952,VCL/FN1/TLN1,3
R-HSA-8948216,Collagen chain trimerization,3/48,44/10899,9.353785589401709e-4,0.010419077837083571,0.008205075078422552,COL6A1/COL3A1/COL15A1,3
R-HSA-76002,"Platelet activation, signaling and aggregation",6/48,263/10899,9.777109367378283e-4,0.010596272584645112,0.008344616814263114,VCL/FN1/PIK3CA/FLNA/HGF/TLN1,6
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,3/48,46/10899,0.0010655181890273906,0.010833326910765176,0.008531298262841719,FURIN/FBN1/ITGB5,3
R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,3/48,47/10899,0.0011346626689579485,0.010833326910765176,0.008531298262841719,VCL/FN1/TLN1,3
R-HSA-6802949,Signaling by RAS mutants,3/48,47/10899,0.0011346626689579485,0.010833326910765176,0.008531298262841719,VCL/FN1/TLN1,3
R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,3/48,47/10899,0.0011346626689579485,0.010833326910765176,0.008531298262841719,VCL/FN1/TLN1,3
R-HSA-9649948,Signaling downstream of RAS mutants,3/48,47/10899,0.0011346626689579485,0.010833326910765176,0.008531298262841719,VCL/FN1/TLN1,3
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,4/48,108/10899,0.0012688443777865753,0.01183271152307946,0.009318318563916097,PIM1/STAT6/FN1/HGF,4
R-HSA-5673001,RAF/MAP kinase cascade,6/48,280/10899,0.0013504902936837906,0.012307877449254545,0.009692514069500889,VCL/FN1/PIK3CA/HGF/IL2RB/TLN1,6
R-HSA-209543,p75NTR recruits signalling complexes,2/48,13/10899,0.0014363366632857103,0.012799355599501553,0.010079555531829546,SQSTM1/IRAK1,2
R-HSA-5684996,MAPK1/MAPK3 signaling,6/48,286/10899,0.0015052296094661874,0.013121675508607416,0.010333384046678632,VCL/FN1/PIK3CA/HGF/IL2RB/TLN1,6
R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,2/48,14/10899,0.0016710250414392921,0.014257043438662896,0.01122749187977128,PLXNA1/TLN1,2
R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins ,2/48,15/10899,0.0019226982871287947,0.0157347349620132,0.012391181227468066,FN1/TLN1,2
R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,2/48,15/10899,0.0019226982871287947,0.0157347349620132,0.012391181227468066,FN1/TLN1,2
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",3/48,57/10899,0.001985372288527122,0.015922685753987517,0.012539193401223928,NFKB1/IRAK1/PANX1,3
R-HSA-844456,The NLRP3 inflammasome,2/48,16/10899,0.0021912085482705926,0.016586916162016137,0.013062278116825938,NFKB1/PANX1,2
R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,2/48,16/10899,0.0021912085482705926,0.016586916162016137,0.013062278116825938,PIM1/PIK3CA,2
R-HSA-3000171,Non-integrin membrane-ECM interactions,3/48,59/10899,0.002192285677273953,0.016586916162016137,0.013062278116825938,COL3A1/FN1/ITGB5,3
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,3/48,61/10899,0.002412137549838193,0.017912354768242877,0.014106067542913412,COL6A1/COL3A1/COL15A1,3
R-HSA-180292,GAB1 signalosome,2/48,17/10899,0.0024764088986635522,0.018055272152074264,0.014218615686106521,PXN/PIK3CA,2
R-HSA-913709,O-linked glycosylation of mucins,3/48,63/10899,0.002645200036672327,0.018941521691171484,0.014916541560182298,ST3GAL1/GALNT10/GCNT1,3
R-HSA-446353,Cell-extracellular matrix interactions,2/48,18/10899,0.0027781533329735856,0.019544552395129963,0.015391431207609893,PXN/FLNA,2
R-HSA-5683057,MAPK family signaling cascades,6/48,325/10899,0.0028666962689924465,0.01981974489424088,0.015608146655131288,VCL/FN1/PIK3CA/HGF/IL2RB/TLN1,6
R-HSA-9703465,Signaling by FLT3 fusion proteins,2/48,19/10899,0.0030962967617430255,0.021044322058626327,0.01657250719933823,PIM1/PIK3CA,2
R-HSA-622312,Inflammasomes,2/48,21/10899,0.003781204794441038,0.025271052042847606,0.01990107786547915,NFKB1/PANX1,2
R-HSA-354192,Integrin signaling,2/48,27/10899,0.006214695586421726,0.04019504726056633,0.0316537975539307,FN1/TLN1,2
R-HSA-912526,Interleukin receptor SHC signaling,2/48,27/10899,0.006214695586421726,0.04019504726056633,0.0316537975539307,PIK3CA/IL2RB,2
R-HSA-9682385,FLT3 signaling in disease,2/48,28/10899,0.006674049620624246,0.042480855521751154,0.0334538828101466,PIM1/PIK3CA,2
R-HSA-186763,Downstream signal transduction,2/48,29/10899,0.0071484010475153185,0.04478920031333817,0.035271715694976905,STAT6/PIK3CA,2
R-HSA-170834,Signaling by TGF-beta Receptor Complex,3/48,93/10899,0.00788345761091462,0.04863486926118096,0.03830019891942325,FURIN/FBN1/ITGB5,3
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",3/48,106/10899,0.011263163532475117,0.06843225115943216,0.05389073460514411,PIK3CA/HGF/IRAK1,3
R-HSA-194138,Signaling by VEGF,3/48,108/10899,0.011846527878494844,0.0709023534220363,0.05583595229455544,NRP2/PXN/PIK3CA,3
R-HSA-397014,Muscle contraction,4/48,205/10899,0.012401043072447732,0.07306114101100127,0.057536008146214415,PXN/VCL/ITGB5/TLN1,4
R-HSA-76009,Platelet Aggregation (Plug Formation),2/48,39/10899,0.012687418699009346,0.07306114101100127,0.057536008146214415,FN1/TLN1,2
R-HSA-5173105,O-linked glycosylation,3/48,111/10899,0.012753815139077527,0.07306114101100127,0.057536008146214415,ST3GAL1/GALNT10/GCNT1,3
R-HSA-199418,Negative regulation of the PI3K/AKT network,3/48,113/10899,0.013380283217187665,0.07557033197313033,0.05951200837889252,PIK3CA/HGF/IRAK1,3
R-HSA-9020702,Interleukin-1 signaling,3/48,115/10899,0.014024124204260842,0.07810658063761941,0.06150931668535457,SQSTM1/NFKB1/IRAK1,3
R-HSA-419037,NCAM1 interactions,2/48,42/10899,0.014619310985219973,0.0803060781516878,0.06324143180340291,COL6A1/COL3A1,2
R-HSA-451927,Interleukin-2 family signaling,2/48,44/10899,0.015973343380690123,0.08655825264401,0.06816504998872029,PIK3CA/IL2RB,2
R-HSA-9006936,Signaling by TGFB family members,3/48,122/10899,0.01641528424178557,0.08776705307941352,0.0691169862812024,FURIN/FBN1/ITGB5,3
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation  ,2/48,45/10899,0.016669819602164713,0.0879552323745796,0.06926517840234646,NFKB1/IRAK1,2
R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",2/48,48/10899,0.018835624791322874,0.09779417618160939,0.07701339507673663,PIK3CA/IL2RB,2
R-HSA-1500931,Cell-Cell communication,3/48,129/10899,0.019022308583953946,0.09779417618160939,0.07701339507673663,PXN/PIK3CA/FLNA,3
R-HSA-177929,Signaling by EGFR,2/48,50/10899,0.020341938026063388,0.10325464744875214,0.08131354307553652,PXN/PIK3CA,2
R-HSA-446652,Interleukin-1 family signaling,3/48,153/10899,0.02961400306197732,0.1484401903481613,0.11689738050780521,SQSTM1/NFKB1/IRAK1,3
R-HSA-375165,NCAM signaling for neurite out-growth,2/48,63/10899,0.031282305229661404,0.15486672095178053,0.12195830498893336,COL6A1/COL3A1,2
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,2/48,64/10899,0.032202161280079786,0.15557911654592763,0.12251932002566816,STAT6/NFKB1,2
R-HSA-450294,MAP kinase activation,2/48,64/10899,0.032202161280079786,0.15557911654592763,0.12251932002566816,NFKB1/IRAK1,2
R-HSA-373755,Semaphorin interactions,2/48,65/10899,0.03313265098260137,0.1581689648097994,0.12455883828045627,PLXNA1/TLN1,2
R-HSA-9658195,Leishmania infection,3/48,164/10899,0.03532294460370829,0.16664118571867087,0.13123075394566547,FURIN/NFKB1/MYO1C,3
R-HSA-9772573,Late SARS-CoV-2 Infection Events,2/48,70/10899,0.03794087539911082,0.17691036087259815,0.13931777992329555,FURIN/ST3GAL1,2
R-HSA-448424,Interleukin-17 signaling,2/48,72/10899,0.03993490110163921,0.18406776254893478,0.14495426897146718,NFKB1/IRAK1,2
R-HSA-1250342,PI3K events in ERBB4 signaling,1/48,10/10899,0.04319558111350985,0.18824483717829296,0.14824373580125444,PIK3CA,1
R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,1/48,10/10899,0.04319558111350985,0.18824483717829296,0.14824373580125444,FURIN,1
R-HSA-8875656,MET receptor recycling,1/48,10/10899,0.04319558111350985,0.18824483717829296,0.14824373580125444,HGF,1
R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,1/48,10/10899,0.04319558111350985,0.18824483717829296,0.14824373580125444,PIM1,1
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",2/48,76/10899,0.044039685926726406,0.18824483717829296,0.14824373580125444,SQSTM1/AKAP13,2
R-HSA-9009391,Extra-nuclear estrogen signaling,2/48,77/10899,0.04508961310678579,0.18824483717829296,0.14824373580125444,ZDHHC7/PIK3CA,2
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,2/48,78/10899,0.04614883357569983,0.18824483717829296,0.14824373580125444,PIK3CA/HGF,2
R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,FURIN,1
R-HSA-193692,Regulated proteolysis of p75NTR,1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,NFKB1,1
R-HSA-196780,Biotin transport and metabolism,1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,HLCS,1
R-HSA-5655291,Signaling by FGFR4 in disease,1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,PIK3CA,1
R-HSA-8851805,MET activates RAS signaling,1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,HGF,1
R-HSA-8875555,MET activates RAP1 and RAC1,1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,HGF,1
R-HSA-9664873,Pexophagy,1/48,11/10899,0.04741328816710122,0.18824483717829296,0.14824373580125444,SQSTM1,1
R-HSA-430116,GP1b-IX-V activation signalling,1/48,12/10899,0.051612788733594206,0.19342736712309605,0.1523250036407109,FLNA,1
R-HSA-9020558,Interleukin-2 signaling,1/48,12/10899,0.051612788733594206,0.19342736712309605,0.1523250036407109,IL2RB,1
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),1/48,12/10899,0.051612788733594206,0.19342736712309605,0.1523250036407109,PIK3CA,1
R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",1/48,12/10899,0.051612788733594206,0.19342736712309605,0.1523250036407109,PIK3CA,1
R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,1/48,12/10899,0.051612788733594206,0.19342736712309605,0.1523250036407109,PIK3CA,1
R-HSA-9700645,ALK mutants bind TKIs,1/48,12/10899,0.051612788733594206,0.19342736712309605,0.1523250036407109,FN1,1
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,2/48,86/10899,0.05494548474620731,0.20339507323200637,0.1601746212615879,MYO1C/PIK3CA,2
R-HSA-5210891,Uptake and function of anthrax toxins,1/48,13/10899,0.05579415973945312,0.20339507323200637,0.1601746212615879,FURIN,1
R-HSA-9733458,Induction of Cell-Cell Fusion,1/48,13/10899,0.05579415973945312,0.20339507323200637,0.1601746212615879,FURIN,1
R-HSA-9013404,RAC2 GTPase cycle,2/48,88/10899,0.05723084311489151,0.20571679863273223,0.16200299144197314,GIT2/PIK3CA,2
R-HSA-8849471,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",1/48,14/10899,0.05995747779314686,0.20571679863273223,0.16200299144197314,PXN,1
R-HSA-8983432,Interleukin-15 signaling,1/48,14/10899,0.05995747779314686,0.20571679863273223,0.16200299144197314,IL2RB,1
R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,1/48,14/10899,0.05995747779314686,0.20571679863273223,0.16200299144197314,IRAK1,1
R-HSA-446728,Cell junction organization,2/48,91/10899,0.060720501127246695,0.20571679863273223,0.16200299144197314,PXN/FLNA,2
R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,1/48,15/10899,0.06410281918643379,0.20571679863273223,0.16200299144197314,DKK1,1
R-HSA-4419969,Depolymerisation of the Nuclear Lamina,1/48,15/10899,0.06410281918643379,0.20571679863273223,0.16200299144197314,LMNA,1
R-HSA-5637810,Constitutive Signaling by EGFRvIII,1/48,15/10899,0.06410281918643379,0.20571679863273223,0.16200299144197314,PIK3CA,1
R-HSA-5637812,Signaling by EGFRvIII in Cancer,1/48,15/10899,0.06410281918643379,0.20571679863273223,0.16200299144197314,PIK3CA,1
R-HSA-937039,IRAK1 recruits IKK complex,1/48,15/10899,0.06410281918643379,0.20571679863273223,0.16200299144197314,IRAK1,1
R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,1/48,15/10899,0.06410281918643379,0.20571679863273223,0.16200299144197314,IRAK1,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/48,97/10899,0.06791272329363195,0.20571679863273223,0.16200299144197314,NFKB1/IRAK1,2
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/48,97/10899,0.06791272329363195,0.20571679863273223,0.16200299144197314,NFKB1/IRAK1,2
R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/48,97/10899,0.06791272329363195,0.20571679863273223,0.16200299144197314,NFKB1/IRAK1,2
R-HSA-175474,Assembly Of The HIV Virion,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,FURIN,1
R-HSA-1834941,STING mediated induction of host immune responses,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,STAT6,1
R-HSA-1963642,PI3K events in ERBB2 signaling,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,PIK3CA,1
R-HSA-205043,NRIF signals cell death from the nucleus,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,SQSTM1,1
R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,PIK3CA,1
R-HSA-399954,Sema3A PAK dependent Axon repulsion,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,PLXNA1,1
R-HSA-399956,CRMPs in Sema3A signaling,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,PLXNA1,1
R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,NFKB1,1
R-HSA-9665348,Signaling by ERBB2 ECD mutants,1/48,16/10899,0.06823025989564435,0.20571679863273223,0.16200299144197314,PIK3CA,1
R-HSA-202424,Downstream TCR signaling,2/48,98/10899,0.06913799503081537,0.20634391788590783,0.1624968509404708,NFKB1/PIK3CA,2
R-HSA-4420097,VEGFA-VEGFR2 Pathway,2/48,99/10899,0.0703706263720084,0.20634391788590783,0.1624968509404708,PXN/PIK3CA,2
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,1/48,17/10899,0.07233987558295607,0.20634391788590783,0.1624968509404708,NFKB1,1
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/48,17/10899,0.07233987558295607,0.20634391788590783,0.1624968509404708,CTF1,1
R-HSA-9034015,Signaling by NTRK3 (TRKC),1/48,17/10899,0.07233987558295607,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/48,103/10899,0.0753730484331447,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,1/48,18/10899,0.07643174159766097,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-1912420,Pre-NOTCH Processing in Golgi,1/48,18/10899,0.07643174159766097,0.20634391788590783,0.1624968509404708,FURIN,1
R-HSA-210993,Tie2 Signaling,1/48,18/10899,0.07643174159766097,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-5654710,PI-3K cascade:FGFR3,1/48,18/10899,0.07643174159766097,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,2/48,104/10899,0.0766412083370366,0.20634391788590783,0.1624968509404708,PIK3CA/HGF,2
R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/48,104/10899,0.0766412083370366,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/48,105/10899,0.07791622408409778,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/48,105/10899,0.07791622408409778,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,LMNA,1
R-HSA-3000480,Scavenging by Class A Receptors,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,COL3A1,1
R-HSA-416700,Other semaphorin interactions,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,PLXNA1,1
R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,FURIN,1
R-HSA-9694614,Attachment and Entry,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,FURIN,1
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,1/48,19/10899,0.08050593297743391,0.20634391788590783,0.1624968509404708,FN1,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/48,108/10899,0.08178158954704143,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-166166,MyD88-independent TLR4 cascade ,2/48,110/10899,0.08439129130997591,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/48,110/10899,0.08439129130997591,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-5654720,PI-3K cascade:FGFR4,1/48,20/10899,0.084562524449592,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-9669938,Signaling by KIT in disease,1/48,20/10899,0.084562524449592,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",1/48,20/10899,0.084562524449592,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-9671555,Signaling by PDGFR in disease,1/48,20/10899,0.084562524449592,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,2/48,113/10899,0.08835344185548952,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,2/48,113/10899,0.08835344185548952,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,1/48,21/10899,0.08860159043234994,0.20634391788590783,0.1624968509404708,NFKB1,1
R-HSA-5621575,CD209 (DC-SIGN) signaling,1/48,21/10899,0.08860159043234994,0.20634391788590783,0.1624968509404708,NFKB1,1
R-HSA-5654689,PI-3K cascade:FGFR1,1/48,21/10899,0.08860159043234994,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-6807004,Negative regulation of MET activity,1/48,21/10899,0.08860159043234994,0.20634391788590783,0.1624968509404708,HGF,1
R-HSA-901032,ER Quality Control Compartment (ERQC),1/48,21/10899,0.08860159043234994,0.20634391788590783,0.1624968509404708,EDEM1,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,2/48,116/10899,0.09237083869368684,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,2/48,116/10899,0.09237083869368684,0.20634391788590783,0.1624968509404708,NFKB1/IRAK1,2
R-HSA-1181150,Signaling by NODAL,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,FURIN,1
R-HSA-3296482,Defects in vitamin and cofactor metabolism,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,HLCS,1
R-HSA-389357,CD28 dependent PI3K/Akt signaling,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-5205685,PINK1-PRKN Mediated Mitophagy,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,SQSTM1,1
R-HSA-5655332,Signaling by FGFR3 in disease,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,LMNA,1
R-HSA-8863678,Neurodegenerative Diseases,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,LMNA,1
R-HSA-912631,Regulation of signaling by CBL,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,PIK3CA,1
R-HSA-9768919,NPAS4 regulates expression of target genes,1/48,22/10899,0.09262320503606836,0.20634391788590783,0.1624968509404708,GEM,1
R-HSA-373753,Nephrin family interactions,1/48,23/10899,0.09662744206450113,0.2117355424473495,0.1667427818196741,PIK3CA,1
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,1/48,23/10899,0.09662744206450113,0.2117355424473495,0.1667427818196741,IRAK1,1
R-HSA-5654695,PI-3K cascade:FGFR2,1/48,23/10899,0.09662744206450113,0.2117355424473495,0.1667427818196741,PIK3CA,1
R-HSA-202403,TCR signaling,2/48,120/10899,0.0978097430246759,0.21316145083095128,0.16786569168994722,NFKB1/PIK3CA,2
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,1/48,24/10899,0.1006143750160371,0.2139704842400907,0.16850280948163068,IRAK1,1
R-HSA-5627123,RHO GTPases activate PAKs,1/48,24/10899,0.1006143750160371,0.2139704842400907,0.16850280948163068,FLNA,1
R-HSA-6783589,Interleukin-6 family signaling,1/48,24/10899,0.1006143750160371,0.2139704842400907,0.16850280948163068,CTF1,1
R-HSA-977068,Termination of O-glycan biosynthesis,1/48,24/10899,0.1006143750160371,0.2139704842400907,0.16850280948163068,ST3GAL1,1
R-HSA-1643713,Signaling by EGFR in Cancer,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,PIK3CA,1
R-HSA-2029485,Role of phospholipids in phagocytosis,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,PIK3CA,1
R-HSA-5654708,Downstream signaling of activated FGFR3,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,PIK3CA,1
R-HSA-9006115,Signaling by NTRK2 (TRKB),1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,PIK3CA,1
R-HSA-9006335,Signaling by Erythropoietin,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,PIK3CA,1
R-HSA-933542,TRAF6 mediated NF-kB activation,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,NFKB1,1
R-HSA-9664565,Signaling by ERBB2 KD Mutants,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,PIK3CA,1
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,1/48,25/10899,0.10458407708493211,0.2139704842400907,0.16850280948163068,LMNA,1
R-HSA-9679506,SARS-CoV Infections,4/48,413/10899,0.1075665046001864,0.21653325913521912,0.17052100732528086,FURIN/ST3GAL1/NFKB1/IRAK1,4
R-HSA-1227990,Signaling by ERBB2 in Cancer,1/48,26/10899,0.10853662116254126,0.21653325913521912,0.17052100732528086,PIK3CA,1
R-HSA-901042,Calnexin/calreticulin cycle,1/48,26/10899,0.10853662116254126,0.21653325913521912,0.17052100732528086,EDEM1,1
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,1/48,26/10899,0.10853662116254126,0.21653325913521912,0.17052100732528086,NFKB1,1
R-HSA-9664424,Cell recruitment (pro-inflammatory response),1/48,26/10899,0.10853662116254126,0.21653325913521912,0.17052100732528086,NFKB1,1
R-HSA-201556,Signaling by ALK,1/48,27/10899,0.1124720798385459,0.2215722494465421,0.17448923699688315,PIK3CA,1
R-HSA-5654716,Downstream signaling of activated FGFR4,1/48,27/10899,0.1124720798385459,0.2215722494465421,0.17448923699688315,PIK3CA,1
R-HSA-1257604,PIP3 activates AKT signaling,3/48,267/10899,0.11272004709998651,0.2215722494465421,0.17448923699688315,PIK3CA/HGF/IRAK1,3
R-HSA-2022854,Keratan sulfate biosynthesis,1/48,28/10899,0.11639052540217276,0.22766472081435274,0.17928708818560396,ST3GAL1,1
R-HSA-166520,Signaling by NTRKs,2/48,134/10899,0.11752268630566338,0.22766472081435274,0.17928708818560396,FURIN/PIK3CA,2
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/48,134/10899,0.11752268630566338,0.22766472081435274,0.17928708818560396,NFKB1/PIK3CA,2
R-HSA-5205647,Mitophagy,1/48,29/10899,0.12029202984341036,0.23079954051295481,0.1817557741275402,SQSTM1,1
R-HSA-9683701,Translation of Structural Proteins,1/48,29/10899,0.12029202984341036,0.23079954051295481,0.1817557741275402,ST3GAL1,1
R-HSA-202733,Cell surface interactions at the vascular wall,2/48,137/10899,0.12187132159129183,0.23271619027670487,0.1832651452500629,FN1/PIK3CA,2
R-HSA-2424491,DAP12 signaling,1/48,30/10899,0.12417666485422141,0.23377860378658585,0.18410180111819335,PIK3CA,1
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,1/48,30/10899,0.12417666485422141,0.23377860378658585,0.18410180111819335,TRAF1,1
R-HSA-5654696,Downstream signaling of activated FGFR2,1/48,30/10899,0.12417666485422141,0.23377860378658585,0.18410180111819335,PIK3CA,1
R-HSA-9678108,SARS-CoV-1 Infection,2/48,141/10899,0.12773123575150364,0.23445591430926485,0.18463518648846164,ST3GAL1/NFKB1,2
R-HSA-1839124,FGFR1 mutant receptor activation,1/48,31/10899,0.12804450182974814,0.23445591430926485,0.18463518648846164,PIK3CA,1
R-HSA-5260271,Diseases of Immune System,1/48,31/10899,0.12804450182974814,0.23445591430926485,0.18463518648846164,NFKB1,1
R-HSA-5339562,Uptake and actions of bacterial toxins,1/48,31/10899,0.12804450182974814,0.23445591430926485,0.18463518648846164,FURIN,1
R-HSA-5602358,Diseases associated with the TLR signaling cascade,1/48,31/10899,0.12804450182974814,0.23445591430926485,0.18463518648846164,NFKB1,1
R-HSA-5654687,Downstream signaling of activated FGFR1,1/48,31/10899,0.12804450182974814,0.23445591430926485,0.18463518648846164,PIK3CA,1
R-HSA-9012999,RHO GTPase cycle,4/48,449/10899,0.13450529758681087,0.24190113945434075,0.19049833793490545,GIT2/AKAP13/PIK3CA/PLXNA1,4
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,2/48,146/10899,0.13514957403839914,0.24190113945434075,0.19049833793490545,NFKB1/IRAK1,2
R-HSA-1592389,Activation of Matrix Metalloproteinases,1/48,33/10899,0.13573006577862012,0.24190113945434075,0.19049833793490545,FURIN,1
R-HSA-389356,CD28 co-stimulation,1/48,33/10899,0.13573006577862012,0.24190113945434075,0.19049833793490545,PIK3CA,1
R-HSA-4085001,Sialic acid metabolism,1/48,33/10899,0.13573006577862012,0.24190113945434075,0.19049833793490545,ST3GAL1,1
R-HSA-8963899,Plasma lipoprotein remodeling,1/48,33/10899,0.13573006577862012,0.24190113945434075,0.19049833793490545,FURIN,1
R-HSA-1638074,Keratan sulfate/keratin metabolism,1/48,34/10899,0.13954793406894106,0.24543298930546212,0.19327968707609566,ST3GAL1,1
R-HSA-4791275,Signaling by WNT in cancer,1/48,34/10899,0.13954793406894106,0.24543298930546212,0.19327968707609566,DKK1,1
R-HSA-9634815,Transcriptional Regulation by NPAS4,1/48,34/10899,0.13954793406894106,0.24543298930546212,0.19327968707609566,GEM,1
R-HSA-9694516,SARS-CoV-2 Infection,3/48,298/10899,0.14314417753071537,0.248844433208152,0.19596621594026933,FURIN/ST3GAL1/IRAK1,3
R-HSA-114604,GPVI-mediated activation cascade,1/48,35/10899,0.14334928696030702,0.248844433208152,0.19596621594026933,PIK3CA,1
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,1/48,35/10899,0.14334928696030702,0.248844433208152,0.19596621594026933,EDEM1,1
R-HSA-1266695,Interleukin-7 signaling,1/48,36/10899,0.14713419438169006,0.25322236887149235,0.19941386182293663,HGF,1
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/48,36/10899,0.14713419438169006,0.25322236887149235,0.19941386182293663,FURIN,1
R-HSA-168638,NOD1/2 Signaling Pathway,1/48,37/10899,0.15090272597238108,0.25733043727945576,0.20264898591373337,IRAK1,1
R-HSA-9694548,Maturation of spike protein,1/48,37/10899,0.15090272597238108,0.25733043727945576,0.20264898591373337,ST3GAL1,1
R-HSA-9006925,Intracellular signaling by second messengers,3/48,309/10899,0.15455277740388482,0.25733043727945576,0.20264898591373337,PIK3CA/HGF/IRAK1,3
R-HSA-111465,Apoptotic cleavage of cellular proteins,1/48,38/10899,0.15465495108316418,0.25733043727945576,0.20264898591373337,LMNA,1
R-HSA-5655302,Signaling by FGFR1 in disease,1/48,38/10899,0.15465495108316418,0.25733043727945576,0.20264898591373337,PIK3CA,1
R-HSA-9013424,RHOV GTPase cycle,1/48,38/10899,0.15465495108316418,0.25733043727945576,0.20264898591373337,GIT2,1
R-HSA-9607240,FLT3 Signaling,1/48,38/10899,0.15465495108316418,0.25733043727945576,0.20264898591373337,PIK3CA,1
R-HSA-9772572,Early SARS-CoV-2 Infection Events,1/48,38/10899,0.15465495108316418,0.25733043727945576,0.20264898591373337,FURIN,1
R-HSA-5689896,Ovarian tumor domain proteases,1/48,39/10899,0.1583909387774841,0.2610699353047273,0.20559385901409152,TNIP1,1
R-HSA-8853884,Transcriptional Regulation by VENTX,1/48,39/10899,0.1583909387774841,0.2610699353047273,0.20559385901409152,NFKB1,1
R-HSA-6798695,Neutrophil degranulation,4/48,482/10899,0.16142469889144462,0.2610699353047273,0.20559385901409152,DNAJC3/NFKB1/VCL/MANBA,4
R-HSA-5357905,Regulation of TNFR1 signaling,1/48,40/10899,0.1621107578326112,0.2610699353047273,0.20559385901409152,TRAF1,1
R-HSA-5654741,Signaling by FGFR3,1/48,40/10899,0.1621107578326112,0.2610699353047273,0.20559385901409152,PIK3CA,1
R-HSA-8853659,RET signaling,1/48,40/10899,0.1621107578326112,0.2610699353047273,0.20559385901409152,PIK3CA,1
R-HSA-9013420,RHOU GTPase cycle,1/48,40/10899,0.1621107578326112,0.2610699353047273,0.20559385901409152,GIT2,1
R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,1/48,40/10899,0.1621107578326112,0.2610699353047273,0.20559385901409152,NFKB1,1
R-HSA-5654743,Signaling by FGFR4,1/48,41/10899,0.1658144767408014,0.26490679351817276,0.20861540374183443,PIK3CA,1
R-HSA-5696400,Dual Incision in GG-NER,1/48,41/10899,0.1658144767408014,0.26490679351817276,0.20861540374183443,CHD1L,1
R-HSA-168898,Toll-like Receptor Cascades,2/48,168/10899,0.16883863647734593,0.2665504613642758,0.2099098002606188,NFKB1/IRAK1,2
R-HSA-163841,"Gamma carboxylation, hypusine formation and arylsulfatase activation",1/48,42/10899,0.16950216371044968,0.2665504613642758,0.2099098002606188,FURIN,1
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,1/48,42/10899,0.16950216371044968,0.2665504613642758,0.2099098002606188,COL3A1,1
R-HSA-9696273,RND1 GTPase cycle,1/48,42/10899,0.16950216371044968,0.2665504613642758,0.2099098002606188,PLXNA1,1
R-HSA-1433557,Signaling by SCF-KIT,1/48,43/10899,0.17317388666724243,0.269157862610714,0.21196314157557214,PIK3CA,1
R-HSA-5655253,Signaling by FGFR2 in disease,1/48,43/10899,0.17317388666724243,0.269157862610714,0.21196314157557214,PIK3CA,1
R-HSA-5696395,Formation of Incision Complex in GG-NER,1/48,43/10899,0.17317388666724243,0.269157862610714,0.21196314157557214,CHD1L,1
R-HSA-109704,PI3K Cascade,1/48,44/10899,0.1768297132553016,0.2727258269822152,0.21477293107931372,PIK3CA,1
R-HSA-6811438,Intra-Golgi traffic,1/48,44/10899,0.1768297132553016,0.2727258269822152,0.21477293107931372,RAB36,1
R-HSA-2172127,DAP12 interactions,1/48,45/10899,0.18046971083832752,0.2762150917792723,0.21752074428082868,PIK3CA,1
R-HSA-9634597,GPER1 signaling,1/48,45/10899,0.18046971083832752,0.2762150917792723,0.21752074428082868,FN1,1
R-HSA-112399,IRS-mediated signalling,1/48,48/10899,0.19129539901170678,0.2916709315729826,0.22969229419056247,PIK3CA,1
R-HSA-6811440,Retrograde transport at the Trans-Golgi-Network,1/48,49/10899,0.1948727486428412,0.29488291398407296,0.23222174614837085,TGOLN2,1
R-HSA-75893,TNF signaling,1/48,49/10899,0.1948727486428412,0.29488291398407296,0.23222174614837085,TRAF1,1
R-HSA-9013149,RAC1 GTPase cycle,2/48,185/10899,0.19577251125034392,0.2951307406443155,0.23241691086309135,GIT2/PIK3CA,2
R-HSA-1227986,Signaling by ERBB2,1/48,50/10899,0.19843460192073437,0.2969114752619943,0.23381924813912142,PIK3CA,1
R-HSA-5654736,Signaling by FGFR1,1/48,50/10899,0.19843460192073437,0.2969114752619943,0.23381924813912142,PIK3CA,1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/48,51/10899,0.20198102455026723,0.3010943897570898,0.23711331389192006,FURIN,1
R-HSA-2428928,IRS-related events triggered by IGF1R,1/48,52/10899,0.20551208196376214,0.30297920907157583,0.23859761837898083,PIK3CA,1
R-HSA-2980766,Nuclear Envelope Breakdown,1/48,52/10899,0.20551208196376214,0.30297920907157583,0.23859761837898083,LMNA,1
R-HSA-75153,Apoptotic execution phase,1/48,52/10899,0.20551208196376214,0.30297920907157583,0.23859761837898083,LMNA,1
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,1/48,53/10899,0.20902783932208602,0.30437097488506426,0.23969364080724315,PIK3CA,1
R-HSA-2428924,IGF1R signaling cascade,1/48,53/10899,0.20902783932208602,0.30437097488506426,0.23969364080724315,PIK3CA,1
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/48,54/10899,0.2125283615157556,0.30437097488506426,0.23969364080724315,PIK3CA,1
R-HSA-74751,Insulin receptor signalling cascade,1/48,54/10899,0.2125283615157556,0.30437097488506426,0.23969364080724315,PIK3CA,1
R-HSA-8848021,Signaling by PTK6,1/48,54/10899,0.2125283615157556,0.30437097488506426,0.23969364080724315,PXN,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/48,54/10899,0.2125283615157556,0.30437097488506426,0.23969364080724315,PXN,1
R-HSA-9013405,RHOD GTPase cycle,1/48,54/10899,0.2125283615157556,0.30437097488506426,0.23969364080724315,PLXNA1,1
R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,1/48,54/10899,0.2125283615157556,0.30437097488506426,0.23969364080724315,MYO1C,1
R-HSA-9013409,RHOJ GTPase cycle,1/48,55/10899,0.21601371316603124,0.3082615622049058,0.24275749747072253,GIT2,1
R-HSA-432722,Golgi Associated Vesicle Biogenesis,1/48,56/10899,0.2194839586260121,0.31210307591854913,0.24578270842778513,TGOLN2,1
R-HSA-9694635,Translation of Structural Proteins,1/48,57/10899,0.22293916198172092,0.3151889579990145,0.24821285575457236,ST3GAL1,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,2/48,202/10899,0.22322609494194542,0.3151889579990145,0.24821285575457236,TGOLN2/RAB36,2
R-HSA-1236394,Signaling by ERBB4,1/48,58/10899,0.22637938705319083,0.3166724524247868,0.24938111491648784,PIK3CA,1
R-HSA-193648,NRAGE signals death through JNK,1/48,59/10899,0.22980469739554354,0.3166724524247868,0.24938111491648784,AKAP13,1
R-HSA-5387390,Hh mutants abrogate ligand secretion,1/48,59/10899,0.22980469739554354,0.3166724524247868,0.24938111491648784,HHAT,1
R-HSA-9013406,RHOQ GTPase cycle,1/48,59/10899,0.22980469739554354,0.3166724524247868,0.24938111491648784,GIT2,1
R-HSA-9664407,Parasite infection,1/48,59/10899,0.22980469739554354,0.3166724524247868,0.24938111491648784,MYO1C,1
R-HSA-9664417,Leishmania phagocytosis,1/48,59/10899,0.22980469739554354,0.3166724524247868,0.24938111491648784,MYO1C,1
R-HSA-9664422,FCGR3A-mediated phagocytosis,1/48,59/10899,0.22980469739554354,0.3166724524247868,0.24938111491648784,MYO1C,1
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/48,61/10899,0.23661082679527679,0.3249347313181712,0.2558877002111861,MYO1C,1
R-HSA-8986944,Transcriptional Regulation by MECP2,1/48,62/10899,0.23999177164800123,0.32845290249436343,0.2586582773285445,IRAK1,1
R-HSA-1226099,Signaling by FGFR in disease,1/48,63/10899,0.24335805336442617,0.33080196406486406,0.2605081748771734,PIK3CA,1
R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,1/48,63/10899,0.24335805336442617,0.33080196406486406,0.2605081748771734,ST3GAL1,1
R-HSA-5358346,Hedgehog ligand biogenesis,1/48,65/10899,0.2500468761162954,0.33760537819068837,0.2658658969870233,HHAT,1
R-HSA-8873719,RAB geranylgeranylation,1/48,65/10899,0.2500468761162954,0.33760537819068837,0.2658658969870233,RAB36,1
R-HSA-1169091,Activation of NF-kappaB in B cells,1/48,67/10899,0.25667778992778645,0.34539528107732337,0.27200048385141623,NFKB1,1
R-HSA-8939211,ESR-mediated signaling,2/48,223/10899,0.2575457499538048,0.3454041663260058,0.272007481028486,ZDHHC7/PIK3CA,2
R-HSA-388841,Costimulation by the CD28 family,1/48,69/10899,0.26325128557292943,0.35071018443436774,0.27618599640454217,PIK3CA,1
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,1/48,69/10899,0.26325128557292943,0.35071018443436774,0.27618599640454217,MYO1C,1
R-HSA-9013026,RHOB GTPase cycle,1/48,70/10899,0.2665166538363182,0.3538846959879589,0.27868593987764184,AKAP13,1
R-HSA-3214841,PKMTs methylate histone lysines,1/48,71/10899,0.26976784975614987,0.3570194975320663,0.2811546115228242,NFKB1,1
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,1/48,72/10899,0.2730049335400162,0.35893435524441475,0.28266257139604783,MYO1C,1
R-HSA-199992,trans-Golgi Network Vesicle Budding,1/48,72/10899,0.2730049335400162,0.35893435524441475,0.28266257139604783,TGOLN2,1
R-HSA-5654738,Signaling by FGFR2,1/48,73/10899,0.2762279651452695,0.36198501314788584,0.28506497951008203,PIK3CA,1
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",1/48,74/10899,0.27943700428004004,0.3638124633645976,0.28650410555028033,FURIN,1
R-HSA-9013106,RHOC GTPase cycle,1/48,74/10899,0.27943700428004004,0.3638124633645976,0.28650410555028033,AKAP13,1
R-HSA-2995410,Nuclear Envelope (NE) Reassembly,1/48,75/10899,0.28263211040424885,0.3667814766087501,0.28884221809325383,LMNA,1
R-HSA-8951664,Neddylation,2/48,240/10899,0.28543909756169883,0.3685245994693793,0.29021493592548575,SQSTM1/KLHL21,2
R-HSA-9659379,Sensory processing of sound,1/48,76/10899,0.28581334273061587,0.3685245994693793,0.29021493592548575,MYO1C,1
R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",1/48,78/10899,0.2921344216107309,0.3735174401594321,0.2941468225431937,ST3GAL1,1
R-HSA-1221632,Meiotic synapsis,1/48,79/10899,0.2952743853629426,0.3735174401594321,0.2941468225431937,LMNA,1
R-HSA-74752,Signaling by Insulin receptor,1/48,79/10899,0.2952743853629426,0.3735174401594321,0.2941468225431937,PIK3CA,1
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,1/48,79/10899,0.2952743853629426,0.3735174401594321,0.2941468225431937,FURIN,1
R-HSA-9664433,Leishmania parasite growth and survival,1/48,79/10899,0.2952743853629426,0.3735174401594321,0.2941468225431937,FURIN,1
R-HSA-9759194,Nuclear events mediated by NFE2L2,1/48,79/10899,0.2952743853629426,0.3735174401594321,0.2941468225431937,SQSTM1,1
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,1/48,80/10899,0.2984007097162311,0.37510559434548174,0.295397501781453,FLNA,1
R-HSA-416482,G alpha (12/13) signalling events,1/48,80/10899,0.2984007097162311,0.37510559434548174,0.295397501781453,AKAP13,1
R-HSA-9663891,Selective autophagy,1/48,81/10899,0.3015134526623089,0.37783404536745585,0.2975461703904364,SQSTM1,1
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/48,82/10899,0.3046126719516612,0.3793468368093669,0.2987375010967583,NFKB1,1
R-HSA-2871837,FCERI mediated NF-kB activation,1/48,82/10899,0.3046126719516612,0.3793468368093669,0.2987375010967583,NFKB1,1
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),1/48,83/10899,0.30769842509452117,0.3820033079346841,0.3008294851828462,NFKB1,1
R-HSA-1483255,PI Metabolism,1/48,84/10899,0.31077076936185344,0.38226711200645164,0.3010372321877818,PIK3CA,1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/48,84/10899,0.31077076936185344,0.38226711200645164,0.3010372321877818,NFKB1,1
R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),1/48,84/10899,0.31077076936185344,0.38226711200645164,0.3010372321877818,CHD1L,1
R-HSA-190236,Signaling by FGFR,1/48,87/10899,0.3199079180516551,0.39230298207557707,0.3089405292628248,PIK3CA,1
R-HSA-192823,Viral mRNA Translation,1/48,89/10899,0.3259333454226284,0.39847338876364025,0.3137997548998348,DNAJC3,1
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,1/48,91/10899,0.33190649168023667,0.40454256280782647,0.3185792593315342,MYO1C,1
R-HSA-9013423,RAC3 GTPase cycle,1/48,94/10899,0.3407691543511985,0.4140861542267593,0.3260948845466014,GIT2,1
R-HSA-9692914,SARS-CoV-1-host interactions,1/48,95/10899,0.343697713406371,0.416383030440951,0.32790368587028557,NFKB1,1
R-HSA-9679191,Potential therapeutics for SARS,1/48,99/10899,0.35528509160775257,0.4291244630563517,0.3379376267670443,FURIN,1
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/48,101/10899,0.3610034198442196,0.43472183590850466,0.3423455854378564,NFKB1,1
R-HSA-9755511,KEAP1-NFE2L2 pathway,1/48,102/10899,0.3638439306654344,0.43683058741568626,0.3440062376288381,SQSTM1,1
R-HSA-1236975,Antigen processing-Cross presentation,1/48,105/10899,0.3722914841471968,0.44368207393350195,0.349401816983989,ITGB5,1
R-HSA-9645723,Diseases of programmed cell death,1/48,105/10899,0.3722914841471968,0.44368207393350195,0.349401816983989,LMNA,1
R-HSA-71387,Metabolism of carbohydrates,2/48,295/10899,0.3745561850947875,0.44368207393350195,0.349401816983989,ST3GAL1/MANBA,2
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,1/48,106/10899,0.37508285053231216,0.44368207393350195,0.349401816983989,MYO1C,1
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/48,106/10899,0.37508285053231216,0.44368207393350195,0.349401816983989,TGOLN2,1
R-HSA-9006931,Signaling by Nuclear Receptors,2/48,299/10899,0.3808994265372023,0.4492372648277004,0.35377655715529627,ZDHHC7/PIK3CA,2
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/48,109/10899,0.3833842237694819,0.45084185845032915,0.355040182530775,FURIN,1
R-HSA-446203,Asparagine N-linked glycosylation,2/48,304/10899,0.38879278434819675,0.45329131283994445,0.35696913991858076,ST3GAL1/EDEM1,2
R-HSA-5696398,Nucleotide Excision Repair,1/48,111/10899,0.3888583830846406,0.45329131283994445,0.35696913991858076,CHD1L,1
R-HSA-977225,Amyloid fiber formation,1/48,111/10899,0.3888583830846406,0.45329131283994445,0.35696913991858076,FURIN,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),1/48,112/10899,0.39157758938904696,0.45382258192198793,0.3573875169355464,NFKB1,1
R-HSA-983705,Signaling by the B Cell Receptor (BCR),1/48,112/10899,0.39157758938904696,0.45382258192198793,0.3573875169355464,NFKB1,1
R-HSA-187037,Signaling by NTRK1 (TRKA),1/48,115/10899,0.3996643231398871,0.4618599238590626,0.3637169632700323,PIK3CA,1
R-HSA-1500620,Meiosis,1/48,118/10899,0.40764578362345305,0.469729767910933,0.3699145041955109,LMNA,1
R-HSA-373760,L1CAM interactions,1/48,119/10899,0.4102831087682516,0.47141411637842084,0.3712409369038621,NRP2,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/48,124/10899,0.42329823470913674,0.48359712854234715,0.3808351189465918,ST3GAL1,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/48,124/10899,0.42329823470913674,0.48359712854234715,0.3808351189465918,HLCS,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/48,126/10899,0.4284251592720071,0.48806388882975804,0.3843527146579011,IRAK1,1
R-HSA-6809371,Formation of the cornified envelope,1/48,130/10899,0.43854547639040775,0.49817772247182296,0.3923174084303633,FURIN,1
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1/48,134/10899,0.4484902712433877,0.5078561738853257,0.3999392365549224,COL3A1,1
R-HSA-168273,Influenza Viral RNA Transcription and Replication,1/48,135/10899,0.4509493949758834,0.5078561738853257,0.3999392365549224,DNAJC3,1
R-HSA-9609690,HCMV Early Events,1/48,135/10899,0.4509493949758834,0.5078561738853257,0.3999392365549224,NFKB1,1
R-HSA-162599,Late Phase of HIV Life Cycle,1/48,136/10899,0.4533977811744304,0.5078561738853257,0.3999392365549224,FURIN,1
R-HSA-1632852,Macroautophagy,1/48,136/10899,0.4533977811744304,0.5078561738853257,0.3999392365549224,SQSTM1,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/48,142/10899,0.4678651666694421,0.5211498106512397,0.4104080409381071,NFKB1,1
R-HSA-68875,Mitotic Prophase,1/48,142/10899,0.4678651666694421,0.5211498106512397,0.4104080409381071,LMNA,1
R-HSA-1474165,Reproduction,1/48,143/10899,0.4702396643918433,0.5223437823299977,0.4113482995117451,LMNA,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/48,146/10899,0.47730108048182773,0.5287230200917484,0.4163719806471309,TGOLN2,1
R-HSA-8980692,RHOA GTPase cycle,1/48,147/10899,0.4796343407940079,0.5298439963041244,0.4172547549317164,AKAP13,1
R-HSA-162587,HIV Life Cycle,1/48,149/10899,0.48427030705722307,0.5305803090982143,0.4178346048811243,FURIN,1
R-HSA-212165,Epigenetic regulation of gene expression,1/48,149/10899,0.48427030705722307,0.5305803090982143,0.4178346048811243,MYO1C,1
R-HSA-5358351,Signaling by Hedgehog,1/48,149/10899,0.48427030705722307,0.5305803090982143,0.4178346048811243,HHAT,1
R-HSA-9612973,Autophagy,1/48,151/10899,0.48886582419027513,0.5341558460498647,0.42065035782900484,SQSTM1,1
R-HSA-9013148,CDC42 GTPase cycle,1/48,155/10899,0.4979368900855572,0.5425888394682294,0.427291381652366,GIT2,1
R-HSA-168255,Influenza Infection,1/48,156/10899,0.5001799121700596,0.5435559479138047,0.42805298431327315,DNAJC3,1
R-HSA-418555,G alpha (s) signalling events,1/48,157/10899,0.5024131211634354,0.5445071934771286,0.42880209487633175,FN1,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/48,381/10899,0.5041100687822592,0.5448736862040052,0.42909070970258967,ITGB5/KLHL21,2
R-HSA-9609646,HCMV Infection,1/48,160/10899,0.5090542889389935,0.5487386286681085,0.4321343709159538,NFKB1,1
R-HSA-109581,Apoptosis,1/48,180/10899,0.5511629765895805,0.5925371410520691,0.4666259149904731,LMNA,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/48,190/10899,0.570869920287536,0.6120824546398448,0.48201794564103806,HLCS,1
R-HSA-9711123,Cellular response to chemical stress,1/48,194/10899,0.578513216893958,0.6186234665986057,0.4871690247528067,SQSTM1,1
R-HSA-2559583,Cellular Senescence,1/48,197/10899,0.584158053694488,0.6229983498177917,0.49061426682067866,NFKB1,1
R-HSA-913531,Interferon Signaling,1/48,200/10899,0.5897288453215751,0.6272712651828956,0.4939792087015846,FLNA,1
R-HSA-375276,Peptide ligand-binding receptors,1/48,201/10899,0.5915694860753429,0.6275644548047951,0.4942100969718821,HEBP1,1
R-HSA-9705683,SARS-CoV-2-host interactions,1/48,202/10899,0.5934020402600865,0.6278475412778223,0.4944330289627162,IRAK1,1
R-HSA-5357801,Programmed Cell Death,1/48,210/10899,0.6077754996135145,0.6413630930132088,0.5050765924766049,LMNA,1
R-HSA-1483257,Phospholipid metabolism,1/48,212/10899,0.6112903992425794,0.6433791341109564,0.5066642347638454,PIK3CA,1
R-HSA-6805567,Keratinization,1/48,214/10899,0.6147744507380373,0.6453522375548507,0.5082180634373413,FURIN,1
R-HSA-416476,G alpha (q) signalling events,1/48,216/10899,0.6182279191243628,0.6472830171510953,0.5097385618724992,PIK3CA,1
R-HSA-162906,HIV Infection,1/48,231/10899,0.643180262304639,0.6716543885004173,0.5289311367636834,FURIN,1
R-HSA-201681,TCF dependent signaling in response to WNT,1/48,233/10899,0.6463841646108365,0.673246883140118,0.5301852341305562,DKK1,1
R-HSA-157118,Signaling by NOTCH,1/48,236/10899,0.6511372678029584,0.6745767620157503,0.5312325202906552,FURIN,1
R-HSA-68882,Mitotic Anaphase,1/48,236/10899,0.6511372678029584,0.6745767620157503,0.5312325202906552,LMNA,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/48,237/10899,0.6527076899304516,0.6745767620157503,0.5312325202906552,LMNA,1
R-HSA-5668914,Diseases of metabolism,1/48,249/10899,0.6710212381030412,0.691721122054806,0.5447337882043359,HLCS,1
R-HSA-3247509,Chromatin modifying enzymes,1/48,274/10899,0.7061895812027112,0.7242506958114763,0.5703509876452104,NFKB1,1
R-HSA-4839726,Chromatin organization,1/48,274/10899,0.7061895812027112,0.7242506958114763,0.5703509876452104,NFKB1,1
R-HSA-5688426,Deubiquitination,1/48,298/10899,0.7364751985834526,0.753384067938685,0.5932936615870993,TNIP1,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/48,309/10899,0.7493132504395199,0.76456644637722,0.6020998396460586,KLHL21,1
R-HSA-418594,G alpha (i) signalling events,1/48,318/10899,0.7593598334877003,0.7728509980420503,0.608623964857895,HEBP1,1
R-HSA-195258,RHO GTPase Effectors,1/48,327/10899,0.7690118447980605,0.7806930373772716,0.6147996094321603,FLNA,1
R-HSA-195721,Signaling by WNT,1/48,332/10899,0.774209190317209,0.7839845588818202,0.617391698817551,DKK1,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/48,335/10899,0.7772724492641743,0.7841509296913585,0.6175227166489239,HEBP1,1
R-HSA-73894,DNA Repair,1/48,336/10899,0.7782844638831936,0.7841509296913585,0.6175227166489239,CHD1L,1
R-HSA-112316,Neuronal System,1/48,410/10899,0.8419062811482994,0.8461263627580654,0.6663286752261965,PANX1,1
R-HSA-68886,M Phase,1/48,418/10899,0.8476040708912945,0.8497230810685227,0.6691611085983905,LMNA,1
R-HSA-500792,GPCR ligand binding,1/48,467/10899,0.878362828839767,0.878362828839767,0.6917150509303849,HEBP1,1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,11/39,200/4383,7.395462212606861e-7,2.2186386637820583e-5,1.9461742664754898e-5,CCN1/COL3A1/FN1/FBN1/PRRX1/FLNA/PDLIM4/ITGB5/DKK1/GEM/PLOD2,11
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,7/39,199/4383,0.00159371174555102,0.01640776358915622,0.014392775078207212,TRAF1/PIM1/AHNAK/COL6A1/FURIN/MYO1C/IL2RB,7
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,7/39,200/4383,0.0016407763589156219,0.01640776358915622,0.014392775078207212,SQSTM1/TRAF1/CCN1/NFKB1/GEM/PANX1/TNIP1,7
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,6/39,200/4383,0.007744031906446291,0.05808023929834718,0.05094757833188349,CTF1/COL3A1/MYO1C/FLII/ITGB5/COL15A1,6
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,4/39,144/4383,0.0377316599602366,0.2263899597614196,0.19858768400124524,CCN1/COL3A1/NFKB1/GCNT1,4
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,4/39,161/4383,0.05321167315239703,0.26605836576198516,0.23338453137016238,SQSTM1/DNAJC3/LMNA/HGF,4
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,4/39,199/4383,0.09859594198270871,0.37493352078440617,0.32888905331965457,PXN/VCL/AKAP13/FLNA,4
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,4/39,200/4383,0.09998227220917498,0.37493352078440617,0.32888905331965457,FLNA/GCNT1/ELF4/IL2RB,4
HALLMARK_COAGULATION,HALLMARK_COAGULATION,3/39,138/4383,0.123056501132124,0.41018833710708,0.35981433079568426,FURIN/FN1/FBN1,3
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,3/39,200/4383,0.26215085030794005,0.5176300567283472,0.45406145327048,TRAF1/VCL/FBN1,3
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,3/39,200/4383,0.26215085030794005,0.5176300567283472,0.45406145327048,PIM1/FN1/PIK3CA,3
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,3/39,200/4383,0.26215085030794005,0.5176300567283472,0.45406145327048,PIM1/NFKB1/IL2RB,3
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,3/39,200/4383,0.26215085030794005,0.5176300567283472,0.45406145327048,SQSTM1/EDEM1/PLOD2,3
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,2/39,113/4383,0.2662249518486477,0.5176300567283472,0.45406145327048,DNAJC3/EDEM1,2
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,1/39,36/4383,0.2760693635884518,0.5176300567283472,0.45406145327048,COL3A1,1
HALLMARK_HEDGEHOG_SIGNALING,HALLMARK_HEDGEHOG_SIGNALING,1/39,36/4383,0.2760693635884518,0.5176300567283472,0.45406145327048,NRP2,1
HALLMARK_WNT_BETA_CATENIN_SIGNALING,HALLMARK_WNT_BETA_CATENIN_SIGNALING,1/39,42/4383,0.31419648841310144,0.544108671422852,0.4772883082656596,DKK1,1
HALLMARK_APICAL_SURFACE,HALLMARK_APICAL_SURFACE,1/39,44/4383,0.32646520285371117,0.544108671422852,0.4772883082656596,IL2RB,1
HALLMARK_TGF_BETA_SIGNALING,HALLMARK_TGF_BETA_SIGNALING,1/39,54/4383,0.38467128662891426,0.6073757157298646,0.5327857155525129,FURIN,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,2/39,158/4383,0.4133384226329466,0.6200076339494199,0.5438663455696666,SQSTM1/FURIN,2
HALLMARK_CHOLESTEROL_HOMEOSTASIS,HALLMARK_CHOLESTEROL_HOMEOSTASIS,1/39,74/4383,0.4867517225344239,0.6528520750794385,0.5726772588416128,ANXA13,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,2/39,200/4383,0.5375452374396263,0.6528520750794385,0.5726772588416128,PIM1/CCN1,2
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,2/39,200/4383,0.5375452374396263,0.6528520750794385,0.5726772588416128,NFKB1/IL2RB,2
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,2/39,200/4383,0.5375452374396263,0.6528520750794385,0.5726772588416128,TRAF1/PRRX1,2
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,1/39,87/4383,0.5440433958995321,0.6528520750794385,0.5726772588416128,PIM1,1
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/39,105/4383,0.6131966590568234,0.707534606604027,0.6206443917579185,SQSTM1,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7364253566556698,COL15A1,1
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7364253566556698,PLOD2,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7364253566556698,HEBP1,1
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,1/39,200/4383,0.8395249065874635,0.8395249065874635,0.7364253566556698,IRAK1,1
PID_AVB3_INTEGRIN_PATHWAY,PID_AVB3_INTEGRIN_PATHWAY,8/62,74/21728,3.578436385978467e-11,7.199814008588676e-8,4.7461366803503886e-8,PXN/COL6A1/COL3A1/VCL/FN1/PIK3CA/COL15A1/TLN1,8
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,12/62,341/21728,1.9684229426216798e-10,1.296228935947988e-7,8.544775867398059e-8,TRAF1/NRP2/DNAJC3/COL6A1/NFKB1/MYO1C/TGOLN2/PLXNA1/PDLIM4/GEM/PANX1/TNIP1,12
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,10/62,199/21728,2.353169014067804e-10,1.296228935947988e-7,8.544775867398059e-8,PXN/COL6A1/COL3A1/VCL/FN1/PIK3CA/FLNA/HGF/ITGB5/TLN1,10
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,13/62,438/21728,2.5769958965168746e-10,1.296228935947988e-7,8.544775867398059e-8,NRP2/CCN1/PXN/STAT6/NFKB1/VCL/FN1/MYO1C/FLII/PIK3CA/ITGB5/DKK1/TPP1,13
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,9/62,162/21728,8.238269892559946e-10,3.315079804766122e-7,2.1853094872895863e-7,AHNAK2/COL6A1/STAT6/PDLIM4/TRAM2/ITGB5/DKK1/KLHL21/PLOD2,9
PID_FAK_PATHWAY,PID_FAK_PATHWAY,6/62,59/21728,1.6868051761648015e-8,5.656420024072634e-6,3.7287272315221935e-6,PXN/VCL/GIT2/PIK3CA/ITGB5/TLN1,6
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,11/62,433/21728,3.536281905639238e-8,1.0164284563065924e-5,6.700323610684873e-6,SQSTM1/AHNAK/AHNAK2/ST3GAL1/STAT6/FN1/MYO1C/FLII/FLNA/TPP1/TNIP1,11
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,8/62,202/21728,1.0682646016637156e-7,2.6866854731842446e-5,1.7710702606530022e-5,PXN/VCL/FN1/PIK3CA/FLNA/HGF/ITGB5/TLN1,8
PID_INTEGRIN5_PATHWAY,PID_INTEGRIN5_PATHWAY,4/62,17/21728,1.3908318336964246e-7,3.109281832663562e-5,2.0496469128157838e-5,CCN1/FN1/FBN1/ITGB5,4
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,10/62,407/21728,2.1493831981792596e-7,4.3245589947366705e-5,2.8507608733745973e-5,CCN1/COL6A1/STAT6/FN1/FBN1/TRAM2/ELF4/IRAK1/TPP1/TLN1,10
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,5/62,50/21728,3.0801900069283955e-7,5.6339475399453924e-5,3.713913309789262e-5,DNAJC3/LMNA/EDEM1/TPP1/TLN1,5
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,8/62,235/21728,3.3983981857046693e-7,5.6979809580314955e-5,3.756124310515688e-5,CCN1/COL6A1/COL3A1/FBN1/FLNA/GEM/COL15A1/IL2RB,8
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,10/62,432/21728,3.716644911481508e-7,5.752222739923688e-5,3.791880638434575e-5,SQSTM1/HHAT/PIM1/LMNA/VCL/FN1/PIK3CA/HGF/DKK1/TLN1,10
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,8/62,243/21728,4.3814041524762373e-7,6.11316205144064e-5,4.029812799421998e-5,PXN/ST3GAL1/FN1/PRRX1/PDLIM4/DKK1/GEM/KLHL21,8
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,5/62,54/21728,4.557526380298688e-7,6.11316205144064e-5,4.029812799421998e-5,PXN/COL6A1/COL3A1/FN1/ITGB5,5
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,5/62,58/21728,6.545838484918302e-7,7.403633698863712e-5,4.880495166144333e-5,COL6A1/COL3A1/FURIN/STAT6/PIK3CA,5
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,8/62,257/21728,6.691428863833474e-7,7.403633698863712e-5,4.880495166144333e-5,COL6A1/COL3A1/FN1/FBN1/PRRX1/GALNT10/TRAM2/PLOD2,8
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,9/62,353/21728,6.769474772395032e-7,7.403633698863712e-5,4.880495166144333e-5,CCN1/AHNAK2/COL6A1/COL3A1/FN1/FBN1/PRRX1/GEM/COL15A1,9
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,10/62,463/21728,6.991502995944858e-7,7.403633698863712e-5,4.880495166144333e-5,CTF1/SQSTM1/PIM1/STAT6/NFKB1/FN1/PIK3CA/HGF/IRAK1/IL2RB,10
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,8/62,274/21728,1.0830934450403525e-6,1.0895920057105946e-4,7.182619688162338e-5,BNC2/NRP2/COL3A1/FBN1/PDLIM4/TRAM2/DKK1/GEM,8
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,9/62,389/21728,1.5124967654090758e-6,1.4127930006078358e-4,9.313169303996407e-5,TRAF1/NRP2/CCN1/DNAJC3/COL6A1/PRRX1/GEM/COL15A1/TBC1D8,9
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,5/62,69/21728,1.5673476017635396e-6,1.4127930006078358e-4,9.313169303996407e-5,PXN/NFKB1/FN1/PIK3CA/TNIP1,5
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,7/62,200/21728,1.6150218197803292e-6,1.4127930006078358e-4,9.313169303996407e-5,BNC2/CCN1/COL3A1/FN1/FBN1/FLNA/GCNT1,7
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,8/62,301/21728,2.1838192744979037e-6,1.8307684917874092e-4,1.2068474938014732e-4,COL6A1/COL3A1/FURIN/FN1/FBN1/ITGB5/COL15A1/PLOD2,8
PID_IL1_PATHWAY,PID_IL1_PATHWAY,4/62,34/21728,2.613496319561059e-6,2.1033418379827403e-4,1.3865285737460777e-4,SQSTM1/NFKB1/PIK3CA/IRAK1,4
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,6/62,140/21728,2.936382135751319e-6,2.2497668567708984e-4,1.4830523383547827e-4,COL6A1/COL3A1/FURIN/FN1/FBN1/COL15A1,6
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,5/62,79/21728,3.0751879086164286e-6,2.2497668567708984e-4,1.4830523383547827e-4,SQSTM1/TRAF1/PIM1/NFKB1/TNIP1,5
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,8/62,316/21728,3.130888269860097e-6,2.2497668567708984e-4,1.4830523383547827e-4,CCN1/AHNAK/COL3A1/VCL/FN1/MYO1C/FLNA/PLOD2,8
WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,3/62,11/21728,3.5915012906021558e-06,2.491758826445358e-4,1.6425740929795705e-4,SQSTM1/NFKB1/IRAK1,3
REACTOME_SMOOTH_MUSCLE_CONTRACTION,REACTOME_SMOOTH_MUSCLE_CONTRACTION,4/62,38/21728,4.1244391575044525e-6,2.766123861632986e-4,1.8234362591072317e-4,PXN/VCL/ITGB5/TLN1,4
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,5/62,85/21728,4.417395015927562e-6,2.867031861950405e-4,1.889955083215188e-4,COL6A1/COL3A1/FN1/FBN1/ITGB5,5
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,7/62,235/21728,4.694971961409021e-6,2.951963620735922e-4,1.945942326110318e-4,COL3A1/PRRX1/PLXNA1/GCNT1/PDLIM4/DKK1/PLOD2,7
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,8/62,336/21728,4.919535069888372e-6,2.99942562442891e-4,1.977229406079537e-4,CCN1/LMNA/COL3A1/VCL/FN1/FBN1/DKK1/GEM,8
REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,3/62,13/21728,6.1999565983393996e-06,3.6689154928996686e-4,2.4185589207144408e-4,SQSTM1/NFKB1/IRAK1,3
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,5/62,92/21728,6.5222042399983535e-6,3.7493356945361966e-4,2.471572133052008e-4,DNAJC3/LMNA/EDEM1/TPP1/TLN1,5
WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,4/62,43/21728,6.822386540184338e-6,3.812956033014135e-4,0.00025135108305942303,COL6A1/COL3A1/FN1/ITGB5,4
REACTOME_ELASTIC_FIBRE_FORMATION,REACTOME_ELASTIC_FIBRE_FORMATION,4/62,45/21728,8.201707659445069e-6,4.4599556245414806e-4,2.9400146944241214e-4,FURIN/FN1/FBN1/ITGB5,4
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,7/62,258/21728,8.646573078351018e-6,4.578132903590065e-4,3.017917473330272e-4,NRP2/CCN1/PRRX1/GALNT10/HEBP1/TRAM2/DKK1,7
PID_SYNDECAN_1_PATHWAY,PID_SYNDECAN_1_PATHWAY,4/62,46/21728,8.963677258880825e-6,4.6243381140687745e-4,3.0483760718461104e-4,COL6A1/COL3A1/HGF/COL15A1,4
CHANG_POU5F1_TARGETS_UP,CHANG_POU5F1_TARGETS_UP,3/62,15/21728,9.823469498709522e-6,4.941205157850889e-4,3.257255675887894e-4,CCN1/COL3A1/FN1,3
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,6/62,177/21728,1.1306817382011691e-5,5.394765497050167e-4,3.5562438664241987e-4,ST3GAL1/FN1/FBN1/PRRX1/COL15A1/PLOD2,6
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,4/62,49/21728,1.1564002878506286e-5,5.394765497050167e-4,3.5562438664241987e-4,PXN/NFKB1/FN1/PIK3CA,4
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,9/62,500/21728,1.1564378623789796e-5,5.394765497050167e-4,3.5562438664241987e-4,COL3A1/STAT6/EHBP1L1/FN1/FBN1/TBC1D2B/HGF/IRAK1/COL15A1,9
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,5/62,104/21728,1.1881199096465316e-5,5.394765497050167e-4,3.5562438664241987e-4,PXN/VCL/GIT2/ITGB5/TLN1,5
REACTOME_P75NTR_SIGNALS_VIA_NF_KB,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,3/62,16/21728,1.2065827403939243e-5,5.394765497050167e-4,3.5562438664241987e-4,SQSTM1/NFKB1/IRAK1,3
ZHOU_TNF_SIGNALING_4HR,ZHOU_TNF_SIGNALING_4HR,4/62,50/21728,1.254278408527264e-5,5.486104691210555e-4,3.6164549078818143e-4,CCN1/NFKB1/FBN1/TNIP1,4
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,5/62,110/21728,1.5606704735526103e-5,6.68099785699543e-4,4.40413168348553e-4,COL3A1/FURIN/EDEM1/DKK1/PLOD2,5
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,4/62,55/21728,1.8377781636467648e-5,7.546142173994471e-4,4.974437134682973e-4,SQSTM1/VCL/FN1/PIK3CA,4
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,4/62,55/21728,1.8377781636467648e-5,7.546142173994471e-4,4.974437134682973e-4,STAT6/NFKB1/PIK3CA/FLNA,4
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,4/62,56/21728,1.97492974686807e-5,7.947117301397114e-4,5.238761012744776e-4,SQSTM1/TRAF1/NFKB1/TNIP1,4
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,5/62,124/21728,2.7845815153444265e-5,0.0010975506628878513,7.235083369460567e-4,CCN1/DNAJC3/FN1/FBN1/TGOLN2,5
VERRECCHIA_RESPONSE_TO_TGFB1_C2,VERRECCHIA_RESPONSE_TO_TGFB1_C2,3/62,21/21728,2.8366120512012058e-5,0.0010975506628878513,7.235083369460567e-4,COL6A1/COL3A1/FN1,3
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,6/62,210/21728,2.9720633475471792e-5,0.001128262538729231,7.437536877675167e-4,COL6A1/COL3A1/FN1/FBN1/PRRX1/COL15A1,6
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,4/62,64/21728,3.35866124421398e-5,0.001228402144053947,8.097659838380105e-4,COL3A1/FN1/FBN1/PRRX1,4
REACTOME_COLLAGEN_DEGRADATION,REACTOME_COLLAGEN_DEGRADATION,4/62,64/21728,3.35866124421398e-5,0.001228402144053947,8.097659838380105e-4,COL6A1/COL3A1/FURIN/COL15A1,4
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,6/62,216/21728,3.480065716256211e-5,0.001228402144053947,8.097659838380105e-4,CCN1/ST3GAL1/NFKB1/VCL/PDLIM4/GEM,6
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,6/62,216/21728,3.480065716256211e-5,0.001228402144053947,8.097659838380105e-4,BNC2/FURIN/STAT6/TGOLN2/GCNT1/ELF4,6
REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,4/62,65/21728,3.571281276062239e-5,0.0012388651599029698,8.166632319125991e-4,LMNA/VCL/FN1/TLN1,4
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,8/62,445/21728,3.7316180605261296e-5,0.001251263646075006,8.248363472085947e-4,NRP2/AHNAK2/COL3A1/FN1/FLII/PDLIM4/ELF4/ITGB5,8
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,5/62,132/21728,3.759354669470584e-5,0.001251263646075006,8.248363472085947e-4,VCL/FN1/FLNA/HGF/TLN1,5
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,4/62,66/21728,3.793592565137941e-5,0.001251263646075006,8.248363472085947e-4,COL6A1/COL3A1/FN1/FBN1,4
REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,4/62,67/21728,4.0258665229622825e-5,0.0013064586200322763,8.61221021890064e-4,COL6A1/COL3A1/COL15A1/PLOD2,4
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,4/62,68/21728,4.268377226840297e-5,0.0013488244082289608,8.891486629530662e-4,SQSTM1/FURIN/PIK3CA/IRAK1,4
WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,3/62,24/21728,4.290495135519557e-5,0.0013488244082289608,8.891486629530662e-4,TRAF1/NFKB1/IRAK1,3
DITTMER_PTHLH_TARGETS_DN,DITTMER_PTHLH_TARGETS_DN,4/62,70/21728,4.7852182638414424e-5,0.0014587665374013608,9.616228090016298e-4,ZDHHC7/LMNA/PIK3CA/PANX1,4
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,4/62,70/21728,4.7852182638414424e-5,0.0014587665374013608,9.616228090016298e-4,COL3A1/FN1/FBN1/PRRX1,4
WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,3/62,25/21728,4.8656528676538e-5,0.001461148293987977,9.631928693234547e-4,NFKB1/PIK3CA/IRAK1,3
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,5/62,140/21728,4.97996735688431e-5,0.0014734844591251812,9.713249024263516e-4,TRAF1/NRP2/EHBP1L1/FN1/PRRX1,5
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,5/62,141/21728,5.151803958619401e-5,0.0015022361688032224,9.902781064623106e-4,SQSTM1/TRAF1/NFKB1/AKAP13/IRAK1,5
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,3/62,26/21728,5.489124775680614e-5,0.001554912527963764,0.0010250025035232516,PXN/VCL/FN1,3
TIAN_TNF_SIGNALING_VIA_NFKB,TIAN_TNF_SIGNALING_VIA_NFKB,3/62,26/21728,5.489124775680614e-5,0.001554912527963764,0.0010250025035232516,TRAF1/NFKB1/TNIP1,3
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,7/62,345/21728,5.564299304840508e-5,0.001554912527963764,0.0010250025035232516,COL6A1/NFKB1/FN1/PIK3CA/HGF/ITGB5/IL2RB,7
LINDVALL_IMMORTALIZED_BY_TERT_DN,LINDVALL_IMMORTALIZED_BY_TERT_DN,4/62,73/21728,5.644256078256866e-5,0.0015556497574592896,0.0010254884871814926,CCN1/FN1/ITGB5/PLOD2,4
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,4/62,74/21728,5.9540870089525964e-5,0.0016018875411728658,0.0010559685580610082,COL3A1/FN1/FBN1/PRRX1,4
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,6/62,238/21728,5.971250774749748e-5,0.0016018875411728658,0.0010559685580610082,AHNAK2/AKAP13/TBC1D2B/PDLIM4/DKK1/TPP1,6
REACTOME_SYNDECAN_INTERACTIONS,REACTOME_SYNDECAN_INTERACTIONS,3/62,27/21728,6.16271642841047e-5,0.0016314980860476138,0.001075487908559168,COL3A1/FN1/ITGB5,3
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,4/62,76/21728,6.610722326025582e-5,0.0017052273487132654,0.0011240904360043501,COL6A1/COL3A1/FN1/ITGB5,4
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,4/62,76/21728,6.610722326025582e-5,0.0017052273487132654,0.0011240904360043501,PXN/NFKB1/PIK3CA/FLNA,4
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,3/62,28/21728,6.888217566249737e-5,0.001738681461875431,0.0011461434770132068,SQSTM1/FN1/PRRX1,3
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,5/62,150/21728,6.913246369286008e-5,0.001738681461875431,0.0011461434770132068,TRAF1/COL6A1/NFKB1/FN1/IL2RB,5
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,8/62,491/21728,7.444656867334709e-5,0.0018492160021083251,0.0012190081420197184,AHNAK2/COL6A1/VCL/FBN1/PRRX1/GALNT10/FLNA/PDLIM4,8
WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,3/62,29/21728,7.66740218778716e-5,0.001864748860734377,0.0012292474440333343,PXN/FN1/TLN1,3
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,4/62,79/21728,7.692552457303842e-5,0.001864748860734377,0.0012292474440333343,COL3A1/FN1/PIK3CA/HGF,4
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,5/62,155/21728,8.074241991593401e-5,0.0019339732008435621,0.001274880314462116,CTF1/PIM1/STAT6/PIK3CA/IL2RB,5
KEGG_O_GLYCAN_BIOSYNTHESIS,KEGG_O_GLYCAN_BIOSYNTHESIS,3/62,30/21728,8.50202863599701e-5,0.0019890792576309282,0.0013112063747070053,ST3GAL1/GALNT10/GCNT1,3
REACTOME_MET_ACTIVATES_PTK2_SIGNALING,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,3/62,30/21728,8.50202863599701e-5,0.0019890792576309282,0.0013112063747070053,COL3A1/FN1/HGF,3
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,4/62,82/21728,8.897865566124279e-5,0.0020577592550623048,0.0013564804129844639,LMNA/VCL/FN1/TLN1,4
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,5/62,160/21728,9.379966467342416e-5,0.002092072879294841,0.001379100045993251,AHNAK/PXN/FN1/PIK3CA/ITGB5,5
URS_ADIPOCYTE_DIFFERENTIATION_DN,URS_ADIPOCYTE_DIFFERENTIATION_DN,3/62,31/21728,9.393839684059984e-5,0.002092072879294841,0.001379100045993251,COL6A1/COL3A1/FN1,3
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,3/62,31/21728,9.393839684059984e-5,0.002092072879294841,0.001379100045993251,LMNA/PRRX1/PIK3CA,3
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,4/62,84/21728,9.774097945015658e-5,0.002092072879294841,0.001379100045993251,TRAF1/NFKB1/FN1/TNIP1,4
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,4/62,84/21728,9.774097945015658e-5,0.002092072879294841,0.001379100045993251,COL6A1/COL3A1/FN1/ITGB5,4
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,4/62,84/21728,9.774097945015658e-5,0.002092072879294841,0.001379100045993251,TRAF1/NFKB1/FN1/PIK3CA,4
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,4/62,84/21728,9.774097945015658e-5,0.002092072879294841,0.001379100045993251,SQSTM1/FURIN/NFKB1/TNIP1,4
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,6/62,261/21728,9.927658257961772e-5,0.00210257351737043,0.0013860220947403692,VCL/FN1/PIK3CA/FLNA/HGF/TLN1,6
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,4/62,86/21728,1.0711392776421466e-4,0.002244929402724999,0.001479863475689808,VCL/ITGB5/GEM/TLN1,4
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,7/62,386/21728,1.1222859330167282e-4,0.0022848089583562053,0.0015061521855858628,EHBP1L1/TGOLN2/FLNA/ELF4/IRAK1/TPP1/TBC1D8,7
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,3/62,33/21728,1.1355909335766427e-4,0.0022848089583562053,0.0015061521855858628,PXN/FN1/TLN1,3
ROZANOV_MMP14_TARGETS_SUBSET,ROZANOV_MMP14_TARGETS_SUBSET,3/62,33/21728,1.1355909335766427e-4,0.0022848089583562053,0.0015061521855858628,COL6A1/FN1/PLOD2,3
WP_INFLAMMATORY_RESPONSE_PATHWAY,WP_INFLAMMATORY_RESPONSE_PATHWAY,3/62,33/21728,1.1355909335766427e-4,0.0022848089583562053,0.0015061521855858628,COL3A1/FN1/IL2RB,3
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,4/62,88/21728,1.1712280086886316e-4,0.002333178963843096,0.0015380378227698552,BNC2/CCN1/COL3A1/GCNT1,4
PID_IL2_PI3K_PATHWAY,PID_IL2_PI3K_PATHWAY,3/62,34/21728,1.2429576403877082e-4,0.002427991041223368,0.0016005381981487098,NFKB1/PIK3CA/IL2RB,3
WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,3/62,34/21728,1.2429576403877082e-4,0.002427991041223368,0.0016005381981487098,PXN/PIK3CA/HGF,3
REACTOME_COLLAGEN_FORMATION,REACTOME_COLLAGEN_FORMATION,4/62,90/21728,1.277932024800992e-4,0.002472306955672688,0.001629751367661184,COL6A1/COL3A1/COL15A1/PLOD2,4
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,7/62,395/21728,1.294316103748514e-4,0.002480156191182867,0.0016349256047349654,CCN1/AHNAK/VCL/PLXNA1/HEBP1/DKK1/PLOD2,7
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,6/62,275/21728,1.3209031151419673e-4,0.0025072236487411683,0.0016527685452620445,CCN1/COL6A1/COL3A1/FN1/FBN1/COL15A1,6
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,3/62,35/21728,1.356724516976789e-4,0.0025511492786516815,0.001681724438161096,COL6A1/COL3A1/FBN1,3
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,6/62,279/21728,1.4289306489576034e-4,0.0026620448756506463,0.0017548271127549517,TRAF1/ZDHHC7/COL3A1/NFKB1/FN1/IRAK1,6
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,6/62,282/21728,1.5144593303956786e-4,0.0027954974061982617,0.001842799378366543,STAT6/HGF/ITGB5/IRAK1/TPP1/KLHL21,6
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,4/62,97/21728,1.7072552190621696e-4,0.003094713893167379,0.0020400436880772723,SQSTM1/NFKB1/AKAP13/IRAK1,4
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,5/62,182/21728,1.7158317435604672e-4,0.003094713893167379,0.0020400436880772723,NRP2/COL3A1/FN1/HGF/ITGB5,5
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,3/62,38/21728,1.7380848405959933e-4,0.003094713893167379,0.0020400436880772723,FN1/FBN1/ITGB5,3
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,3/62,38/21728,1.7380848405959933e-4,0.003094713893167379,0.0020400436880772723,NFKB1/GIT2/ELF4,3
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,4/62,98/21728,1.776121595809393e-4,0.0031346988164635955,0.0020664018566203465,TRAF1/NFKB1/FN1/PIK3CA,4
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,5/62,184/21728,1.8054197944257947e-4,0.0031586996751171294,0.002082223286935013,FURIN/EHBP1L1/AKAP13/TLN1/TNIP1,5
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,7/62,423/21728,1.9715004704605796e-4,0.003419533574626454,0.0022541656921781584,EHBP1L1/TGOLN2/GIT2/FLNA/ELF4/IRAK1/TPP1,7
GAVIN_FOXP3_TARGETS_CLUSTER_P4,GAVIN_FOXP3_TARGETS_CLUSTER_P4,4/62,101/21728,1.9947619486510574e-4,0.003427738888607751,0.0022595746571339157,PIM1/MYO1C/IL2RB/APOL3,4
REACTOME_MAP2K_AND_MAPK_ACTIVATION,REACTOME_MAP2K_AND_MAPK_ACTIVATION,3/62,40/21728,2.0273405951507076e-4,0.003427738888607751,0.0022595746571339157,VCL/FN1/TLN1,3
WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,3/62,40/21728,2.0273405951507076e-4,0.003427738888607751,0.0022595746571339157,STAT6/NFKB1/IL2RB,3
REACTOME_MET_PROMOTES_CELL_MOTILITY,REACTOME_MET_PROMOTES_CELL_MOTILITY,3/62,41/21728,2.1829550773396918e-4,0.0036600880130062165,0.0024127398223228176,COL3A1/FN1/HGF,3
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,5/62,194/21728,2.3082024276891986e-4,0.003837693259236841,0.0025298176763829754,AHNAK/VCL/MANBA/GIT2/PLOD2,5
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,3/62,42/21728,2.3461047260742117e-4,0.003837693259236841,0.0025298176763829754,STAT6/PIK3CA/HGF,3
PID_UPA_UPAR_PATHWAY,PID_UPA_UPAR_PATHWAY,3/62,42/21728,2.3461047260742117e-4,0.003837693259236841,0.0025298176763829754,FN1/HGF/ITGB5,3
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,6/62,309/21728,2.481368497246583e-4,0.004026220497145262,0.002654095336613493,COL3A1/FN1/PIK3CA/HGF/ITGB5/IL2RB,6
PID_INTEGRIN3_PATHWAY,PID_INTEGRIN3_PATHWAY,3/62,43/21728,2.5169457906246384e-4,0.004051275944589418,0.002670611954683827,CCN1/FN1/FBN1,3
NABA_COLLAGENS,NABA_COLLAGENS,3/62,44/21728,2.6956330714409944e-4,0.004204351736232,0.00277151992657336,COL6A1/COL3A1/COL15A1,3
REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,3/62,44/21728,2.6956330714409944e-4,0.004204351736232,0.00277151992657336,COL6A1/COL3A1/COL15A1,3
VANHARANTA_UTERINE_FIBROID_UP,VANHARANTA_UTERINE_FIBROID_UP,3/62,44/21728,2.6956330714409944e-4,0.004204351736232,0.00277151992657336,COL3A1/FN1/TGOLN2,3
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,3/62,44/21728,2.6956330714409944e-4,0.004204351736232,0.00277151992657336,NFKB1/PIK3CA/IRAK1,3
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,6/62,315/21728,2.7508270513162974e-4,0.004249910786494969,0.002801552574544136,TRAF1/AHNAK/LMNA/FURIN/NFKB1/GCNT1,6
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,4/62,110/21728,2.7670890309683947e-4,0.004249910786494969,0.002801552574544136,NFKB1/FN1/FBN1/HGF,4
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,4/62,111/21728,2.864435451296026e-4,0.004295724218940789,0.0028317529119312517,PIM1/STAT6/FN1/HGF,4
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,3/62,45/21728,2.882319928215738e-4,0.004295724218940789,0.0028317529119312517,SQSTM1/CCN1/TPP1,3
PID_RHOA_PATHWAY,PID_RHOA_PATHWAY,3/62,45/21728,2.882319928215738e-4,0.004295724218940789,0.0028317529119312517,CCN1/VCL/TLN1,3
REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,3/62,45/21728,2.882319928215738e-4,0.004295724218940789,0.0028317529119312517,VCL/FN1/TLN1,3
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,7/62,451/21728,2.910805208482706e-4,0.004306279470196474,0.0028387109618329795,SQSTM1/PXN/FN1/PDLIM4/GEM/TPP1/KLHL21,7
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,7/62,454/21728,3.0297843090126684e-4,0.0044495810436010865,0.002933175742878189,CTF1/SQSTM1/TRAF1/ST3GAL1/NFKB1/HGF/TNIP1,7
PID_TNF_PATHWAY,PID_TNF_PATHWAY,3/62,46/21728,3.077158287910644e-4,0.004486407590779866,0.002957451901424418,SQSTM1/TRAF1/NFKB1,3
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,3/62,47/21728,3.280298652747646e-4,0.0047142577780916175,0.0031076513552346125,COL3A1/FN1/FBN1,3
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,3/62,47/21728,3.280298652747646e-4,0.0047142577780916175,0.0031076513552346125,STAT6/NFKB1/PIK3CA,3
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,6/62,327/21728,3.358629977638145e-4,0.004792598237594289,0.003159293595986609,VCL/FN1/PIK3CA/HGF/IL2RB/TLN1,6
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,7/62,466/21728,3.5455089809004474e-4,0.004963429239080136,0.0032719058497650793,BNC2/PIM1/AHNAK2/COL6A1/VCL/FBN1/TRAM2,7
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,5/62,213/21728,3.549963596076235e-4,0.004963429239080136,0.0032719058497650793,PXN/VCL/FN1/PIK3CA/ITGB5,5
BIOCARTA_RNA_PATHWAY,BIOCARTA_RNA_PATHWAY,2/62,10/21728,3.552354922602086e-4,0.004963429239080136,0.0032719058497650793,DNAJC3/NFKB1,2
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,4/62,118/21728,3.616056838715552e-4,0.005017590592755648,0.003307609159188091,COL3A1/FN1/FBN1/GALNT10,4
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,3/62,49/21728,3.7120803307322644e-4,0.005110602954328695,0.0033689231570859877,TRAF1/NFKB1/TNIP1,3
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,4/62,119/21728,3.733889832436969e-4,0.005110602954328695,0.0033689231570859877,LMNA/COL3A1/FLNA/TRAM2,4
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,5/62,222/21728,4.289654827289117e-4,0.005831611832774124,0.003844214141098355,FBN1/AKAP13/HGF/COL15A1/IL2RB,5
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,5/62,223/21728,4.3785033963799247e-4,0.005873032555677606,0.0038715187925885655,COL3A1/FN1/FBN1/HGF/COL15A1,5
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,5/62,223/21728,4.3785033963799247e-4,0.005873032555677606,0.0038715187925885655,SQSTM1/TRAF1/DNAJC3/NFKB1/TNIP1,5
KENNY_CTNNB1_TARGETS_DN,KENNY_CTNNB1_TARGETS_DN,3/62,52/21728,4.425699399416058e-4,0.005897024630215303,0.0038873344323905423,COL6A1/FN1/ITGB5,3
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,5/62,226/21728,4.6534033774368297e-4,0.006116654487720587,0.004032115022772805,HHAT/AHNAK/PXN/AKAP13/TBC1D2B,5
GENTILE_RESPONSE_CLUSTER_D3,GENTILE_RESPONSE_CLUSTER_D3,3/62,53/21728,4.6817335542195343e-4,0.006116654487720587,0.004032115022772805,CCN1/ELF4/DKK1,3
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,3/62,53/21728,4.6817335542195343e-4,0.006116654487720587,0.004032115022772805,COL3A1/FN1/HGF,3
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,3/62,54/21728,4.947084000773842e-4,0.006380469877921134,0.00420602283466602,SQSTM1/TRAF1/COL6A1,3
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,3/62,54/21728,4.947084000773842e-4,0.006380469877921134,0.00420602283466602,SQSTM1/TRAF1/NFKB1,3
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,3/62,55/21728,5.22189012679745e-4,0.006649647427288905,0.004383465396245695,NFKB1/PLXNA1/HGF,3
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,3/62,55/21728,5.22189012679745e-4,0.006649647427288905,0.004383465396245695,SQSTM1/TRAF1/NFKB1,3
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,6/62,359/21728,5.503033882316344e-4,0.006881152429055584,0.004536074113534602,FN1/FBN1/ELF4/ITGB5/GEM/PLOD2,6
BIOCARTA_HIVNEF_PATHWAY,BIOCARTA_HIVNEF_PATHWAY,3/62,56/21728,5.506289965596169e-4,0.006881152429055584,0.004536074113534602,TRAF1/LMNA/NFKB1,3
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,3/62,56/21728,5.506289965596169e-4,0.006881152429055584,0.004536074113534602,NFKB1/IRAK1/PANX1,3
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,3/62,57/21728,5.800420203703002e-4,0.007159782484570822,0.004719747792486783,PIM1/NFKB1/PIK3CA,3
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,3/62,57/21728,5.800420203703002e-4,0.007159782484570822,0.004719747792486783,SQSTM1/NFKB1/IRAK1,3
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,5/62,238/21728,5.885157250926814e-4,0.00722008316394192,0.004759498161853521,SQSTM1/LMNA/RAB36/GEM/KLHL21,5
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,5/62,239/21728,5.997849691431438e-4,0.007313741563127305,0.004821238029475989,CCN1/PXN/VCL/PDLIM4/ITGB5,5
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,2/62,13/21728,6.123528245125862e-4,0.00742201134288749,0.004892609758312356,SQSTM1/IRAK1,2
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,3/62,59/21728,6.41841193570786e-4,0.007732841206373781,0.005097509636931551,COL3A1/FN1/ITGB5,3
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,5/62,243/21728,6.464910158668566e-4,0.007742499547167354,0.005103876441054131,PIM1/NFKB1/FN1/HGF/PLOD2,5
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,4/62,138/21728,6.531857261948496e-4,0.00777638864558602,0.005126216225509253,NFKB1/PIK3CA/IRAK1/IL2RB,4
PID_FCER1_PATHWAY,PID_FCER1_PATHWAY,3/62,60/21728,6.742540137086485e-4,0.007979994562245888,0.005260433791163449,PXN/NFKB1/PIK3CA,3
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,3/62,61/21728,7.076932167774874e-4,0.008198602940656803,0.005404541019790506,COL6A1/GEM/IRAK1,3
REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,3/62,61/21728,7.076932167774874e-4,0.008198602940656803,0.005404541019790506,COL6A1/COL3A1/COL15A1,3
PID_IL5_PATHWAY,PID_IL5_PATHWAY,2/62,14/21728,7.130991623334695e-4,0.008198602940656803,0.005404541019790506,PIM1/PIK3CA,2
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,2/62,14/21728,7.130991623334695e-4,0.008198602940656803,0.005404541019790506,PLXNA1/TLN1,2
VERRECCHIA_RESPONSE_TO_TGFB1_C3,VERRECCHIA_RESPONSE_TO_TGFB1_C3,2/62,14/21728,7.130991623334695e-4,0.008198602940656803,0.005404541019790506,PXN/ITGB5,2
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,3/62,62/21728,7.421718093842216e-4,0.008436438872774316,0.005561323103325122,STAT6/NFKB1/IL2RB,3
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,3/62,62/21728,7.421718093842216e-4,0.008436438872774316,0.005561323103325122,ST3GAL1/GALNT10/GCNT1,3
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,6/62,382/21728,7.612193037510236e-4,0.00860434404015202,0.005672006639422176,PIM1/CCN1/DNAJC3/COL6A1/HEBP1/ITGB5,6
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,4/62,145/21728,7.860819553394383e-4,0.00883573683878743,0.005824541392106395,FURIN/FLNA/TPP1/TLN1,4
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,2/62,15/21728,8.212954227695874e-4,0.009129538069681824,0.00601821595050701,FN1/TLN1,2
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,2/62,15/21728,8.212954227695874e-4,0.009129538069681824,0.00601821595050701,FN1/TLN1,2
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,3/62,66/21728,8.907356670735805e-4,0.009807084338689511,0.006464856265956253,CCN1/PXN/NFKB1,3
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,4/62,150/21728,8.919962395527735e-4,0.009807084338689511,0.006464856265956253,PXN/VCL/FN1/PIK3CA,4
REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,2/62,16/21728,9.368996506789646e-4,0.010134634931000412,0.006680778493805861,PIM1/PIK3CA,2
REACTOME_THE_NLRP3_INFLAMMASOME,REACTOME_THE_NLRP3_INFLAMMASOME,2/62,16/21728,9.368996506789646e-4,0.010134634931000412,0.006680778493805861,NFKB1/PANX1,2
XU_RESPONSE_TO_TRETINOIN_UP,XU_RESPONSE_TO_TRETINOIN_UP,2/62,16/21728,9.368996506789646e-4,0.010134634931000412,0.006680778493805861,PIM1/ELF4,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,6/62,399/21728,9.537577949406341e-4,0.010261821836473561,0.006764620442584853,PXN/GALNT10/AKAP13/EDEM1/ITGB5/PLOD2,6
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,4/62,154/21728,9.836824397918826e-4,0.010500809444882882,0.006922161714215985,STAT6/NFKB1/PIK3CA/IRAK1,4
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,5/62,267/21728,9.864080442757777e-4,0.010500809444882882,0.006922161714215985,COL6A1/FN1/PLOD2/IL2RB/APOL3,5
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,3/62,69/21728,0.0010136902708518382,0.01073444644712578,0.0070761758519297295,PXN/VCL/PIK3CA,3
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,3/62,70/21728,0.0010569367524136334,0.01087989064666344,0.00717205305786122,COL3A1/FURIN/FN1,3
BIOCARTA_GCR_PATHWAY,BIOCARTA_GCR_PATHWAY,2/62,17/21728,0.0010598700629950468,0.01087989064666344,0.00717205305786122,NFKB1/PIK3CA,2
BIOCARTA_HCMV_PATHWAY,BIOCARTA_HCMV_PATHWAY,2/62,17/21728,0.0010598700629950468,0.01087989064666344,0.00717205305786122,NFKB1/PIK3CA,2
BIOCARTA_TNFR2_PATHWAY,BIOCARTA_TNFR2_PATHWAY,2/62,17/21728,0.0010598700629950468,0.01087989064666344,0.00717205305786122,TRAF1/NFKB1,2
PID_NFKAPPAB_ATYPICAL_PATHWAY,PID_NFKAPPAB_ATYPICAL_PATHWAY,2/62,17/21728,0.0010598700629950468,0.01087989064666344,0.00717205305786122,NFKB1/PIK3CA,2
REACTOME_GAB1_SIGNALOSOME,REACTOME_GAB1_SIGNALOSOME,2/62,17/21728,0.0010598700629950468,0.01087989064666344,0.00717205305786122,PXN/PIK3CA,2
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,5/62,276/21728,0.0011431167362332883,0.01167487752944861,0.007696110540496626,AHNAK/ST3GAL1/FLNA/TBC1D2B/ITGB5,5
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,2/62,18/21728,0.0011901650481118745,0.0120332265165884,0.007932335152716012,PXN/FLNA,2
WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,2/62,18/21728,0.0011901650481118745,0.0120332265165884,0.007932335152716012,PXN/VCL,2
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,5/62,281/21728,0.0012377800111418194,0.012186023993652791,0.00803305965889009,VCL/FN1/FLNA/ITGB5/IRAK1,5
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,3/62,74/21728,0.001241546240508706,0.012186023993652791,0.00803305965889009,PIM1/CCN1/ITGB5,3
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,3/62,74/21728,0.001241546240508706,0.012186023993652791,0.00803305965889009,PIM1/CCN1/TNIP1,3
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,3/62,74/21728,0.001241546240508706,0.012186023993652791,0.00803305965889009,COL3A1/FN1/FBN1,3
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,3/62,74/21728,0.001241546240508706,0.012186023993652791,0.00803305965889009,VCL/DKK1/TLN1,3
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,4/62,164/21728,0.0012416177528324166,0.012186023993652791,0.00803305965889009,NRP2/CCN1/HGF/COL15A1,4
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,5/62,285/21728,0.0013175979721937068,0.01254187440622465,0.008267637204061451,COL3A1/VCL/FN1/ITGB5/IRAK1,5
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,4/62,167/21728,0.0013274158803870753,0.01254187440622465,0.008267637204061451,PIM1/ST3GAL1/PDLIM4/GEM,4
BIOCARTA_CXCR4_PATHWAY,BIOCARTA_CXCR4_PATHWAY,2/62,19/21728,0.0013277431652712972,0.01254187440622465,0.008267637204061451,NFKB1/PIK3CA,2
BIOCARTA_ECM_PATHWAY,BIOCARTA_ECM_PATHWAY,2/62,19/21728,0.0013277431652712972,0.01254187440622465,0.008267637204061451,PIK3CA/TLN1,2
FARMER_BREAST_CANCER_CLUSTER_4,FARMER_BREAST_CANCER_CLUSTER_4,2/62,19/21728,0.0013277431652712972,0.01254187440622465,0.008267637204061451,COL3A1/FBN1,2
REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,2/62,19/21728,0.0013277431652712972,0.01254187440622465,0.008267637204061451,PIM1/PIK3CA,2
WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,2/62,19/21728,0.0013277431652712972,0.01254187440622465,0.008267637204061451,COL3A1/FN1,2
WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,2/62,19/21728,0.0013277431652712972,0.01254187440622465,0.008267637204061451,NFKB1/IRAK1,2
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,5/62,286/21728,0.001338133951766816,0.012549138349354925,0.0082724256148306,TRAF1/ST3GAL1/COL15A1/PLOD2/APOL3,5
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,3/62,76/21728,0.0013409864538326585,0.012549138349354925,0.0082724256148306,NRP2/FN1/GALNT10,3
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,6/62,428/21728,0.0013666237147945699,0.012729846824845716,0.00839154912593157,FN1/AKAP13/DKK1/GEM/COL15A1/APOL3,6
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,5/62,289/21728,0.0014011641188245104,0.012991438742280714,0.008563991218621796,CCN1/PRRX1/ELF4/DKK1/GEM,5
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,5/62,291/21728,0.0014443861489436115,0.013259178373376283,0.008740485900624735,LMNA/AHNAK2/PRRX1/AKAP13/DKK1,5
WONG_ENDMETRIUM_CANCER_DN,WONG_ENDMETRIUM_CANCER_DN,3/62,78/21728,0.001445303657095275,0.013259178373376283,0.008740485900624735,COL3A1/FBN1/HGF,3
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,6/62,433/21728,0.0014498107565321982,0.013259178373376283,0.008740485900624735,BNC2/NRP2/COL6A1/COL3A1/FN1/PDLIM4,6
BIOCARTA_GSK3_PATHWAY,BIOCARTA_GSK3_PATHWAY,2/62,20/21728,0.00147256314395219,0.013286085406420657,0.00875822308888251,NFKB1/PIK3CA,2
WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,2/62,20/21728,0.00147256314395219,0.013286085406420657,0.00875822308888251,NFKB1/IRAK1,2
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,2/62,20/21728,0.00147256314395219,0.013286085406420657,0.00875822308888251,FN1/COL15A1,2
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,5/62,293/21728,0.0014885853773030763,0.013289114492328839,0.008760219870427088,CCN1/FBN1/FLNA/DKK1/IRAK1,5
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,5/62,293/21728,0.0014885853773030763,0.013289114492328839,0.008760219870427088,HGF/ITGB5/IRAK1/TPP1/KLHL21,5
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,3/62,79/21728,0.0014993185833790488,0.013289114492328839,0.008760219870427088,PDLIM4/IRAK1/PLOD2,3
PID_MET_PATHWAY,PID_MET_PATHWAY,3/62,79/21728,0.0014993185833790488,0.013289114492328839,0.008760219870427088,PXN/PIK3CA/HGF,3
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,6/62,437/21728,0.0015191058150504026,0.013405442543339518,0.00883690363325719,CCN1/COL3A1/FLNA/TRAM2/ITGB5/PLOD2,6
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,5/62,295/21728,0.0015337752761162796,0.013475789762209409,0.008883276708372845,COL3A1/FN1/PRRX1/ITGB5/COL15A1,5
GRABARCZYK_BCL11B_TARGETS_UP,GRABARCZYK_BCL11B_TARGETS_UP,3/62,81/21728,0.0016111149569524785,0.014028595592800465,0.009247687792680018,AHNAK/TRAM2/IL2RB,3
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,3/62,81/21728,0.0016111149569524785,0.014028595592800465,0.009247687792680018,NFKB1/FN1/ANXA13,3
BIOCARTA_RHO_PATHWAY,BIOCARTA_RHO_PATHWAY,2/62,21/21728,0.001624583883261684,0.014028595592800465,0.009247687792680018,VCL/TLN1,2
REACTOME_INFLAMMASOMES,REACTOME_INFLAMMASOMES,2/62,21/21728,0.001624583883261684,0.014028595592800465,0.009247687792680018,NFKB1/PANX1,2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,5/62,304/21728,0.0017497525405911196,0.015044880819099712,0.009917625736144,COL3A1/FN1/FBN1/PRRX1/COL15A1,5
BIOCARTA_AKT_PATHWAY,BIOCARTA_AKT_PATHWAY,2/62,22/21728,0.0017837644513283995,0.015055349209084596,0.00992452652686334,NFKB1/PIK3CA,2
BIOCARTA_RAS_PATHWAY,BIOCARTA_RAS_PATHWAY,2/62,22/21728,0.0017837644513283995,0.015055349209084596,0.00992452652686334,NFKB1/PIK3CA,2
PID_HEDGEHOG_2PATHWAY,PID_HEDGEHOG_2PATHWAY,2/62,22/21728,0.0017837644513283995,0.015055349209084596,0.00992452652686334,HHAT/PIK3CA,2
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,3/62,84/21728,0.0017883839269240646,0.015055349209084596,0.00992452652686334,FBN1/PRRX1/GALNT10,3
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,3/62,84/21728,0.0017883839269240646,0.015055349209084596,0.00992452652686334,COL3A1/FLNA/TRAM2,3
BURTON_ADIPOGENESIS_9,BURTON_ADIPOGENESIS_9,3/62,85/21728,0.0018500681113900305,0.015381558017011326,0.010139564246852712,CCN1/HEBP1/GEM,3
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,3/62,85/21728,0.0018500681113900305,0.015381558017011326,0.010139564246852712,COL3A1/FBN1/COL15A1,3
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,3/62,85/21728,0.0018500681113900305,0.015381558017011326,0.010139564246852712,VCL/ITGB5/GEM,3
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,2/62,23/21728,0.001950064084697681,0.015949304627689977,0.010513824333414969,VCL/GIT2,2
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,2/62,23/21728,0.001950064084697681,0.015949304627689977,0.010513824333414969,PIM1/ST3GAL1,2
WP_ESTROGEN_SIGNALING_PATHWAY,WP_ESTROGEN_SIGNALING_PATHWAY,2/62,23/21728,0.001950064084697681,0.015949304627689977,0.010513824333414969,NFKB1/PIK3CA,2
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,2/62,23/21728,0.001950064084697681,0.015949304627689977,0.010513824333414969,LMNA/FBN1,2
KEGG_APOPTOSIS,KEGG_APOPTOSIS,3/62,87/21728,0.001977388925909097,0.01610731384181823,0.01061798443062204,NFKB1/PIK3CA/IRAK1,3
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,6/62,461/21728,0.001989541361271518,0.01614095652773506,0.010640161779295896,SQSTM1/AHNAK2/FN1/FBN1/AKAP13/FLNA,6
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,4/62,187/21728,0.0020081937701003603,0.016226850865228612,0.010696783556653789,CTF1/LMNA/PRRX1/HLCS,4
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,2/62,24/21728,0.0021234421877288196,0.016953832070279305,0.011176011514362209,FN1/FBN1,2
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,2/62,24/21728,0.0021234421877288196,0.016953832070279305,0.011176011514362209,COL6A1/GEM,2
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,2/62,24/21728,0.0021234421877288196,0.016953832070279305,0.011176011514362209,AHNAK/DKK1,2
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,4/62,192/21728,0.0022101246987711316,0.01757616954121548,0.011586258042236846,COL3A1/FN1/FBN1/GALNT10,4
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,3/62,91/21728,0.0022481154857320893,0.017807906918476234,0.011739019942073903,ZDHHC7/AHNAK2/GALNT10,3
LEI_MYB_TARGETS,LEI_MYB_TARGETS,5/62,323/21728,0.0022780843956934356,0.017897154301051703,0.011797852055731476,AHNAK2/STAT6/VCL/FN1/TNIP1,5
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,4/62,194/21728,0.0022946841629611276,0.017897154301051703,0.011797852055731476,BNC2/NRP2/PRRX1/HGF,4
PID_INTEGRIN_A9B1_PATHWAY,PID_INTEGRIN_A9B1_PATHWAY,2/62,25/21728,0.00230385833199423,0.017897154301051703,0.011797852055731476,PXN/FN1,2
PID_LYMPH_ANGIOGENESIS_PATHWAY,PID_LYMPH_ANGIOGENESIS_PATHWAY,2/62,25/21728,0.00230385833199423,0.017897154301051703,0.011797852055731476,FN1/PIK3CA,2
WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,2/62,25/21728,0.00230385833199423,0.017897154301051703,0.011797852055731476,FBN1/FLNA,2
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,4/62,195/21728,0.002337790028469371,0.018036883235460863,0.011889961743580982,PXN/VCL/ITGB5/TLN1,4
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,5/62,325/21728,0.0023397746145404,0.018036883235460863,0.011889961743580982,TRAF1/NFKB1/FN1/PIK3CA/HGF,5
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,6/62,480/21728,0.002434499563025839,0.018695469926748046,0.012324103854610517,NRP2/PXN/PRRX1/PDLIM4/GEM/KLHL21,6
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,3/62,94/21728,0.0024655355061148996,0.018773182690747337,0.012375332316805298,COL3A1/FN1/FLNA,3
BIOCARTA_RACCYCD_PATHWAY,BIOCARTA_RACCYCD_PATHWAY,2/62,26/21728,0.0024912722556806855,0.018773182690747337,0.012375332316805298,NFKB1/PIK3CA,2
PID_IL3_PATHWAY,PID_IL3_PATHWAY,2/62,26/21728,0.0024912722556806855,0.018773182690747337,0.012375332316805298,PIM1/PIK3CA,2
PID_VEGFR1_PATHWAY,PID_VEGFR1_PATHWAY,2/62,26/21728,0.0024912722556806855,0.018773182690747337,0.012375332316805298,NRP2/PIK3CA,2
WEINMANN_ADAPTATION_TO_HYPOXIA_UP,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,2/62,26/21728,0.0024912722556806855,0.018773182690747337,0.012375332316805298,COL3A1/COL15A1,2
WESTON_VEGFA_TARGETS,WESTON_VEGFA_TARGETS,3/62,95/21728,0.002540796424012693,0.019074934347438576,0.01257424781718772,PIM1/COL6A1/GEM,3
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,6/62,485/21728,0.0025631782553814345,0.019171429925009094,0.012637857960401518,AHNAK/PRRX1/FLNA/PDLIM4/GEM/IL2RB,6
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,4/62,201/21728,0.002608219810943201,0.01943606762821378,0.012812307843229762,SQSTM1/TRAF1/PIM1/COL6A1,4
NAKAMURA_CANCER_MICROENVIRONMENT_UP,NAKAMURA_CANCER_MICROENVIRONMENT_UP,2/62,27/21728,0.002685643862992411,0.01972085931511216,0.013000043286094654,CTF1/COL3A1,2
REACTOME_INTEGRIN_SIGNALING,REACTOME_INTEGRIN_SIGNALING,2/62,27/21728,0.002685643862992411,0.01972085931511216,0.013000043286094654,FN1/TLN1,2
REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,2/62,27/21728,0.002685643862992411,0.01972085931511216,0.013000043286094654,PIK3CA/IL2RB,2
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,2/62,27/21728,0.002685643862992411,0.01972085931511216,0.013000043286094654,STAT6/PIK3CA,2
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,3/62,97/21728,0.002695553649735246,0.019721650702790236,0.013000564970971903,AHNAK/IL2RB/APOL3,3
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,6/62,495/21728,0.0028358591227422227,0.020673002010715046,0.013627698301507249,SQSTM1/TRAF1/FN1/PDLIM4/GEM/TPP1,6
HWANG_PROSTATE_CANCER_MARKERS,HWANG_PROSTATE_CANCER_MARKERS,2/62,28/21728,0.0028869332235562516,0.02089391958919129,0.013773327761002945,PIM1/FLNA,2
REACTOME_FLT3_SIGNALING_IN_DISEASE,REACTOME_FLT3_SIGNALING_IN_DISEASE,2/62,28/21728,0.0028869332235562516,0.02089391958919129,0.013773327761002945,PIM1/PIK3CA,2
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,3/62,100/21728,0.0029384094254769665,0.021190250050393034,0.013968669594797126,CCN1/DKK1/GEM,3
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,3/62,101/21728,0.003022254320291608,0.021560034853610827,0.014212432727607851,CTF1/NFKB1/PIK3CA,3
BIOCARTA_DEATH_PATHWAY,BIOCARTA_DEATH_PATHWAY,2/62,29/21728,0.003095100571828726,0.021560034853610827,0.014212432727607851,LMNA/NFKB1,2
PID_IGF1_PATHWAY,PID_IGF1_PATHWAY,2/62,29/21728,0.003095100571828726,0.021560034853610827,0.014212432727607851,PXN/PIK3CA,2
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,2/62,29/21728,0.003095100571828726,0.021560034853610827,0.014212432727607851,STAT6/PIK3CA,2
WOTTON_RUNX_TARGETS_DN,WOTTON_RUNX_TARGETS_DN,2/62,29/21728,0.003095100571828726,0.021560034853610827,0.014212432727607851,PRRX1/PLOD2,2
WP_PDGFRBETA_PATHWAY,WP_PDGFRBETA_PATHWAY,2/62,29/21728,0.003095100571828726,0.021560034853610827,0.014212432727607851,STAT6/PIK3CA,2
WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,2/62,29/21728,0.003095100571828726,0.021560034853610827,0.014212432727607851,DNAJC3/EDEM1,2
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,4/62,211/21728,0.0031054982366026667,0.021560034853610827,0.014212432727607851,COL6A1/FURIN/TGOLN2/IRAK1,4
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,3/62,102/21728,0.00310755969559997,0.021560034853610827,0.014212432727607851,VCL/TRAM2/TBC1D8,3
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,3/62,102/21728,0.00310755969559997,0.021560034853610827,0.014212432727607851,NFKB1/PIK3CA/IRAK1,3
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,3/62,102/21728,0.00310755969559997,0.021560034853610827,0.014212432727607851,SQSTM1/NFKB1/IRAK1,3
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,3/62,104/21728,0.003282584755273844,0.022499776650973625,0.01483191303768273,NFKB1/PIK3CA/IRAK1,3
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,2/62,30/21728,0.0033101063065050663,0.022499776650973625,0.01483191303768273,PIM1/ELF4,2
PID_IL2_STAT5_PATHWAY,PID_IL2_STAT5_PATHWAY,2/62,30/21728,0.0033101063065050663,0.022499776650973625,0.01483191303768273,PIK3CA/IL2RB,2
PID_NECTIN_PATHWAY,PID_NECTIN_PATHWAY,2/62,30/21728,0.0033101063065050663,0.022499776650973625,0.01483191303768273,PIK3CA/TLN1,2
VALK_AML_CLUSTER_12,VALK_AML_CLUSTER_12,2/62,30/21728,0.0033101063065050663,0.022499776650973625,0.01483191303768273,VCL/HGF,2
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,2/62,30/21728,0.0033101063065050663,0.022499776650973625,0.01483191303768273,NFKB1/IRAK1,2
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,4/62,217/21728,0.0034330526427880496,0.023228870766935382,0.015312533831923504,CCN1/NFKB1/PLOD2/IL2RB,4
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,3/62,106/21728,0.003463549319125554,0.023228870766935382,0.015312533831923504,NRP2/PXN/PIK3CA,3
ROESSLER_LIVER_CANCER_METASTASIS_UP,ROESSLER_LIVER_CANCER_METASTASIS_UP,3/62,106/21728,0.003463549319125554,0.023228870766935382,0.015312533831923504,NFKB1/TGOLN2/IL2RB,3
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,3/62,106/21728,0.003463549319125554,0.023228870766935382,0.015312533831923504,SQSTM1/MYO1C/FBN1,3
BILANGES_SERUM_SENSITIVE_VIA_TSC2,BILANGES_SERUM_SENSITIVE_VIA_TSC2,2/62,31/21728,0.003531910989930199,0.023299032497506755,0.015358784632655914,CCN1/COL3A1,2
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,2/62,31/21728,0.003531910989930199,0.023299032497506755,0.015358784632655914,NFKB1/IRAK1,2
PID_AVB3_OPN_PATHWAY,PID_AVB3_OPN_PATHWAY,2/62,31/21728,0.003531910989930199,0.023299032497506755,0.015358784632655914,NFKB1/PIK3CA,2
PID_CD40_PATHWAY,PID_CD40_PATHWAY,2/62,31/21728,0.003531910989930199,0.023299032497506755,0.015358784632655914,TRAF1/NFKB1,2
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,2/62,31/21728,0.003531910989930199,0.023299032497506755,0.015358784632655914,AHNAK/FN1,2
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,3/62,107/21728,0.0035562786951679423,0.023383113512019278,0.01541421106264743,VCL/FBN1/PLOD2,3
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,2/62,32/21728,0.0037604753475116775,0.024328219933098055,0.01603722774704591,NFKB1/IRAK1,2
TAVOR_CEBPA_TARGETS_DN,TAVOR_CEBPA_TARGETS_DN,2/62,32/21728,0.0037604753475116775,0.024328219933098055,0.01603722774704591,ITGB5/PLOD2,2
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,2/62,32/21728,0.0037604753475116775,0.024328219933098055,0.01603722774704591,CCN1/COL6A1,2
WP_IL17_SIGNALING_PATHWAY,WP_IL17_SIGNALING_PATHWAY,2/62,32/21728,0.0037604753475116775,0.024328219933098055,0.01603722774704591,NFKB1/PIK3CA,2
WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,2/62,32/21728,0.0037604753475116775,0.024328219933098055,0.01603722774704591,NFKB1/IRAK1,2
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,5/62,366/21728,0.003891275584591639,0.02509373870576403,0.016541859772555553,PIM1/AHNAK/LMNA/VCL/GEM,5
REACTOME_O_LINKED_GLYCOSYLATION,REACTOME_O_LINKED_GLYCOSYLATION,3/62,111/21728,0.003942356191373199,0.025341919032085863,0.016705460908458824,ST3GAL1/GALNT10/GCNT1,3
BIOCARTA_MET_PATHWAY,BIOCARTA_MET_PATHWAY,2/62,33/21728,0.003995760267134515,0.025441359675552673,0.016771012447000296,PIK3CA/HGF,2
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,2/62,33/21728,0.003995760267134515,0.025441359675552673,0.016771012447000296,PIM1/ELF4,2
WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,2/62,33/21728,0.003995760267134515,0.025441359675552673,0.016771012447000296,NFKB1/PIK3CA,2
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,3/62,113/21728,0.004144595445535745,0.026223037850370813,0.01728629679369427,COL6A1/TBC1D8/TNIP1,3
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,3/62,113/21728,0.004144595445535745,0.026223037850370813,0.01728629679369427,PIK3CA/HGF/IRAK1,3
BIOCARTA_INTEGRIN_PATHWAY,BIOCARTA_INTEGRIN_PATHWAY,2/62,34/21728,0.004237726798578,0.026461479185066136,0.017443477960229846,VCL/TLN1,2
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,2/62,34/21728,0.004237726798578,0.026461479185066136,0.017443477960229846,FN1/FBN1,2
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,2/62,34/21728,0.004237726798578,0.026461479185066136,0.017443477960229846,CCN1/FN1,2
SIG_CD40PATHWAYMAP,SIG_CD40PATHWAYMAP,2/62,34/21728,0.004237726798578,0.026461479185066136,0.017443477960229846,NFKB1/PIK3CA,2
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,3/62,114/21728,0.004248040644521054,0.026461479185066136,0.017443477960229846,PXN/NFKB1/PIK3CA,3
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,5/62,378/21728,0.004459075012385115,0.027106631650762696,0.01786876419376426,NRP2/CCN1/PRRX1/GEM/COL15A1,5
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,5/62,378/21728,0.004459075012385115,0.027106631650762696,0.01786876419376426,NRP2/LMNA/FURIN/PLXNA1/HLCS,5
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,3/62,116/21728,0.0044596174535285246,0.027106631650762696,0.01786876419376426,PXN/VCL/PIK3CA,3
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,CCN1/COL15A1,2
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,CCN1/COL15A1,2
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,PXN/HGF,2
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,PIK3CA/TLN1,2
PID_HIV_NEF_PATHWAY,PID_HIV_NEF_PATHWAY,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,TRAF1/NFKB1,2
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,ITGB5/TPP1,2
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,2/62,35/21728,0.004486336152934383,0.027106631650762696,0.01786876419376426,NFKB1/IRAK1,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,5/62,383/21728,0.004712291652621781,0.02830859940796261,0.018661104558979225,AHNAK/PXN/AHNAK2/EHBP1L1/GALNT10,5
CUI_TCF21_TARGETS_UP,CUI_TCF21_TARGETS_UP,2/62,36/21728,0.0047415497020295225,0.02830859940796261,0.018661104558979225,COL6A1/COL3A1,2
PID_GMCSF_PATHWAY,PID_GMCSF_PATHWAY,2/62,36/21728,0.0047415497020295225,0.02830859940796261,0.018661104558979225,PIM1/PIK3CA,2
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,2/62,36/21728,0.0047415497020295225,0.02830859940796261,0.018661104558979225,CCN1/GEM,2
BIOCARTA_IL2RB_PATHWAY,BIOCARTA_IL2RB_PATHWAY,2/62,37/21728,0.005003328977845407,0.029695274051401054,0.01957520419837048,PIK3CA/IL2RB,2
PID_IL23_PATHWAY,PID_IL23_PATHWAY,2/62,37/21728,0.005003328977845407,0.029695274051401054,0.01957520419837048,NFKB1/PIK3CA,2
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,5/62,390/21728,0.005083816438131452,0.0300842313927073,0.019831605919645914,PXN/FLII/FBN1/AKAP13/PLOD2,5
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,4/62,243/21728,0.005125468097934407,0.030241764847636445,0.019935452395114538,BNC2/LMNA/COL3A1/TRAM2,4
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,2/62,38/21728,0.005271635671944614,0.030922830822019135,0.020384412909775097,VCL/GALNT10,2
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,2/62,38/21728,0.005271635671944614,0.030922830822019135,0.020384412909775097,COL3A1/COL15A1,2
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,3/62,125/21728,0.005490370174171197,0.032019202291108544,0.02110714391901055,COL3A1/FN1/FBN1,3
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,3/62,125/21728,0.005490370174171197,0.032019202291108544,0.02110714391901055,COL3A1/FBN1/GALNT10,3
PID_RET_PATHWAY,PID_RET_PATHWAY,2/62,39/21728,0.005546431634896661,0.032159713110697645,0.021199769027665082,PXN/PIK3CA,2
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,2/62,39/21728,0.005546431634896661,0.032159713110697645,0.021199769027665082,FN1/TLN1,2
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,3/62,126/21728,0.00561297187662189,0.03245200981541162,0.02139245179837744,NFKB1/PIK3CA/IRAK1,3
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,5/62,401/21728,0.005709072482320731,0.03291127602670452,0.02169520131508198,TGOLN2/AKAP13/FLNA/TPP1/TBC1D8,5
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,3/62,127/21728,0.00573721077175211,0.03291127602670452,0.02169520131508198,ST3GAL1/STAT6/FLNA,3
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,4/62,251/21728,0.005741480062312766,0.03291127602670452,0.02169520131508198,PIM1/COL3A1/FN1/MYO1C,4
CROONQUIST_NRAS_SIGNALING_UP,CROONQUIST_NRAS_SIGNALING_UP,2/62,40/21728,0.0058276788757062195,0.032936207578429536,0.021711636260762383,GCNT1/ELF4,2
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,2/62,40/21728,0.0058276788757062195,0.032936207578429536,0.021711636260762383,AHNAK/AHNAK2,2
NABA_BASEMENT_MEMBRANES,NABA_BASEMENT_MEMBRANES,2/62,40/21728,0.0058276788757062195,0.032936207578429536,0.021711636260762383,COL6A1/COL15A1,2
PID_EPHB_FWD_PATHWAY,PID_EPHB_FWD_PATHWAY,2/62,40/21728,0.0058276788757062195,0.032936207578429536,0.021711636260762383,PXN/PIK3CA,2
WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,2/62,40/21728,0.0058276788757062195,0.032936207578429536,0.021711636260762383,NFKB1/PIK3CA,2
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,3/62,129/21728,0.005990623490794905,0.0337622814103063,0.022256186343510485,COL6A1/COL3A1/HGF,3
PID_AMB2_NEUTROPHILS_PATHWAY,PID_AMB2_NEUTROPHILS_PATHWAY,2/62,41/21728,0.006115339561243261,0.034108186279669696,0.02248420775995805,NFKB1/TLN1,2
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,2/62,41/21728,0.006115339561243261,0.034108186279669696,0.02248420775995805,VCL/HGF,2
WP_OXIDATIVE_DAMAGE_RESPONSE,WP_OXIDATIVE_DAMAGE_RESPONSE,2/62,41/21728,0.006115339561243261,0.034108186279669696,0.02248420775995805,TRAF1/NFKB1,2
REACTOME_CELL_CELL_COMMUNICATION,REACTOME_CELL_CELL_COMMUNICATION,3/62,130/21728,0.006119808770855249,0.034108186279669696,0.02248420775995805,PXN/PIK3CA/FLNA,3
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,3/62,131/21728,0.006250654156979892,0.034645499073949156,0.02283840579322797,PIM1/TGOLN2/HGF,3
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,3/62,131/21728,0.006250654156979892,0.034645499073949156,0.02283840579322797,NFKB1/PIK3CA/FLNA,3
REACTOME_NCAM1_INTERACTIONS,REACTOME_NCAM1_INTERACTIONS,2/62,42/21728,0.006409376015675055,0.035234056129885824,0.023226384181048516,COL6A1/COL3A1,2
WP_MELATONIN_METABOLISM_AND_EFFECTS,WP_MELATONIN_METABOLISM_AND_EFFECTS,2/62,42/21728,0.006409376015675055,0.035234056129885824,0.023226384181048516,NFKB1/IRAK1,2
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,2/62,42/21728,0.006409376015675055,0.035234056129885824,0.023226384181048516,TRAF1/NFKB1,2
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,5/62,414/21728,0.006516052994363508,0.03563288744623702,0.02348929485312266,TRAF1/PIM1/LMNA/NFKB1/PLOD2,5
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,3/62,133/21728,0.0065173472068664135,0.03563288744623702,0.02348929485312266,LMNA/VCL/FN1,3
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,4/62,262/21728,0.0066666732056613175,0.03635053249265737,0.023962368390053522,COL6A1/COL3A1/FBN1/PRRX1,4
PID_THROMBIN_PAR1_PATHWAY,PID_THROMBIN_PAR1_PATHWAY,2/62,43/21728,0.006709750719900049,0.03648653634713216,0.024052022495232046,AKAP13/PIK3CA,2
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,3/62,135/21728,0.006790745705156606,0.036827440320148494,0.0242767473074119,COL6A1/COL3A1/HGF,3
BIOCARTA_TCR_PATHWAY,BIOCARTA_TCR_PATHWAY,2/62,44/21728,0.0070164263109836825,0.03774612229331329,0.024882344924963242,NFKB1/PIK3CA,2
GNATENKO_PLATELET_SIGNATURE,GNATENKO_PLATELET_SIGNATURE,2/62,44/21728,0.0070164263109836825,0.03774612229331329,0.024882344924963242,FLNA/TLN1,2
REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,2/62,44/21728,0.0070164263109836825,0.03774612229331329,0.024882344924963242,PIK3CA/IL2RB,2
PID_ILK_PATHWAY,PID_ILK_PATHWAY,2/62,45/21728,0.0073293655815958635,0.039219903058965104,0.025853865153445656,PXN/GIT2,2
WANG_TARGETS_OF_MLL_CBP_FUSION_DN,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,2/62,45/21728,0.0073293655815958635,0.039219903058965104,0.025853865153445656,TMEM109/IRAK1,2
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,5/62,428/21728,0.007471580421036301,0.03983573516281098,0.026259823325908673,NRP2/VCL/FN1/TMEM109/TLN1,5
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,3/62,140/21728,0.007503848721026521,0.03983573516281098,0.026259823325908673,NRP2/MANBA/EDEM1,3
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,3/62,140/21728,0.007503848721026521,0.03983573516281098,0.026259823325908673,SQSTM1/NFKB1/IRAK1,3
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,2/62,46/21728,0.007648531479450628,0.04017975283721844,0.026486600698386126,GCNT1/PDLIM4,2
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,2/62,46/21728,0.007648531479450628,0.04017975283721844,0.026486600698386126,AHNAK/AHNAK2,2
JAEGER_METASTASIS_UP,JAEGER_METASTASIS_UP,2/62,46/21728,0.007648531479450628,0.04017975283721844,0.026486600698386126,FN1/PLOD2,2
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,2/62,46/21728,0.007648531479450628,0.04017975283721844,0.026486600698386126,TMEM109/FLNA,2
HUANG_FOXA2_TARGETS_UP,HUANG_FOXA2_TARGETS_UP,2/62,47/21728,0.007973887106747334,0.041563370100455015,0.027398684904558608,FN1/HLCS,2
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,2/62,47/21728,0.007973887106747334,0.041563370100455015,0.027398684904558608,CCN1/COL3A1,2
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,2/62,47/21728,0.007973887106747334,0.041563370100455015,0.027398684904558608,ITGB5/DKK1,2
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,3/62,145/21728,0.0082597332985614,0.04273773961090319,0.028172832431588378,LMNA/COL3A1/COL15A1,3
LEE_CALORIE_RESTRICTION_MUSCLE_DN,LEE_CALORIE_RESTRICTION_MUSCLE_DN,2/62,48/21728,0.008305395719613891,0.04273773961090319,0.028172832431588378,FBN1/IRAK1,2
REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,2/62,48/21728,0.008305395719613891,0.04273773961090319,0.028172832431588378,PIK3CA/IL2RB,2
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,2/62,48/21728,0.008305395719613891,0.04273773961090319,0.028172832431588378,HGF/DKK1,2
WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,2/62,48/21728,0.008305395719613891,0.04273773961090319,0.028172832431588378,PIM1/PIK3CA,2
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,4/62,280/21728,0.008385468983119674,0.043039703046012207,0.02837188753687108,EDEM1/ITGB5/TBC1D8/IL2RB,4
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,3/62,146/21728,0.008416094580875508,0.043086977854253236,0.028403051217096936,AHNAK/TGOLN2/TPP1,3
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,2/62,49/21728,0.008643020727551798,0.04413644087267568,0.029094860050000712,NRP2/PRRX1,2
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,3/62,148/21728,0.008734036228212234,0.04448830605357725,0.029326810519779926,GALNT10/TRAM2/TNIP1,3
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,5/62,446/21728,0.008839013952845665,0.04486672976198625,0.029576268442033423,NFKB1/FN1/PIK3CA/HGF/DKK1,5
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,AHNAK/COL3A1,2
REACTOME_SIGNALING_BY_EGFR,REACTOME_SIGNALING_BY_EGFR,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,PXN/PIK3CA,2
ROY_WOUND_BLOOD_VESSEL_UP,ROY_WOUND_BLOOD_VESSEL_UP,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,CCN1/COL3A1,2
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,FBN1/PLOD2,2
TSUNODA_CISPLATIN_RESISTANCE_DN,TSUNODA_CISPLATIN_RESISTANCE_DN,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,FN1/FBN1,2
WESTON_VEGFA_TARGETS_6HR,WESTON_VEGFA_TARGETS_6HR,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,COL6A1/GEM,2
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,2/62,50/21728,0.008986725692882933,0.04486672976198625,0.029576268442033423,NFKB1/IRAK1,2
BIOCARTA_NFAT_PATHWAY,BIOCARTA_NFAT_PATHWAY,2/62,51/21728,0.009336474330198328,0.04638268235150379,0.0305755884497723,CTF1/PIK3CA,2
KOHOUTEK_CCNT1_TARGETS,KOHOUTEK_CCNT1_TARGETS,2/62,51/21728,0.009336474330198328,0.04638268235150379,0.0305755884497723,SQSTM1/AHNAK2,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,3/62,152/21728,0.009390910818477748,0.04653820829255475,0.03067811156671497,STAT6/MYO1C/FBN1,3
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,2/62,52/21728,0.0096922305058086,0.04791343434321106,0.031584664263077294,PXN/COL6A1,2
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,3/62,156/21728,0.010075981595397996,0.049688419043972476,0.03275473893240835,COL3A1/ST3GAL1/TPP1,3
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,2/62,54/21728,0.010421621692470117,0.05126724412041534,0.03379550465194273,AHNAK/LMNA,2
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,3/62,160/21728,0.010789481150797253,0.052718234470677805,0.0347520013775526,CTF1/TRAF1/FBN1,3
PID_FGF_PATHWAY,PID_FGF_PATHWAY,2/62,55/21728,0.010795185189820703,0.052718234470677805,0.0347520013775526,PIK3CA/HGF,2
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,2/62,55/21728,0.010795185189820703,0.052718234470677805,0.0347520013775526,PIK3CA/IL2RB,2
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,2/62,56/21728,0.011174613196978512,0.054439035719905,0.035886358170492995,PDLIM4/TRAM2,2
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,3/62,164/21728,0.011531623365971256,0.05577568130770938,0.03676747852239919,SQSTM1/DKK1/KLHL21,3
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,3/62,164/21728,0.011531623365971256,0.05577568130770938,0.03676747852239919,NRP2/FN1/PIK3CA,3
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,2/62,57/21728,0.011559870330673365,0.05577568130770938,0.03676747852239919,CCN1/GEM,2
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,2/62,57/21728,0.011559870330673365,0.05577568130770938,0.03676747852239919,PIK3CA/IL2RB,2
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,3/62,165/21728,0.0117216576572717,0.05642099331681977,0.037192869927379364,PXN/NFKB1/PIK3CA,3
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,2/62,58/21728,0.011950921356095682,0.05711461702723162,0.03765010853526831,CCN1/FN1,2
CROMER_TUMORIGENESIS_UP,CROMER_TUMORIGENESIS_UP,2/62,58/21728,0.011950921356095682,0.05711461702723162,0.03765010853526831,COL3A1/FN1,2
HUPER_BREAST_BASAL_VS_LUMINAL_DN,HUPER_BREAST_BASAL_VS_LUMINAL_DN,2/62,58/21728,0.011950921356095682,0.05711461702723162,0.03765010853526831,CCN1/DKK1,2
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,3/62,167/21728,0.012107145142953336,0.057724113809531075,0.038051890446797715,CCN1/FURIN/PLOD2,3
IBRAHIM_NRF2_DOWN,IBRAHIM_NRF2_DOWN,3/62,168/21728,0.012302603895164792,0.058059847486548924,0.038273206986005885,TRAF1/STAT6/MANBA,3
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,3/62,168/21728,0.012302603895164792,0.058059847486548924,0.038273206986005885,CCN1/FN1/PLOD2,3
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,2/62,59/21728,0.012347731186359711,0.058059847486548924,0.038273206986005885,EHBP1L1/DKK1,2
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,2/62,59/21728,0.012347731186359711,0.058059847486548924,0.038273206986005885,PIK3CA/HGF,2
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,2/62,59/21728,0.012347731186359711,0.058059847486548924,0.038273206986005885,NFKB1/PIK3CA,2
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,4/62,314/21728,0.012376725598939002,0.058059847486548924,0.038273206986005885,SQSTM1/COL3A1/STAT6/TPP1,4
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,5/62,485/21728,0.012379559926306903,0.058059847486548924,0.038273206986005885,COL6A1/FN1/TMEM109/MANBA/FLNA,5
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,3/62,169/21728,0.0124998762452492,0.05848779303591021,0.03855530983846754,COL6A1/COL3A1/FBN1,3
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,3/62,170/21728,0.012698964802407836,0.0591095229090331,0.038965155836236116,COL3A1/FURIN/GEM,3
NADLER_OBESITY_UP,NADLER_OBESITY_UP,2/62,60/21728,0.012750264881968374,0.0591095229090331,0.038965155836236116,FLNA/TLN1,2
VANASSE_BCL2_TARGETS_DN,VANASSE_BCL2_TARGETS_DN,2/62,60/21728,0.012750264881968374,0.0591095229090331,0.038965155836236116,TRAF1/FN1,2
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,2/62,60/21728,0.012750264881968374,0.0591095229090331,0.038965155836236116,CCN1/PDLIM4,2
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,4/62,318/21728,0.012913852094271126,0.059730276813042535,0.0393743584725508,FLNA/EDEM1/DKK1/TPP1,4
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,3/62,172/21728,0.013102600639821377,0.06044492500539546,0.039845456475252845,PIM1/CCN1/AHNAK2,3
ISSAEVA_MLL2_TARGETS,ISSAEVA_MLL2_TARGETS,2/62,61/21728,0.013158487650279925,0.06044492500539546,0.039845456475252845,AHNAK/DKK1,2
PID_TRKR_PATHWAY,PID_TRKR_PATHWAY,2/62,61/21728,0.013158487650279925,0.06044492500539546,0.039845456475252845,SQSTM1/PIK3CA,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,3/62,173/21728,0.013307152804885161,0.060988590987309674,0.04020384254682965,CCN1/VCL/GEM,3
GERHOLD_ADIPOGENESIS_DN,GERHOLD_ADIPOGENESIS_DN,2/62,62/21728,0.013572364844976453,0.06164243356228583,0.04063485732367906,CCN1/FN1,2
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,2/62,62/21728,0.013572364844976453,0.06164243356228583,0.04063485732367906,FLNA/ITGB5,2
WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,2/62,62/21728,0.013572364844976453,0.06164243356228583,0.04063485732367906,NFKB1/PIK3CA,2
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,2/62,62/21728,0.013572364844976453,0.06164243356228583,0.04063485732367906,NFKB1/FBN1,2
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,3/62,176/21728,0.01393177421375584,0.06283845150592503,0.041423275555857245,PIM1/AHNAK/ST3GAL1,3
PID_BCR_5PATHWAY,PID_BCR_5PATHWAY,2/62,63/21728,0.013991861965534001,0.06283845150592503,0.041423275555857245,NFKB1/PIK3CA,2
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2/62,63/21728,0.013991861965534001,0.06283845150592503,0.041423275555857245,COL6A1/COL3A1,2
WILCOX_RESPONSE_TO_PROGESTERONE_DN,WILCOX_RESPONSE_TO_PROGESTERONE_DN,2/62,63/21728,0.013991861965534001,0.06283845150592503,0.041423275555857245,COL6A1/FN1,2
WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,2/62,63/21728,0.013991861965534001,0.06283845150592503,0.041423275555857245,NFKB1/IRAK1,2
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,2/62,64/21728,0.014416944656694644,0.0643168351425047,0.04239783000918486,STAT6/PIK3CA,2
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,2/62,64/21728,0.014416944656694644,0.0643168351425047,0.04239783000918486,STAT6/NFKB1,2
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,2/62,64/21728,0.014416944656694644,0.0643168351425047,0.04239783000918486,PLXNA1/TLN1,2
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,4/62,329/21728,0.014467332620116189,0.06439883458334905,0.04245188426023847,HHAT/AHNAK/GALNT10/ITGB5,4
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,2/62,65/21728,0.014847578707940106,0.06565566672609999,0.04328039137537197,PIM1/GCNT1,2
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,2/62,65/21728,0.014847578707940106,0.06565566672609999,0.04328039137537197,CCN1/PIK3CA,2
PID_LYSOPHOSPHOLIPID_PATHWAY,PID_LYSOPHOSPHOLIPID_PATHWAY,2/62,65/21728,0.014847578707940106,0.06565566672609999,0.04328039137537197,PXN/NFKB1,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,3/62,182/21728,0.015230551161580586,0.06699534829318074,0.044163513052949535,AHNAK/FLNA/ITGB5,3
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,3/62,182/21728,0.015230551161580586,0.06699534829318074,0.044163513052949535,COL6A1/COL3A1/TNIP1,3
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,2/62,66/21728,0.015283730052967178,0.06699534829318074,0.044163513052949535,PLXNA1/RAB36,2
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,2/62,66/21728,0.015283730052967178,0.06699534829318074,0.044163513052949535,FN1/COL15A1,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,3/62,183/21728,0.01545345793179702,0.06744546064810326,0.044460228323014606,AHNAK/TGOLN2/TRAM2,3
WU_CELL_MIGRATION,WU_CELL_MIGRATION,3/62,183/21728,0.01545345793179702,0.06744546064810326,0.044460228323014606,CCN1/AHNAK2/FN1,3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,3/62,184/21728,0.015678210595250014,0.06827826778710612,0.0450092170198565,LMNA/TMEM109/TPP1,3
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,3/62,185/21728,0.015904810800929023,0.06911550611548423,0.045561126768604236,FN1/FBN1/GALNT10,3
LINDVALL_IMMORTALIZED_BY_TERT_UP,LINDVALL_IMMORTALIZED_BY_TERT_UP,2/62,68/21728,0.01617244907709427,0.06982611060754007,0.046029559153238725,DKK1/COL15A1,2
WP_MELANOMA,WP_MELANOMA,2/62,68/21728,0.01617244907709427,0.06982611060754007,0.046029559153238725,VCL/PIK3CA,2
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,2/62,68/21728,0.01617244907709427,0.06982611060754007,0.046029559153238725,VCL/FN1,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,4/62,341/21728,0.016292318748833433,0.07019303066949222,0.04627143384093345,SQSTM1/TRAF1/ST3GAL1/PLXNA1,4
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,3/62,188/21728,0.016595712254711525,0.07132067819192753,0.047014782108312586,VCL/PDLIM4/IL2RB,3
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,2/62,69/21728,0.0166249493399672,0.07132067819192753,0.047014782108312586,COL6A1/COL3A1,2
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,3/62,189/21728,0.016829717913412146,0.07204551583358561,0.047492597023290714,PXN/NFKB1/PIK3CA,3
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,2/62,70/21728,0.01708283206313053,0.07266523913534594,0.04790112028384215,NFKB1/PIK3CA,2
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,2/62,70/21728,0.01708283206313053,0.07266523913534594,0.04790112028384215,PIK3CA/HGF,2
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,2/62,70/21728,0.01708283206313053,0.07266523913534594,0.04790112028384215,LMNA/ITGB5,2
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,2/62,71/21728,0.017546063893549478,0.0737007944756191,0.048583761138055924,COL6A1/FN1,2
KEGG_MELANOMA,KEGG_MELANOMA,2/62,71/21728,0.017546063893549478,0.0737007944756191,0.048583761138055924,PIK3CA/HGF,2
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,2/62,71/21728,0.017546063893549478,0.0737007944756191,0.048583761138055924,AKAP13/HLCS,2
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,2/62,71/21728,0.017546063893549478,0.0737007944756191,0.048583761138055924,VCL/ITGB5,2
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,2/62,71/21728,0.017546063893549478,0.0737007944756191,0.048583761138055924,NFKB1/IRAK1,2
REACTOME_SARS_COV_2_INFECTION,REACTOME_SARS_COV_2_INFECTION,2/62,71/21728,0.017546063893549478,0.0737007944756191,0.048583761138055924,FURIN/ST3GAL1,2
FUJII_YBX1_TARGETS_DN,FUJII_YBX1_TARGETS_DN,3/62,193/21728,0.017784302038218108,0.0745458660435309,0.049140834579286884,DNAJC3/FLNA/DKK1,3
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,2/62,72/21728,0.01801461161929345,0.07519792236103408,0.04957067185042532,NFKB1/IRAK1,2
LANDIS_BREAST_CANCER_PROGRESSION_DN,LANDIS_BREAST_CANCER_PROGRESSION_DN,2/62,72/21728,0.01801461161929345,0.07519792236103408,0.04957067185042532,AHNAK/COL3A1,2
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,3/62,195/21728,0.018272747659908026,0.07611753269510341,0.0501768814459717,COL6A1/TBC1D2B/TNIP1,3
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,2/62,73/21728,0.01848844216902368,0.07667029301175475,0.050541262527367896,FBN1/AKAP13,2
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,2/62,73/21728,0.01848844216902368,0.07667029301175475,0.050541262527367896,NFKB1/PIK3CA,2
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,3/62,196/21728,0.018519762626099806,0.07667029301175475,0.050541262527367896,CCN1/FN1/FBN1,3
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,2/62,74/21728,0.01896752261148245,0.07820216289816125,0.05155107525985307,PIM1/ITGB5,2
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,2/62,74/21728,0.01896752261148245,0.07820216289816125,0.05155107525985307,LMNA/ITGB5,2
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,3/62,199/21728,0.0192719873649679,0.07921335237094063,0.05221765406894694,CCN1/TMEM109/MYO1C,3
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,4/62,359/21728,0.019291522197694286,0.07921335237094063,0.05221765406894694,NFKB1/PRRX1/TPP1/PLOD2,4
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,2/62,75/21728,0.019451820154983923,0.07938552160614129,0.05233114848997491,NFKB1/PIK3CA,2
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,2/62,75/21728,0.019451820154983923,0.07938552160614129,0.05233114848997491,EDEM1/PLOD2,2
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,2/62,75/21728,0.019451820154983923,0.07938552160614129,0.05233114848997491,ZDHHC7/PIK3CA,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,3/62,200/21728,0.019526458350538085,0.0795288141726369,0.05242560733364158,CTF1/AHNAK2/EHBP1L1,3
KEGG_VEGF_SIGNALING_PATHWAY,KEGG_VEGF_SIGNALING_PATHWAY,2/62,76/21728,0.019941302146906915,0.08040460905726796,0.05300293366755134,PXN/PIK3CA,2
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,2/62,76/21728,0.019941302146906915,0.08040460905726796,0.05300293366755134,SQSTM1/AKAP13,2
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,2/62,76/21728,0.019941302146906915,0.08040460905726796,0.05300293366755134,NFKB1/TPP1,2
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,2/62,76/21728,0.019941302146906915,0.08040460905726796,0.05300293366755134,LMNA/ITGB5,2
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,2/62,76/21728,0.019941302146906915,0.08040460905726796,0.05300293366755134,NFKB1/PIK3CA,2
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,4/62,364/21728,0.020181494406083328,0.0812103334900793,0.053534069371926306,TRAF1/STAT6/FN1/DKK1,4
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,2/62,77/21728,0.02043593607318913,0.08174374429275652,0.05388569520187989,COL6A1/FBN1,2
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,2/62,77/21728,0.02043593607318913,0.08174374429275652,0.05388569520187989,PIM1/PIK3CA,2
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,2/62,77/21728,0.02043593607318913,0.08174374429275652,0.05388569520187989,BNC2/FN1,2
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,4/62,367/21728,0.020727502997526903,0.08274550799806375,0.05454606051980765,SQSTM1/FURIN/FN1/PDLIM4,4
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,3/62,205/21728,0.020826815381225352,0.08291851848492186,0.05466010949618162,PIM1/CCN1/FN1,3
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,2/62,78/21728,0.020935689557823215,0.08291851848492186,0.05466010949618162,PIK3CA/HGF,2
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,2/62,78/21728,0.020935689557823215,0.08291851848492186,0.05466010949618162,PRRX1/TNIP1,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,2/62,78/21728,0.020935689557823215,0.08291851848492186,0.05466010949618162,COL3A1/FBN1,2
WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,2/62,79/21728,0.021440530362354222,0.0846997675027162,0.05583431362008079,CTF1/IL2RB,2
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,4/62,371/21728,0.021469622975340587,0.0846997675027162,0.05583431362008079,FURIN/NFKB1/TGOLN2/ELF4,4
PID_BETA_CATENIN_NUC_PATHWAY,PID_BETA_CATENIN_NUC_PATHWAY,2/62,80/21728,0.021950426385379276,0.08625831618629512,0.05686171308712559,CCN1/DKK1,2
ROSS_AML_WITH_PML_RARA_FUSION,ROSS_AML_WITH_PML_RARA_FUSION,2/62,80/21728,0.021950426385379276,0.08625831618629512,0.05686171308712559,GCNT1/HGF,2
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,3/62,210/21728,0.022173889724689578,0.08696660063562463,0.057328616093380254,DNAJC3/FN1/PLXNA1,3
HARRIS_HYPOXIA,HARRIS_HYPOXIA,2/62,81/21728,0.022465345662048292,0.08776752518842945,0.057856587703997646,NFKB1/HGF,2
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,2/62,81/21728,0.022465345662048292,0.08776752518842945,0.057856587703997646,ST3GAL1/TBC1D8,2
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,3/62,212/21728,0.022725809956524068,0.08861304192350082,0.05841395460061266,CCN1/FN1/TMEM109,3
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,2/62,82/21728,0.022985256363566877,0.08910662004527276,0.05873932262061509,ZDHHC7/GALNT10,2
MCLACHLAN_DENTAL_CARIES_DN,MCLACHLAN_DENTAL_CARIES_DN,2/62,82/21728,0.022985256363566877,0.08910662004527276,0.05873932262061509,CCN1/AHNAK,2
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,2/62,82/21728,0.022985256363566877,0.08910662004527276,0.05873932262061509,PIM1/NFKB1,2
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,2/62,83/21728,0.023510126796700448,0.0904443118832912,0.059621132663464964,LMNA/ITGB5,2
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,2/62,83/21728,0.023510126796700448,0.0904443118832912,0.059621132663464964,HHAT/FN1,2
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,2/62,83/21728,0.023510126796700448,0.0904443118832912,0.059621132663464964,FLNA/PLOD2,2
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,2/62,83/21728,0.023510126796700448,0.0904443118832912,0.059621132663464964,APOL3/TNIP1,2
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,4/62,384/21728,0.023993838691667036,0.09160668543825762,0.06038737242450801,CCN1/VCL/FN1/HEBP1,4
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,2/62,84/21728,0.02403992540328033,0.09160668543825762,0.06038737242450801,LMNA/TRAM2,2
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,2/62,84/21728,0.02403992540328033,0.09160668543825762,0.06038737242450801,CCN1/TGOLN2,2
LEIN_MIDBRAIN_MARKERS,LEIN_MIDBRAIN_MARKERS,2/62,84/21728,0.02403992540328033,0.09160668543825762,0.06038737242450801,BNC2/COL15A1,2
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,2/62,84/21728,0.02403992540328033,0.09160668543825762,0.06038737242450801,PIK3CA/HGF,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,2/62,85/21728,0.02457462075971145,0.09329082446894232,0.061497561384779395,NFKB1/DKK1,2
SANA_TNF_SIGNALING_DN,SANA_TNF_SIGNALING_DN,2/62,85/21728,0.02457462075971145,0.09329082446894232,0.061497561384779395,AHNAK2/PDLIM4,2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,3/62,219/21728,0.024716453206041853,0.09365254962439964,0.06173601157619731,HHAT/COL3A1/APOL3,3
WP_APOPTOSIS,WP_APOPTOSIS,2/62,86/21728,0.02511418157648133,0.09498070175165496,0.06261153301615845,TRAF1/NFKB1,2
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,2/62,87/21728,0.025658576697671263,0.09685751653980221,0.06384873435186293,SQSTM1/PLOD2,2
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,3/62,224/21728,0.026194439750169034,0.09819374953844133,0.06472958272388621,CCN1/STAT6/GEM,3
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,2/62,88/21728,0.026207775100468688,0.09819374953844133,0.06472958272388621,LMNA/PLXNA1,2
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,2/62,88/21728,0.026207775100468688,0.09819374953844133,0.06472958272388621,GIT2/PIK3CA,2
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,2/62,88/21728,0.026207775100468688,0.09819374953844133,0.06472958272388621,COL15A1/TLN1,2
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,NFKB1/PIK3CA,2
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,FN1/PLOD2,2
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,NRP2/AHNAK2,2
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,FURIN/MYO1C,2
WALLACE_PROSTATE_CANCER_RACE_DN,WALLACE_PROSTATE_CANCER_RACE_DN,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,PIK3CA/PLOD2,2
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,NFKB1/DKK1,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/62,89/21728,0.026761745894681464,0.09897910430165277,0.06524729068749739,NFKB1/PIK3CA,2
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,4/62,399/21728,0.02712251352336597,0.09998520235970938,0.06591051322236781,SQSTM1/PIM1/FLNA/IRAK1,4
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,2/62,90/21728,0.027320458322253393,0.09998520235970938,0.06591051322236781,LMNA/ITGB5,2
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,4/62,400/21728,0.02733940669121143,0.09998520235970938,0.06591051322236781,SQSTM1/FN1/HEBP1/TPP1,4
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,4/62,400/21728,0.02733940669121143,0.09998520235970938,0.06591051322236781,COL3A1/VCL/ELF4/DKK1,4
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,3/62,229/21728,0.027719124905430256,0.09998520235970938,0.06591051322236781,COL3A1/ST3GAL1/AKAP13,3
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,2/62,91/21728,0.027883881756782004,0.09998520235970938,0.06591051322236781,NFKB1/IRAK1,2
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,3/62,230/21728,0.02802965960321858,0.09998520235970938,0.06591051322236781,SQSTM1/LMNA/STAT6,3
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,SQSTM1,1
BIOCARTA_FREE_PATHWAY,BIOCARTA_FREE_PATHWAY,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,NFKB1,1
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,NFKB1,1
KRISHNAN_FURIN_TARGETS_DN,KRISHNAN_FURIN_TARGETS_DN,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,APOL3,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,PIM1,1
OSAWA_TNF_TARGETS,OSAWA_TNF_TARGETS,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,COL3A1,1
PID_VEGF_VEGFR_PATHWAY,PID_VEGF_VEGFR_PATHWAY,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,NRP2,1
REACTOME_MET_RECEPTOR_RECYCLING,REACTOME_MET_RECEPTOR_RECYCLING,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,HGF,1
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,PIK3CA,1
REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,DKK1,1
REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,FURIN,1
REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER,REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,PIK3CA,1
REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,PIM1,1
SCHLESINGER_METHYLATED_IN_COLON_CANCER,SCHLESINGER_METHYLATED_IN_COLON_CANCER,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,DKK1,1
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,PIM1,1
WP_SARSCOV2_AND_COVID19_PATHWAY,WP_SARSCOV2_AND_COVID19_PATHWAY,1/62,10/21728,0.028176744402562237,0.09998520235970938,0.06591051322236781,FURIN,1
REACTOME_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_JUNCTION_ORGANIZATION,2/62,92/21728,0.02845198570303707,0.1007841465396313,0.06643717936587604,PXN/FLNA,2
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,3/62,232/21728,0.028656321022284915,0.10132955693644508,0.06679671536042733,NFKB1/GEM/PANX1,3
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,2/62,93/21728,0.029024739796481618,0.10227281343348689,0.06741851256994533,CCN1/PDLIM4,2
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,2/62,93/21728,0.029024739796481618,0.10227281343348689,0.06741851256994533,COL3A1/FLNA,2
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2/62,94/21728,0.029602113802793917,0.10394319890265508,0.06851963514562384,NFKB1/IRAK1,2
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,2/62,94/21728,0.029602113802793917,0.10394319890265508,0.06851963514562384,TRAF1/NFKB1,2
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,2/62,96/21728,0.030770601264955774,0.10501872897374585,0.06922862744947149,SQSTM1/AHNAK,2
BIOCARTA_AKAP13_PATHWAY,BIOCARTA_AKAP13_PATHWAY,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,AKAP13,1
BIOCARTA_EPONFKB_PATHWAY,BIOCARTA_EPONFKB_PATHWAY,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,NFKB1,1
BIOCARTA_IL4_PATHWAY,BIOCARTA_IL4_PATHWAY,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,STAT6,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,PIM1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,FN1,1
REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,HLCS,1
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,FURIN,1
REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,HGF,1
REACTOME_MET_ACTIVATES_RAS_SIGNALING,REACTOME_MET_ACTIVATES_RAS_SIGNALING,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,HGF,1
REACTOME_PEXOPHAGY,REACTOME_PEXOPHAGY,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,SQSTM1,1
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,NFKB1,1
REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,PIK3CA,1
REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,FURIN,1
WHITESIDE_CISPLATIN_RESISTANCE_UP,WHITESIDE_CISPLATIN_RESISTANCE_UP,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,PXN,1
WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,LMNA,1
WP_INCLUSION_BODY_MYOSITIS,WP_INCLUSION_BODY_MYOSITIS,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,NFKB1,1
WP_NAD_METABOLISM_SIRTUINS_AND_AGING,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,NFKB1,1
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,1/62,11/21728,0.030951080982681844,0.10501872897374585,0.06922862744947149,CCN1,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,4/62,416/21728,0.030952339106079172,0.10501872897374585,0.06922862744947149,STAT6/HLCS/TPP1/TBC1D8,4
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,2/62,97/21728,0.03136165489896041,0.10622836642543491,0.07002602369783824,NFKB1/IRAK1,2
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,4/62,422/21728,0.03237679061291878,0.1094825255683909,0.07217117412167655,SQSTM1/TRAF1/ST3GAL1/PLXNA1,4
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,3/62,244/21728,0.032572479835690976,0.10992835973179703,0.07246506919643418,PIM1/ELF4/DKK1,3
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,4/62,423/21728,0.03261790793234733,0.10992835973179703,0.07246506919643418,CCN1/AHNAK/COL3A1/VCL,4
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,2/62,100/21728,0.03316169917633068,0.11066861530315013,0.07295304765196672,PXN/PIK3CA,2
BAUS_TFF2_TARGETS_DN,BAUS_TFF2_TARGETS_DN,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,HEBP1,1
BIOCARTA_CELL2CELL_PATHWAY,BIOCARTA_CELL2CELL_PATHWAY,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,VCL,1
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,NRP2,1
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,HGF,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,HGF,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,HGF,1
PARK_TRETINOIN_RESPONSE,PARK_TRETINOIN_RESPONSE,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,PIM1,1
REACTOME_ALK_MUTANTS_BIND_TKIS,REACTOME_ALK_MUTANTS_BIND_TKIS,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,FN1,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,PIK3CA,1
REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,FLNA,1
REACTOME_INTERLEUKIN_2_SIGNALING,REACTOME_INTERLEUKIN_2_SIGNALING,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,IL2RB,1
REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,PIK3CA,1
SASAKI_TARGETS_OF_TP73_AND_TP63,SASAKI_TARGETS_OF_TP73_AND_TP63,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,CCN1,1
WP_MAPK_AND_NFKB_SIGNALING_PATHWAYS_INHIBITED_BY_YERSINIA_YOPJ,WP_MAPK_AND_NFKB_SIGNALING_PATHWAYS_INHIBITED_BY_YERSINIA_YOPJ,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,NFKB1,1
WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,1/62,12/21728,0.03371762484136731,0.11066861530315013,0.07295304765196672,NFKB1,1
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,2/62,102/21728,0.03438383719328184,0.11230565005338161,0.07403218534438674,CCN1/VCL,2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,2/62,102/21728,0.03438383719328184,0.11230565005338161,0.07403218534438674,PDLIM4/DKK1,2
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,2/62,102/21728,0.03438383719328184,0.11230565005338161,0.07403218534438674,AHNAK2/TPP1,2
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,3/62,250/21728,0.03463055821904996,0.11292817364137522,0.0744425545611242,PIM1/AHNAK2/FN1,3
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,2/62,103/21728,0.03500145112198245,0.11358535428617529,0.0748757698025431,NRP2/COL3A1,2
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2/62,103/21728,0.03500145112198245,0.11358535428617529,0.0748757698025431,NFKB1/IRAK1,2
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,2/62,103/21728,0.03500145112198245,0.11358535428617529,0.0748757698025431,TPP1/APOL3,2
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,3/62,254/21728,0.036039445582667154,0.1146726746702981,0.07559253431232375,PIM1/CCN1/GCNT1,3
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,3/62,254/21728,0.036039445582667154,0.1146726746702981,0.07559253431232375,TRAF1/IL2RB/TLN1,3
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,2/62,105/21728,0.03624962402887597,0.1146726746702981,0.07559253431232375,PIK3CA/HGF,2
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,2/62,105/21728,0.03624962402887597,0.1146726746702981,0.07559253431232375,FLNA/GEM,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,2/62,105/21728,0.03624962402887597,0.1146726746702981,0.07559253431232375,GIT2/GCNT1,2
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,4/62,438/21728,0.03636228516546178,0.1146726746702981,0.07559253431232375,NRP2/GIT2/TBC1D2B/TRAM2,4
BIOCARTA_PCAF_PATHWAY,BIOCARTA_PCAF_PATHWAY,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,NFKB1,1
FRIDMAN_SENESCENCE_DN,FRIDMAN_SENESCENCE_DN,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,COL3A1,1
GILMORE_CORE_NFKB_PATHWAY,GILMORE_CORE_NFKB_PATHWAY,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,NFKB1,1
GRANDVAUX_IRF3_TARGETS_UP,GRANDVAUX_IRF3_TARGETS_UP,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,AHNAK,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,STAT6,1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,IRAK1,1
WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,NFKB1,1
WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,DKK1,1
WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,DKK1,1
WP_GANGLIO_SPHINGOLIPID_METABOLISM,WP_GANGLIO_SPHINGOLIPID_METABOLISM,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,ST3GAL1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,FN1,1
WP_OSTEOPONTIN_SIGNALING,WP_OSTEOPONTIN_SIGNALING,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,NFKB1,1
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,TNIP1,1
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,1/62,13/21728,0.03647639750943876,0.1146726746702981,0.07559253431232375,TRAM2,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,2/62,106/21728,0.03688012546560193,0.1155807047302042,0.07619111016012206,TPP1/TLN1,2
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,2/62,106/21728,0.03688012546560193,0.1155807047302042,0.07619111016012206,AHNAK/FN1,2
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,4/62,441/21728,0.037139948898363855,0.11621396140514476,0.07660855465652527,TGOLN2/GIT2/TBC1D2B/TRAM2,4
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,2/62,107/21728,0.03751486540408639,0.11684196469508021,0.07702253610746106,HGF/TPP1,2
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,2/62,107/21728,0.03751486540408639,0.11684196469508021,0.07702253610746106,HGF/HEBP1,2
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,2/62,107/21728,0.03751486540408639,0.11684196469508021,0.07702253610746106,PIM1/NFKB1,2
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,2/62,108/21728,0.03815381538373664,0.11858317369102998,0.07817034574170649,NFKB1/PIK3CA,2
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,4/62,445/21728,0.038191797490948025,0.11858317369102998,0.07817034574170649,SQSTM1/CCN1/GEM/KLHL21,4
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,3/62,262/21728,0.038945147384440985,0.11886381018665955,0.07835534207135662,LMNA/AHNAK2/EHBP1L1,3
BIOCARTA_ACH_PATHWAY,BIOCARTA_ACH_PATHWAY,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,PIK3CA,1
BIOCARTA_ERK5_PATHWAY,BIOCARTA_ERK5_PATHWAY,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,PIK3CA,1
BIOCARTA_RANKL_PATHWAY,BIOCARTA_RANKL_PATHWAY,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,NFKB1,1
BIOCARTA_TRKA_PATHWAY,BIOCARTA_TRKA_PATHWAY,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,PIK3CA,1
BIOCARTA_UCALPAIN_PATHWAY,BIOCARTA_UCALPAIN_PATHWAY,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,TLN1,1
HOEGERKORP_CD44_TARGETS_DIRECT_DN,HOEGERKORP_CD44_TARGETS_DIRECT_DN,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,HLCS,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,ST3GAL1,1
LY_AGING_MIDDLE_UP,LY_AGING_MIDDLE_UP,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,COL15A1,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,PRRX1,1
OZANNE_AP1_TARGETS_UP,OZANNE_AP1_TARGETS_UP,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,STAT6,1
REACTOME_INTERLEUKIN_15_SIGNALING,REACTOME_INTERLEUKIN_15_SIGNALING,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,IL2RB,1
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,IRAK1,1
REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,PXN,1
WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,PIK3CA,1
ZHANG_ADIPOGENESIS_BY_BMP7,ZHANG_ADIPOGENESIS_BY_BMP7,1/62,14/21728,0.03922742045921568,0.11886381018665955,0.07835534207135662,MYO1C,1
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,3/62,263/21728,0.03931656764299578,0.1189547881168534,0.07841531496663978,AHNAK/PLOD2/TLN1,3
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,2/62,110/21728,0.039444232239895564,0.11916185475475957,0.07855181384900967,CCN1/PDLIM4,2
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,4/62,450/21728,0.03953068033782034,0.11924397127390483,0.07860594527839286,GIT2/AKAP13/PIK3CA/PLXNA1,4
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,3/62,265/21728,0.04006485832133098,0.12067439362652384,0.07954888352486139,CTF1/HGF/IL2RB,3
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,3/62,266/21728,0.040441724624613234,0.12144589543988334,0.08005745958682275,BNC2/AHNAK/COL3A1,3
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,3/62,266/21728,0.040441724624613234,0.12144589543988334,0.08005745958682275,NFKB1/PIK3CA/DKK1,3
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,3/62,269/21728,0.041583182001160866,0.1221552493237103,0.08052506756716281,FN1/PDLIM4/IRAK1,3
BAKER_HEMATOPOIESIS_STAT3_TARGETS,BAKER_HEMATOPOIESIS_STAT3_TARGETS,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,PIM1,1
BIOCARTA_BCELLSURVIVAL_PATHWAY,BIOCARTA_BCELLSURVIVAL_PATHWAY,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,PIK3CA,1
BIOCARTA_CD40_PATHWAY,BIOCARTA_CD40_PATHWAY,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,NFKB1,1
BIOCARTA_LONGEVITY_PATHWAY,BIOCARTA_LONGEVITY_PATHWAY,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,PIK3CA,1
BIOCARTA_RELA_PATHWAY,BIOCARTA_RELA_PATHWAY,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,NFKB1,1
BIOCARTA_TALL1_PATHWAY,BIOCARTA_TALL1_PATHWAY,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,NFKB1,1
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,HGF,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,APOL3,1
HAHTOLA_CTCL_PATHOGENESIS,HAHTOLA_CTCL_PATHOGENESIS,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,IL2RB,1
HUMMEL_BURKITTS_LYMPHOMA_DN,HUMMEL_BURKITTS_LYMPHOMA_DN,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,SQSTM1,1
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,FN1,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,ST3GAL1,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,ST3GAL1,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,PIK3CA,1
REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA,REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,LMNA,1
REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,DKK1,1
TERAMOTO_OPN_TARGETS_CLUSTER_4,TERAMOTO_OPN_TARGETS_CLUSTER_4,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,COL3A1,1
TSUNODA_CISPLATIN_RESISTANCE_UP,TSUNODA_CISPLATIN_RESISTANCE_UP,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,CCN1,1
WP_FOXP3_IN_COVID19,WP_FOXP3_IN_COVID19,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,IL2RB,1
WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,1/62,15/21728,0.041970715104676426,0.1221552493237103,0.08052506756716281,PIK3CA,1
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,2/62,114/21728,0.04207434780384257,0.1221552493237103,0.08052506756716281,CCN1/PRRX1,2
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,2/62,114/21728,0.04207434780384257,0.1221552493237103,0.08052506756716281,NFKB1/PIK3CA,2
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,2/62,115/21728,0.042741981470084796,0.12373649887454764,0.08156743150671238,CCN1/TRAM2,2
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,2/62,115/21728,0.042741981470084796,0.12373649887454764,0.08156743150671238,PIM1/IL2RB,2
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,4/62,463/21728,0.04313710102463852,0.124700929973524,0.08220318707054527,AHNAK/FURIN/PRRX1/ITGB5,4
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,2/62,116/21728,0.043413601891427886,0.12496161231123448,0.08237502956584465,AHNAK/LMNA,2
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,2/62,116/21728,0.043413601891427886,0.12496161231123448,0.08237502956584465,PDLIM4/ITGB5,2
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,2/62,116/21728,0.043413601891427886,0.12496161231123448,0.08237502956584465,PXN/PDLIM4,2
HOELZEL_NF1_TARGETS_DN,HOELZEL_NF1_TARGETS_DN,2/62,117/21728,0.04408918170023427,0.12545199614621763,0.08269829190343948,COL3A1/FN1,2
BIOCARTA_CDMAC_PATHWAY,BIOCARTA_CDMAC_PATHWAY,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,NFKB1,1
BIOCARTA_IL7_PATHWAY,BIOCARTA_IL7_PATHWAY,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,PIK3CA,1
DASU_IL6_SIGNALING_SCAR_DN,DASU_IL6_SIGNALING_SCAR_DN,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,CCN1,1
DEMAGALHAES_AGING_DN,DEMAGALHAES_AGING_DN,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,COL3A1,1
KEGG_OTHER_GLYCAN_DEGRADATION,KEGG_OTHER_GLYCAN_DEGRADATION,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,MANBA,1
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,COL6A1,1
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,PIM1,1
REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,FURIN,1
REACTOME_CRMPS_IN_SEMA3A_SIGNALING,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,PLXNA1,1
REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,NFKB1,1
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,SQSTM1,1
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,PIK3CA,1
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,PLXNA1,1
REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,PIK3CA,1
REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,STAT6,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,FN1,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/62,16/21728,0.044706302801609366,0.12545199614621763,0.08269829190343948,NFKB1,1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,2/62,118/21728,0.04476869364808151,0.1254521053202507,0.08269836387125452,NRP2/EDEM1,2
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,2/62,119/21728,0.045452110605323115,0.12719005081767748,0.08384402219853178,PIM1/PIK3CA,2
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,2/62,120/21728,0.046139405560650194,0.1279324666939938,0.08433342473288281,FN1/PDLIM4,2
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,4/62,474/21728,0.04633016287122677,0.1279324666939938,0.08433342473288281,SQSTM1/AKAP13/TPP1/TLN1,4
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,2/62,121/21728,0.04683055162065543,0.1279324666939938,0.08433342473288281,FLNA/ITGB5,2
KEGG_LYSOSOME,KEGG_LYSOSOME,2/62,121/21728,0.04683055162065543,0.1279324666939938,0.08433342473288281,MANBA/TPP1,2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,2/62,121/21728,0.04683055162065543,0.1279324666939938,0.08433342473288281,COL3A1/FN1,2
BIOCARTA_ARF_PATHWAY,BIOCARTA_ARF_PATHWAY,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,PIK3CA,1
CROONQUIST_IL6_DEPRIVATION_UP,CROONQUIST_IL6_DEPRIVATION_UP,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,AHNAK,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,SQSTM1,1
GENTILE_UV_RESPONSE_CLUSTER_D1,GENTILE_UV_RESPONSE_CLUSTER_D1,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,GEM,1
GOUYER_TATI_TARGETS_DN,GOUYER_TATI_TARGETS_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,FN1,1
HAHTOLA_MYCOSIS_FUNGOIDES_DN,HAHTOLA_MYCOSIS_FUNGOIDES_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,FLNA,1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,FN1,1
KANG_AR_TARGETS_UP,KANG_AR_TARGETS_UP,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,COL6A1,1
KASLER_HDAC7_TARGETS_1_DN,KASLER_HDAC7_TARGETS_1_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,EDEM1,1
KIM_HYPOXIA,KIM_HYPOXIA,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,PDLIM4,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,PLXNA1,1
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,IRAK1,1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,ITGB5,1
NELSON_RESPONSE_TO_ANDROGEN_DN,NELSON_RESPONSE_TO_ANDROGEN_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,FN1,1
REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,CTF1,1
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,NFKB1,1
REACTOME_SIGNALING_BY_NTRK3_TRKC,REACTOME_SIGNALING_BY_NTRK3_TRKC,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,PIK3CA,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,COL15A1,1
SA_PTEN_PATHWAY,SA_PTEN_PATHWAY,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,PIK3CA,1
SA_TRKA_RECEPTOR,SA_TRKA_RECEPTOR,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,PIK3CA,1
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,COL3A1,1
WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/62,17/21728,0.047434204847773054,0.1279324666939938,0.08433342473288281,NFKB1,1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,2/62,122/21728,0.04752552200939781,0.12800716235998447,0.08438266431598851,CCN1/DKK1,2
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,4/62,479/21728,0.04782440764258929,0.12863998419370273,0.0847998221638932,DNAJC3/NFKB1/VCL/MANBA,4
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,2/62,124/21728,0.04892682925406255,0.13037563084740444,0.08594396508722905,NFKB1/PIK3CA,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,4/62,483/21728,0.04903906890541258,0.13037563084740444,0.08594396508722905,TRAF1/PIM1/NFKB1/GEM,4
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,2/62,125/21728,0.04963311314154047,0.13037563084740444,0.08594396508722905,SQSTM1/PANX1,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/62,125/21728,0.04963311314154047,0.13037563084740444,0.08594396508722905,SQSTM1/TNIP1,2
AMIT_EGF_RESPONSE_40_MCF10A,AMIT_EGF_RESPONSE_40_MCF10A,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,CCN1,1
BIOCARTA_41BB_PATHWAY,BIOCARTA_41BB_PATHWAY,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,NFKB1,1
BIOCARTA_CARDIACEGF_PATHWAY,BIOCARTA_CARDIACEGF_PATHWAY,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,NFKB1,1
BIOCARTA_CHEMICAL_PATHWAY,BIOCARTA_CHEMICAL_PATHWAY,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,TLN1,1
BIOCARTA_PTEN_PATHWAY,BIOCARTA_PTEN_PATHWAY,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,PIK3CA,1
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,LMNA,1
GRANDVAUX_IRF3_TARGETS_DN,GRANDVAUX_IRF3_TARGETS_DN,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,GEM,1
GRATIAS_RETINOBLASTOMA_16Q24,GRATIAS_RETINOBLASTOMA_16Q24,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,ZDHHC7,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,CCN1,1
KARAKAS_TGFB1_SIGNALING,KARAKAS_TGFB1_SIGNALING,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,FN1,1
KIM_PTEN_TARGETS_UP,KIM_PTEN_TARGETS_UP,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,GALNT10,1
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,CCN1,1
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,AHNAK,1
REACTOME_PI_3K_CASCADE_FGFR3,REACTOME_PI_3K_CASCADE_FGFR3,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,PIK3CA,1
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,FURIN,1
REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,PIK3CA,1
REACTOME_TIE2_SIGNALING,REACTOME_TIE2_SIGNALING,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,PIK3CA,1
SCHEIDEREIT_IKK_TARGETS,SCHEIDEREIT_IKK_TARGETS,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,NFKB1,1
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,SQSTM1,1
WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,TRAF1,1
WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,FN1,1
WU_HBX_TARGETS_3_UP,WU_HBX_TARGETS_3_UP,1/62,18/21728,0.050154442483047235,0.13037563084740444,0.08594396508722905,VCL,1
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,2/62,126/21728,0.050343115420006884,0.13052879925909003,0.08604493411449901,ST3GAL1/GEM,2
WHITFIELD_CELL_CYCLE_M_G1,WHITFIELD_CELL_CYCLE_M_G1,2/62,126/21728,0.050343115420006884,0.13052879925909003,0.08604493411449901,VCL/AKAP13,2
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,3/62,292/21728,0.05086916496221018,0.1317229857193911,0.08683214502795479,EHBP1L1/GCNT1/HEBP1,3
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,2/62,128/21728,0.051774170484460785,0.13279460452166772,0.08753855901292316,CTF1/NFKB1,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,4/62,493/21728,0.05215053337083521,0.13279460452166772,0.08753855901292316,ZDHHC7/ST3GAL1/GALNT10/TRAM2,4
BIOCARTA_ERAD_PATHWAY,BIOCARTA_ERAD_PATHWAY,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,EDEM1,1
BIOCARTA_IGF1MTOR_PATHWAY,BIOCARTA_IGF1MTOR_PATHWAY,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PIK3CA,1
BIOCARTA_MCALPAIN_PATHWAY,BIOCARTA_MCALPAIN_PATHWAY,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,TLN1,1
BIOCARTA_PAR1_PATHWAY,BIOCARTA_PAR1_PATHWAY,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PIK3CA,1
BIOCARTA_TID_PATHWAY,BIOCARTA_TID_PATHWAY,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,NFKB1,1
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,AHNAK,1
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,IL2RB,1
KIM_MYCL1_AMPLIFICATION_TARGETS_DN,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,AHNAK,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PRRX1,1
PID_EPHA2_FWD_PATHWAY,PID_EPHA2_FWD_PATHWAY,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PIK3CA,1
RASHI_NFKB1_TARGETS,RASHI_NFKB1_TARGETS,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,TNIP1,1
REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,FURIN,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PIK3CA,1
REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,LMNA,1
REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,FN1,1
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PLXNA1,1
REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,COL3A1,1
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,FBN1,1
WP_APOPTOSIS_MODULATION_BY_HSP70,WP_APOPTOSIS_MODULATION_BY_HSP70,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,NFKB1,1
WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY_CGL,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY_CGL,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,PIK3CA,1
WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,FN1,1
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,1/62,19/21728,0.05286703688959038,0.13279460452166772,0.08753855901292316,CCN1,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,4/62,497/21728,0.05342499013009447,0.13402877823160855,0.08835212962845393,NRP2/COL3A1/FN1/RAB36,4
WP_ADIPOGENESIS,WP_ADIPOGENESIS,2/62,131/21728,0.053947989861397726,0.13517229838248096,0.08910594117501623,LMNA/STAT6,2
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,3/62,300/21728,0.054317213122299104,0.13592815025132562,0.08960420075163247,COL3A1/ST3GAL1/PDLIM4,3
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,2/62,133/21728,0.055415060352332936,0.13618865102836614,0.08977592356165186,PIM1/AHNAK2,2
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,2/62,133/21728,0.055415060352332936,0.13618865102836614,0.08977592356165186,BNC2/COL3A1,2
BIOCARTA_ATM_PATHWAY,BIOCARTA_ATM_PATHWAY,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,NFKB1,1
BIOCARTA_NGF_PATHWAY,BIOCARTA_NGF_PATHWAY,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,PIK3CA,1
BIOCARTA_NKCELLS_PATHWAY,BIOCARTA_NKCELLS_PATHWAY,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,PIK3CA,1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,CHD1L,1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,PIM1,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,IL2RB,1
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,NRP2,1
REACTOME_PI_3K_CASCADE_FGFR4,REACTOME_PI_3K_CASCADE_FGFR4,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,PIK3CA,1
REACTOME_SIGNALING_BY_KIT_IN_DISEASE,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,PIK3CA,1
REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,PIK3CA,1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,KLHL21,1
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,KLHL21,1
WP_ASPIRIN_AND_MIRNAS,WP_ASPIRIN_AND_MIRNAS,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,NFKB1,1
WP_HYPERTROPHY_MODEL,WP_HYPERTROPHY_MODEL,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,CCN1,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/62,20/21728,0.055572009191992344,0.13618865102836614,0.08977592356165186,FN1,1
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,2/62,134/21728,0.056153876332875316,0.13728019341645825,0.0904954712277584,FURIN/PIK3CA,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,2/62,134/21728,0.056153876332875316,0.13728019341645825,0.0904954712277584,NRP2/HGF,2
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,3/62,307/21728,0.057424699110461414,0.1383780705749428,0.0912191947914764,PIK3CA/HGF/IRAK1,3
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,3/62,307/21728,0.057424699110461414,0.1383780705749428,0.0912191947914764,GIT2/FLNA/IL2RB,3
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,3/62,308/21728,0.057875449985766214,0.1383780705749428,0.0912191947914764,FURIN/NFKB1/MYO1C,3
BIOCARTA_CERAMIDE_PATHWAY,BIOCARTA_CERAMIDE_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,NFKB1,1
BIOCARTA_IGF1_PATHWAY,BIOCARTA_IGF1_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,PIK3CA,1
BIOCARTA_INSULIN_PATHWAY,BIOCARTA_INSULIN_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,PIK3CA,1
BIOCARTA_NFKB_PATHWAY,BIOCARTA_NFKB_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,NFKB1,1
BIOCARTA_RAC1_PATHWAY,BIOCARTA_RAC1_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,PIK3CA,1
JACKSON_DNMT1_TARGETS_DN,JACKSON_DNMT1_TARGETS_DN,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,COL6A1,1
KANG_CISPLATIN_RESISTANCE_UP,KANG_CISPLATIN_RESISTANCE_UP,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,AHNAK2,1
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,NFKB1,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,FN1,1
PID_ECADHERIN_KERATINOCYTE_PATHWAY,PID_ECADHERIN_KERATINOCYTE_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,PIK3CA,1
REACTOME_CD209_DC_SIGN_SIGNALING,REACTOME_CD209_DC_SIGN_SIGNALING,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,NFKB1,1
REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,EDEM1,1
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,HGF,1
REACTOME_PI_3K_CASCADE_FGFR1,REACTOME_PI_3K_CASCADE_FGFR1,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,PIK3CA,1
REACTOME_RHO_GTPASES_ACTIVATE_PAKS,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,FLNA,1
REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,NFKB1,1
WOTTON_RUNX_TARGETS_UP,WOTTON_RUNX_TARGETS_UP,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,ITGB5,1
WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,PIM1,1
WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,1/62,21/21728,0.05826938045742924,0.1383780705749428,0.0912191947914764,FN1,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,3/62,309/21728,0.05832789726639018,0.1383780705749428,0.0912191947914764,FBN1/TPP1/KLHL21,3
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,2/62,137/21728,0.05839114409449625,0.1383780705749428,0.0912191947914764,TRAF1/COL6A1,2
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,2/62,137/21728,0.05839114409449625,0.1383780705749428,0.0912191947914764,COL6A1/PDLIM4,2
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,2/62,137/21728,0.05839114409449625,0.1383780705749428,0.0912191947914764,HGF/DKK1,2
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,3/62,313/21728,0.06015458451084802,0.14033164010523924,0.09250699305880583,AHNAK2/PRRX1/TNIP1,3
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,2/62,140/21728,0.060659116375764266,0.14033164010523924,0.09250699305880583,AHNAK2/HGF,2
BIOCARTA_CASPASE_PATHWAY,BIOCARTA_CASPASE_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,LMNA,1
BIOCARTA_CREB_PATHWAY,BIOCARTA_CREB_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
BIOCARTA_CTLA4_PATHWAY,BIOCARTA_CTLA4_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
BIOCARTA_EDG1_PATHWAY,BIOCARTA_EDG1_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
BIOCARTA_IL2_PATHWAY,BIOCARTA_IL2_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,IL2RB,1
BIOCARTA_MTOR_PATHWAY,BIOCARTA_MTOR_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,FBN1,1
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,ST3GAL1,1
HASLINGER_B_CLL_WITH_17P13_DELETION,HASLINGER_B_CLL_WITH_17P13_DELETION,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,TBC1D2B,1
KIM_LIVER_CANCER_POOR_SURVIVAL_UP,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PLOD2,1
MURATA_VIRULENCE_OF_H_PILORI,MURATA_VIRULENCE_OF_H_PILORI,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,COL6A1,1
OKAWA_NEUROBLASTOMA_1P36_31_DELETION,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,KLHL21,1
PID_PDGFRA_PATHWAY,PID_PDGFRA_PATHWAY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,HLCS,1
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,IRAK1,1
REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,SQSTM1,1
REACTOME_REGULATION_OF_SIGNALING_BY_CBL,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,NFKB1,1
WP_PI3KAKTMTOR_VITD3_SIGNALING,WP_PI3KAKTMTOR_VITD3_SIGNALING,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,NFKB1,1
WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,NFKB1,1
YIH_RESPONSE_TO_ARSENITE_C1,YIH_RESPONSE_TO_ARSENITE_C1,1/62,22/21728,0.06095917169581466,0.14033164010523924,0.09250699305880583,PIK3CA,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,2/62,141/21728,0.06142181467875913,0.14107384832609976,0.09299625870612414,FBN1/ITGB5,2
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,2/62,141/21728,0.06142181467875913,0.14107384832609976,0.09299625870612414,TGOLN2/TBC1D8,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,3/62,317/21728,0.06200814791378493,0.14209612027623608,0.09367014311397796,SQSTM1/TMEM109/FLNA,3
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,3/62,317/21728,0.06200814791378493,0.14209612027623608,0.09367014311397796,VCL/EHBP1L1/FN1,3
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,2/62,142/21728,0.062187825802507056,0.14215535948146005,0.09370919375674358,PDLIM4/TNIP1,2
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,2/62,143/21728,0.06295712533992434,0.14215535948146005,0.09370919375674358,MYO1C/PIK3CA,2
BIOCARTA_GLEEVEC_PATHWAY,BIOCARTA_GLEEVEC_PATHWAY,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,PIK3CA,1
BIOCARTA_HER2_PATHWAY,BIOCARTA_HER2_PATHWAY,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,PIK3CA,1
BIOCARTA_IGF1R_PATHWAY,BIOCARTA_IGF1R_PATHWAY,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,PIK3CA,1
BIOCARTA_NTHI_PATHWAY,BIOCARTA_NTHI_PATHWAY,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,NFKB1,1
CHEOK_RESPONSE_TO_HD_MTX_UP,CHEOK_RESPONSE_TO_HD_MTX_UP,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,FLNA,1
GOLUB_ALL_VS_AML_DN,GOLUB_ALL_VS_AML_DN,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,SQSTM1,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,GEM,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,TRAM2,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,HGF,1
PID_NFKAPPAB_CANONICAL_PATHWAY,PID_NFKAPPAB_CANONICAL_PATHWAY,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,NFKB1,1
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,IRAK1,1
REACTOME_NEPHRIN_FAMILY_INTERACTIONS,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,PIK3CA,1
REACTOME_PI_3K_CASCADE_FGFR2,REACTOME_PI_3K_CASCADE_FGFR2,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,PIK3CA,1
REACTOME_SIGNALING_BY_NODAL,REACTOME_SIGNALING_BY_NODAL,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,FURIN,1
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,ST3GAL1,1
WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,NFKB1,1
WP_NRF2ARE_REGULATION,WP_NRF2ARE_REGULATION,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,PIK3CA,1
YAN_ESCAPE_FROM_ANOIKIS,YAN_ESCAPE_FROM_ANOIKIS,1/62,23/21728,0.06364140385995654,0.14215535948146005,0.09370919375674358,NFKB1,1
PECE_MAMMARY_STEM_CELL_DN,PECE_MAMMARY_STEM_CELL_DN,2/62,144/21728,0.06372968899218537,0.14215535948146005,0.09370919375674358,COL6A1/FN1,2
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,2/62,144/21728,0.06372968899218537,0.14215535948146005,0.09370919375674358,SQSTM1/NFKB1,2
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,2/62,144/21728,0.06372968899218537,0.14215535948146005,0.09370919375674358,STAT6/NFKB1,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,2/62,144/21728,0.06372968899218537,0.14215535948146005,0.09370919375674358,VCL/IRAK1,2
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,3/62,321/21728,0.06388836864115047,0.14235149247618464,0.09383848515224061,SQSTM1/AKAP13/HGF,3
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,2/62,145/21728,0.06450549256831996,0.14300963436823064,0.09427233405041886,COL3A1/PLOD2,2
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,2/62,145/21728,0.06450549256831996,0.14300963436823064,0.09427233405041886,NFKB1/ELF4,2
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,2/62,145/21728,0.06450549256831996,0.14300963436823064,0.09427233405041886,SQSTM1/HGF,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,3/62,323/21728,0.06483840568429788,0.14300963436823064,0.09427233405041886,PIM1/PRRX1/PIK3CA,3
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,2/62,146/21728,0.06528451198481226,0.14300963436823064,0.09427233405041886,GCNT1/DKK1,2
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,3/62,324/21728,0.065315893466881,0.14300963436823064,0.09427233405041886,FLNA/DKK1/PLOD2,3
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,3/62,325/21728,0.0657950226447199,0.14300963436823064,0.09427233405041886,GIT2/GALNT10/IL2RB,3
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,2/62,147/21728,0.0660667232652007,0.14300963436823064,0.09427233405041886,ST3GAL1/COL15A1,2
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,2/62,147/21728,0.0660667232652007,0.14300963436823064,0.09427233405041886,COL6A1/CHD1L,2
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,2/62,147/21728,0.0660667232652007,0.14300963436823064,0.09427233405041886,NRP2/COL3A1,2
AZARE_STAT3_TARGETS,AZARE_STAT3_TARGETS,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,FN1,1
BIOCARTA_CTCF_PATHWAY,BIOCARTA_CTCF_PATHWAY,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PIK3CA,1
BIOCARTA_EIF4_PATHWAY,BIOCARTA_EIF4_PATHWAY,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PIK3CA,1
BIOCARTA_STRESS_PATHWAY,BIOCARTA_STRESS_PATHWAY,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,NFKB1,1
BIOCARTA_TFF_PATHWAY,BIOCARTA_TFF_PATHWAY,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PIK3CA,1
BIOCARTA_TPO_PATHWAY,BIOCARTA_TPO_PATHWAY,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PIK3CA,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,ANXA13,1
DAZARD_UV_RESPONSE_CLUSTER_G24,DAZARD_UV_RESPONSE_CLUSTER_G24,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PDLIM4,1
HASLINGER_B_CLL_WITH_13Q14_DELETION,HASLINGER_B_CLL_WITH_13Q14_DELETION,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,ITGB5,1
JEON_SMAD6_TARGETS_UP,JEON_SMAD6_TARGETS_UP,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,FBN1,1
JIANG_TIP30_TARGETS_DN,JIANG_TIP30_TARGETS_DN,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,TLN1,1
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,HGF,1
PID_TOLL_ENDOGENOUS_PATHWAY,PID_TOLL_ENDOGENOUS_PATHWAY,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,IRAK1,1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,CTF1,1
WALLACE_JAK2_TARGETS_UP,WALLACE_JAK2_TARGETS_UP,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,TMEM109,1
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,GEM,1
WANG_NFKB_TARGETS,WANG_NFKB_TARGETS,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,ITGB5,1
WANG_TNF_TARGETS,WANG_TNF_TARGETS,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,TRAF1,1
WP_ANGIOGENESIS,WP_ANGIOGENESIS,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PIK3CA,1
WP_KALLMANN_SYNDROME,WP_KALLMANN_SYNDROME,1/62,24/21728,0.06631609784570536,0.14300963436823064,0.09427233405041886,PIK3CA,1
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,2/62,148/21728,0.06685210253968007,0.14401116735528513,0.0949325472782564,SQSTM1/KLHL21,2
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,2/62,150/21728,0.06843227012258735,0.14609931397697484,0.09630905912471922,TGOLN2/IRAK1,2
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,CCN1,1
BIOCARTA_BAD_PATHWAY,BIOCARTA_BAD_PATHWAY,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
BIOCARTA_HDAC_PATHWAY,BIOCARTA_HDAC_PATHWAY,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
BIOCARTA_TOLL_PATHWAY,BIOCARTA_TOLL_PATHWAY,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,NFKB1,1
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PLOD2,1
REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,LMNA,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
REACTOME_SIGNALING_BY_EGFR_IN_CANCER,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
REACTOME_SIGNALING_BY_ERYTHROPOIETIN,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
REACTOME_SIGNALING_BY_NTRK2_TRKB,REACTOME_SIGNALING_BY_NTRK2_TRKB,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,NFKB1,1
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,APOL3,1
WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,CTF1,1
WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PIK3CA,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,1/62,25/21728,0.06898327449211039,0.14609931397697484,0.09630905912471922,PXN,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,2/62,152/21728,0.07002482589315193,0.14814926361411324,0.0976603914166489,AHNAK/COL3A1,2
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,3/62,336/21728,0.07117273072174694,0.14912367660534886,0.09830272707059723,NFKB1/PIK3CA/DKK1,3
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,2/62,154/21728,0.071629582692209,0.14912367660534886,0.09830272707059723,AHNAK/KLHL21,2
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,NFKB1,1
ALONSO_METASTASIS_DN,ALONSO_METASTASIS_DN,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,AKAP13,1
BIOCARTA_VIP_PATHWAY,BIOCARTA_VIP_PATHWAY,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,NFKB1,1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,TPP1,1
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,VCL,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,GIT2,1
JI_METASTASIS_REPRESSED_BY_STK11,JI_METASTASIS_REPRESSED_BY_STK11,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,ITGB5,1
PID_INTEGRIN_CS_PATHWAY,PID_INTEGRIN_CS_PATHWAY,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,ITGB5,1
REACTOME_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,EDEM1,1
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,NFKB1,1
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,PIK3CA,1
WAGNER_APO2_SENSITIVITY,WAGNER_APO2_SENSITIVITY,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,GALNT10,1
WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,1/62,26/21728,0.07164295458156755,0.14912367660534886,0.09830272707059723,DKK1,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,3/62,337/21728,0.07167127001857472,0.14912367660534886,0.09830272707059723,LMNA/FURIN/TLN1,3
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,2/62,155/21728,0.07243647844680932,0.1504047416253667,0.09914720856333688,PRRX1/AKAP13,2
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,2/62,155/21728,0.07243647844680932,0.1504047416253667,0.09914720856333688,NFKB1/IRAK1,2
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,2/62,156/21728,0.07324635502929516,0.15192955290612564,0.10015236824407153,FURIN/ST3GAL1,2
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,2/62,157/21728,0.07405918951205358,0.1523770230234738,0.10044734174404991,CCN1/PDLIM4,2
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,2/62,157/21728,0.07405918951205358,0.1523770230234738,0.10044734174404991,ST3GAL1/ANXA13,2
BIOCARTA_EGF_PATHWAY,BIOCARTA_EGF_PATHWAY,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,PIK3CA,1
BIOCARTA_GH_PATHWAY,BIOCARTA_GH_PATHWAY,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,PIK3CA,1
BIOCARTA_VEGF_PATHWAY,BIOCARTA_VEGF_PATHWAY,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,PIK3CA,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,GEM,1
GROSS_ELK3_TARGETS_UP,GROSS_ELK3_TARGETS_UP,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,CCN1,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,PIK3CA,1
REACTOME_SIGNALING_BY_ALK,REACTOME_SIGNALING_BY_ALK,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,PIK3CA,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_7,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,STAT6,1
WESTON_VEGFA_TARGETS_12HR,WESTON_VEGFA_TARGETS_12HR,1/62,27/21728,0.07429515883997406,0.1523770230234738,0.10044734174404991,GEM,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,2/62,160/21728,0.07651521262469795,0.1560515068235879,0.10286957130779574,NFKB1/PIK3CA,2
ABBUD_LIF_SIGNALING_1_DN,ABBUD_LIF_SIGNALING_1_DN,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,AHNAK,1
BIOCARTA_PDGF_PATHWAY,BIOCARTA_PDGF_PATHWAY,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,PIK3CA,1
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,DKK1,1
DORN_ADENOVIRUS_INFECTION_12HR_UP,DORN_ADENOVIRUS_INFECTION_12HR_UP,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,CCN1,1
PID_REELIN_PATHWAY,PID_REELIN_PATHWAY,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,PIK3CA,1
PID_TRAIL_PATHWAY,PID_TRAIL_PATHWAY,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,PIK3CA,1
PID_WNT_SIGNALING_PATHWAY,PID_WNT_SIGNALING_PATHWAY,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,DKK1,1
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,ST3GAL1,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_3,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,NFKB1,1
WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,1/62,28/21728,0.07693990793687833,0.1560515068235879,0.10286957130779574,CHD1L,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,2/62,161/21728,0.07733965148155358,0.15670430894349024,0.10329990021387346,MYO1C/PIK3CA,2
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,3/62,351/21728,0.07881632746142209,0.15836733100008601,0.10439616880826012,HEBP1/ITGB5/GEM,3
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,CCN1,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,PRRX1,1
BIOCARTA_TNFR1_PATHWAY,BIOCARTA_TNFR1_PATHWAY,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,LMNA,1
GILDEA_METASTASIS,GILDEA_METASTASIS,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,FN1,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,HGF,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,NFKB1,1
PAL_PRMT5_TARGETS_DN,PAL_PRMT5_TARGETS_DN,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,CCN1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,IL2RB,1
PID_INTEGRIN2_PATHWAY,PID_INTEGRIN2_PATHWAY,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,CCN1,1
REACTOME_DAP12_SIGNALING,REACTOME_DAP12_SIGNALING,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,PIK3CA,1
REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,ST3GAL1,1
REACTOME_MITOPHAGY,REACTOME_MITOPHAGY,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,SQSTM1,1
REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,ST3GAL1,1
REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,FURIN,1
VALK_AML_CLUSTER_2,VALK_AML_CLUSTER_2,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,PIM1,1
WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,NFKB1,1
WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1/62,29/21728,0.0795772224856297,0.15836733100008601,0.10439616880826012,NFKB1,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,2/62,164/21728,0.07982994765935111,0.1587132951488285,0.10462422930183318,DKK1/TBC1D8,2
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,2/62,165/21728,0.08066563219925399,0.16021643828716586,0.10561510528504185,HEBP1/APOL3,2
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,2/62,166/21728,0.08150407286861204,0.16058323452775172,0.10585689834936024,CCN1/FN1,2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,3/62,357/21728,0.08197140911445455,0.16058323452775172,0.10585689834936024,VCL/ELF4/PLOD2,3
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,3/62,357/21728,0.08197140911445455,0.16058323452775172,0.10585689834936024,AHNAK/FN1/PDLIM4,3
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,CCN1,1
BIOCARTA_FAS_PATHWAY,BIOCARTA_FAS_PATHWAY,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,LMNA,1
CHOW_RASSF1_TARGETS_DN,CHOW_RASSF1_TARGETS_DN,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,KLHL21,1
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,PANX1,1
MARSHALL_VIRAL_INFECTION_RESPONSE_DN,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,PIM1,1
PID_EPHRINB_REV_PATHWAY,PID_EPHRINB_REV_PATHWAY,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,PIK3CA,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,PIK3CA,1
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,TRAF1,1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,TRAF1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,HGF,1
TING_SILENCED_BY_DICER,TING_SILENCED_BY_DICER,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,CCN1,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,HGF,1
WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,PIK3CA,1
WP_PI3KAKTMTOR_SIGNALING_PATHWAY_AND_THERAPEUTIC_OPPORTUNITIES,WP_PI3KAKTMTOR_SIGNALING_PATHWAY_AND_THERAPEUTIC_OPPORTUNITIES,1/62,30/21728,0.08220712304353095,0.16058323452775172,0.10585689834936024,PIK3CA,1
DURAND_STROMA_NS_UP,DURAND_STROMA_NS_UP,2/62,167/21728,0.08234524775013521,0.16069703052693698,0.10593191297684454,HHAT/TMEM109,2
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,TBC1D2B,1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,FLNA,1
BURTON_ADIPOGENESIS_10,BURTON_ADIPOGENESIS_10,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,VCL,1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,FURIN,1
PID_AR_NONGENOMIC_PATHWAY,PID_AR_NONGENOMIC_PATHWAY,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,PIK3CA,1
PID_NEPHRIN_NEPH1_PATHWAY,PID_NEPHRIN_NEPH1_PATHWAY,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,PIK3CA,1
REACTOME_DISEASES_OF_IMMUNE_SYSTEM,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,NFKB1,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,PIK3CA,1
REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,PIK3CA,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,DKK1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,COL15A1,1
YIH_RESPONSE_TO_ARSENITE_C3,YIH_RESPONSE_TO_ARSENITE_C3,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,PIM1,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/62,31/21728,0.08482963011198441,0.16327776240320574,0.10763313834259668,ELF4,1
LIN_NPAS4_TARGETS_UP,LIN_NPAS4_TARGETS_UP,2/62,170/21728,0.08488495997701452,0.16327776240320574,0.10763313834259668,ZDHHC7/PANX1,2
NABA_ECM_AFFILIATED,NABA_ECM_AFFILIATED,2/62,170/21728,0.08488495997701452,0.16327776240320574,0.10763313834259668,PLXNA1/ANXA13,2
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,2/62,171/21728,0.08573685450799971,0.1647588837345706,0.10860949749166002,SQSTM1/ST3GAL1,2
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,3/62,367/21728,0.08735051167053255,0.16536314201595254,0.1090078261693524,FN1/HGF/DKK1,3
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,FBN1,1
CAFFAREL_RESPONSE_TO_THC_DN,CAFFAREL_RESPONSE_TO_THC_DN,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,TMEM109,1
CHO_NR4A1_TARGETS,CHO_NR4A1_TARGETS,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,HLCS,1
FARDIN_HYPOXIA_11,FARDIN_HYPOXIA_11,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,TNIP1,1
LIU_BREAST_CANCER,LIU_BREAST_CANCER,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,GIT2,1
MODY_HIPPOCAMPUS_NEONATAL,MODY_HIPPOCAMPUS_NEONATAL,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,FN1,1
PID_NETRIN_PATHWAY,PID_NETRIN_PATHWAY,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,PIK3CA,1
PID_SYNDECAN_4_PATHWAY,PID_SYNDECAN_4_PATHWAY,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,FN1,1
PID_WNT_NONCANONICAL_PATHWAY,PID_WNT_NONCANONICAL_PATHWAY,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,FLNA,1
POS_HISTAMINE_RESPONSE_NETWORK,POS_HISTAMINE_RESPONSE_NETWORK,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,GCNT1,1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,FURIN,1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,NFKB1,1
WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,NFKB1,1
WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,1/62,32/21728,0.08744476413664448,0.16536314201595254,0.1090078261693524,NFKB1,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,2/62,173/21728,0.0874485005491916,0.16536314201595254,0.1090078261693524,TGOLN2/HGF,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,2/62,173/21728,0.0874485005491916,0.16536314201595254,0.1090078261693524,DNAJC3/PIK3CA,2
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,2/62,175/21728,0.08917048085240696,0.16653099408200814,0.10977767737958055,NRP2/DKK1,2
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,2/62,175/21728,0.08917048085240696,0.16653099408200814,0.10977767737958055,HHAT/PANX1,2
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,3/62,371/21728,0.08954359479678416,0.16653099408200814,0.10977767737958055,PIM1/PLXNA1/ITGB5,3
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,TRAF1,1
BIOCARTA_AGR_PATHWAY,BIOCARTA_AGR_PATHWAY,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,GIT2,1
BURTON_ADIPOGENESIS_12,BURTON_ADIPOGENESIS_12,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,DNAJC3,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PIM1,1
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PLOD2,1
DUTTA_APOPTOSIS_VIA_NFKB,DUTTA_APOPTOSIS_VIA_NFKB,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,TRAF1,1
JEPSEN_SMRT_TARGETS,JEPSEN_SMRT_TARGETS,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PDLIM4,1
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PRRX1,1
PID_EPO_PATHWAY,PID_EPO_PATHWAY,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,NFKB1,1
PID_NCADHERIN_PATHWAY,PID_NCADHERIN_PATHWAY,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PIK3CA,1
PID_SYNDECAN_2_PATHWAY,PID_SYNDECAN_2_PATHWAY,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,FN1,1
REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,FURIN,1
REACTOME_CD28_CO_STIMULATION,REACTOME_CD28_CO_STIMULATION,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PIK3CA,1
REACTOME_SIALIC_ACID_METABOLISM,REACTOME_SIALIC_ACID_METABOLISM,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,ST3GAL1,1
SIMBULAN_UV_RESPONSE_NORMAL_DN,SIMBULAN_UV_RESPONSE_NORMAL_DN,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,AHNAK,1
WEIGEL_OXIDATIVE_STRESS_RESPONSE,WEIGEL_OXIDATIVE_STRESS_RESPONSE,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,NFKB1,1
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,NFKB1,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,NFKB1,1
WP_PROSTAGLANDIN_SIGNALING,WP_PROSTAGLANDIN_SIGNALING,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,NFKB1,1
WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PIK3CA,1
WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,1/62,33/21728,0.09005254550756703,0.16653099408200814,0.10977767737958055,PLOD2,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,2/62,178/21728,0.09177245942771264,0.16955572852943787,0.11177159042957609,FN1/GEM,2
BIOCARTA_FMLP_PATHWAY,BIOCARTA_FMLP_PATHWAY,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,NFKB1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,NRP2,1
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,ST3GAL1,1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,FURIN,1
REACTOME_SIGNALING_BY_WNT_IN_CANCER,REACTOME_SIGNALING_BY_WNT_IN_CANCER,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,DKK1,1
SCHRAETS_MLL_TARGETS_DN,SCHRAETS_MLL_TARGETS_DN,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,COL6A1,1
WP_16P112_DISTAL_DELETION_SYNDROME,WP_16P112_DISTAL_DELETION_SYNDROME,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,TRAF1,1
WP_OXIDATIVE_STRESS_RESPONSE,WP_OXIDATIVE_STRESS_RESPONSE,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,NFKB1,1
WP_PURINERGIC_SIGNALING,WP_PURINERGIC_SIGNALING,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,PANX1,1
WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1/62,34/21728,0.0926529945593545,0.1696249545527036,0.11181722440954615,PIK3CA,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,2/62,181/21728,0.09439674793767304,0.17207904951593184,0.11343497038300415,LMNA/STAT6,2
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,2/62,181/21728,0.09439674793767304,0.17207904951593184,0.11343497038300415,GIT2/IL2RB,2
ANDERSEN_LIVER_CANCER_KRT19_UP,ANDERSEN_LIVER_CANCER_KRT19_UP,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,ZDHHC7,1
DORSAM_HOXA9_TARGETS_UP,DORSAM_HOXA9_TARGETS_UP,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,PIM1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,AHNAK,1
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,PRRX1,1
LIU_CDX2_TARGETS_UP,LIU_CDX2_TARGETS_UP,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,IL2RB,1
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,PLOD2,1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,PIK3CA,1
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,EDEM1,1
REACTOME_REGULATION_OF_TNFR1_SIGNALING,REACTOME_REGULATION_OF_TNFR1_SIGNALING,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,TRAF1,1
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,FLNA,1
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,DKK1,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/62,35/21728,0.09524613157130768,0.17207904951593184,0.11343497038300415,NFKB1,1
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,2/62,182/21728,0.09527637234629625,0.17207904951593184,0.11343497038300415,FN1/ITGB5,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,2/62,183/21728,0.09615839350004775,0.17351631185838212,0.1143824175690915,COL6A1/COL3A1,2
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,2/62,184/21728,0.09704279111438616,0.17375153839079163,0.1145374795293489,BNC2/AHNAK,2
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,2/62,184/21728,0.09704279111438616,0.17375153839079163,0.1145374795293489,GIT2/PIK3CA,2
HAN_JNK_SINGALING_UP,HAN_JNK_SINGALING_UP,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,CCN1,1
HEIDENBLAD_AMPLICON_12P11_12_UP,HEIDENBLAD_AMPLICON_12P11_12_UP,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,GEM,1
KIM_ALL_DISORDERS_CALB1_CORR_DN,KIM_ALL_DISORDERS_CALB1_CORR_DN,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,PXN,1
KYNG_DNA_DAMAGE_BY_4NQO,KYNG_DNA_DAMAGE_BY_4NQO,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,ITGB5,1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,FLNA,1
PID_PI3K_PLC_TRK_PATHWAY,PID_PI3K_PLC_TRK_PATHWAY,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,PIK3CA,1
REACTOME_INTERLEUKIN_7_SIGNALING,REACTOME_INTERLEUKIN_7_SIGNALING,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,HGF,1
REACTOME_NOD1_2_SIGNALING_PATHWAY,REACTOME_NOD1_2_SIGNALING_PATHWAY,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,IRAK1,1
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,PIK3CA,1
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,CCN1,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,HGF,1
WP_CAMKK2_PATHWAY,WP_CAMKK2_PATHWAY,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,SQSTM1,1
WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,DKK1,1
YANG_BREAST_CANCER_ESR1_UP,YANG_BREAST_CANCER_ESR1_UP,1/62,36/21728,0.09783197676757294,0.17375153839079163,0.1145374795293489,AHNAK,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,2/62,185/21728,0.09792954499759329,0.17375153839079163,0.1145374795293489,LMNA/HGF,2
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,2/62,185/21728,0.09792954499759329,0.17375153839079163,0.1145374795293489,MYO1C/FLII,2
WP_RAS_SIGNALING,WP_RAS_SIGNALING,2/62,185/21728,0.09792954499759329,0.17375153839079163,0.1145374795293489,NFKB1/PIK3CA,2
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2/62,186/21728,0.09881863505042346,0.17517453191317356,0.11547552067102582,NFKB1/PIK3CA,2
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,3/62,388/21728,0.09912049581584574,0.17555496265975495,0.11572630163821872,LMNA/PXN/FN1,3
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,AHNAK2,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,PLOD2,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,RAB36,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,HGF,1
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,GALNT10,1
REACTOME_RHOV_GTPASE_CYCLE,REACTOME_RHOV_GTPASE_CYCLE,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,GIT2,1
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,TLN1,1
WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,NFKB1,1
WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,NFKB1,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,NFKB1,1
WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,PIK3CA,1
WP_PRION_DISEASE_PATHWAY,WP_PRION_DISEASE_PATHWAY,1/62,37/21728,0.10041055031728785,0.1759808599637484,0.11600705428184734,NFKB1,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,2/62,190/21728,0.10239795819007966,0.17877439787530253,0.11784856195609564,FN1/GEM,2
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,2/62,190/21728,0.10239795819007966,0.17877439787530253,0.11784856195609564,TGOLN2/GEM,2
APPIERTO_RESPONSE_TO_FENRETINIDE_UP,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,CCN1,1
DORN_ADENOVIRUS_INFECTION_32HR_DN,DORN_ADENOVIRUS_INFECTION_32HR_DN,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,CCN1,1
HUANG_FOXA2_TARGETS_DN,HUANG_FOXA2_TARGETS_DN,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,COL6A1,1
MA_MYELOID_DIFFERENTIATION_UP,MA_MYELOID_DIFFERENTIATION_UP,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,MYO1C,1
PID_ERBB4_PATHWAY,PID_ERBB4_PATHWAY,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,PIK3CA,1
PID_FAS_PATHWAY,PID_FAS_PATHWAY,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,PIK3CA,1
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,LMNA,1
REACTOME_FLT3_SIGNALING,REACTOME_FLT3_SIGNALING,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,PIK3CA,1
REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,1/62,38/21728,0.10298187233472944,0.17877439787530253,0.11784856195609564,PIK3CA,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,3/62,395/21728,0.10318110591929547,0.17896584923243317,0.1179747672035502,BNC2/DNAJC3/PLOD2,3
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,3/62,398/21728,0.10494169254218996,0.18119324002856435,0.11944306918279331,TRAF1/MYO1C/FBN1,3
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,2/62,193/21728,0.1051060090915321,0.18119324002856435,0.11944306918279331,ITGB5/TLN1,2
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,CCN1,1
BIOCARTA_FCER1_PATHWAY,BIOCARTA_FCER1_PATHWAY,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,PIK3CA,1
CONRAD_STEM_CELL,CONRAD_STEM_CELL,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,PRRX1,1
DORN_ADENOVIRUS_INFECTION_48HR_DN,DORN_ADENOVIRUS_INFECTION_48HR_DN,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,CCN1,1
GEISS_RESPONSE_TO_DSRNA_UP,GEISS_RESPONSE_TO_DSRNA_UP,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,TRAF1,1
HAN_JNK_SINGALING_DN,HAN_JNK_SINGALING_DN,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,COL6A1,1
PID_ECADHERIN_NASCENT_AJ_PATHWAY,PID_ECADHERIN_NASCENT_AJ_PATHWAY,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,PIK3CA,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,COL15A1,1
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,TNIP1,1
SESTO_RESPONSE_TO_UV_C6,SESTO_RESPONSE_TO_UV_C6,1/62,39/21728,0.10554596287946194,0.18119324002856435,0.11944306918279331,ITGB5,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,2/62,194/21728,0.1060130759105525,0.18153047551662266,0.1196653757198622,CCN1/MANBA,2
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2/62,194/21728,0.1060130759105525,0.18153047551662266,0.1196653757198622,FN1/PIK3CA,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,2/62,194/21728,0.1060130759105525,0.18153047551662266,0.1196653757198622,FN1/GEM,2
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,2/62,195/21728,0.10692230211004095,0.18277556135835257,0.12048613964189822,MYO1C/PRRX1,2
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,TGOLN2,1
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,IL2RB,1
MALONEY_RESPONSE_TO_17AAG_UP,MALONEY_RESPONSE_TO_17AAG_UP,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,STAT6,1
PID_ER_NONGENOMIC_PATHWAY,PID_ER_NONGENOMIC_PATHWAY,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
PID_IFNG_PATHWAY,PID_IFNG_PATHWAY,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
REACTOME_RET_SIGNALING,REACTOME_RET_SIGNALING,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
REACTOME_RHOU_GTPASE_CYCLE,REACTOME_RHOU_GTPASE_CYCLE,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,GIT2,1
REACTOME_SIGNALING_BY_FGFR3,REACTOME_SIGNALING_BY_FGFR3,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,VCL,1
WP_G13_SIGNALING_PATHWAY,WP_G13_SIGNALING_PATHWAY,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,LMNA,1
WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,PIK3CA,1
WP_PDGF_PATHWAY,WP_PDGF_PATHWAY,1/62,40/21728,0.1081028419564809,0.18277556135835257,0.12048613964189822,NFKB1,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,2/62,197/21728,0.10874715596502287,0.1837105607066549,0.12110249371684903,EDEM1/GEM,2
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,2/62,199/21728,0.11058041817063774,0.18491103769677852,0.12189385136441404,MYO1C/PLOD2,2
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,2/62,199/21728,0.11058041817063774,0.18491103769677852,0.12189385136441404,PIM1/MANBA,2
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,APOL3,1
LEE_AGING_MUSCLE_DN,LEE_AGING_MUSCLE_DN,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,COL3A1,1
LI_LUNG_CANCER,LI_LUNG_CANCER,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,NFKB1,1
LIAO_HAVE_SOX4_BINDING_SITES,LIAO_HAVE_SOX4_BINDING_SITES,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,DKK1,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,NFKB1,1
PID_ERBB1_INTERNALIZATION_PATHWAY,PID_ERBB1_INTERNALIZATION_PATHWAY,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,PIK3CA,1
REACTOME_DUAL_INCISION_IN_GG_NER,REACTOME_DUAL_INCISION_IN_GG_NER,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,CHD1L,1
REACTOME_SIGNALING_BY_FGFR4,REACTOME_SIGNALING_BY_FGFR4,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,PIK3CA,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,NFKB1,1
VALK_AML_WITH_FLT3_ITD,VALK_AML_WITH_FLT3_ITD,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,PIM1,1
WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1/62,41/21728,0.11065252951636251,0.18491103769677852,0.12189385136441404,PIK3CA,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,3/62,409/21728,0.11149907836081438,0.18601850094419356,0.1226238941036329,NRP2/LMNA/PRRX1,3
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,2/62,200/21728,0.11150015513851762,0.18601850094419356,0.1226238941036329,CCN1/DNAJC3,2
BYSTROEM_CORRELATED_WITH_IL5_UP,BYSTROEM_CORRELATED_WITH_IL5_UP,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,NFKB1,1
DORN_ADENOVIRUS_INFECTION_24HR_DN,DORN_ADENOVIRUS_INFECTION_24HR_DN,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,CCN1,1
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,PIK3CA,1
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,FURIN,1
REACTOME_RND1_GTPASE_CYCLE,REACTOME_RND1_GTPASE_CYCLE,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,PLXNA1,1
WP_IL2_SIGNALING_PATHWAY,WP_IL2_SIGNALING_PATHWAY,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,IL2RB,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,VCL,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,ZHAN_MULTIPLE_MYELOMA_MF_DN,1/62,42/21728,0.11319504545540338,0.1876016733577196,0.12366752559941756,DKK1,1
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,2/62,202/21728,0.11334574703715551,0.18769682554630196,0.12373025017701188,NRP2/AKAP13,2
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2/62,203/21728,0.11427156472189359,0.18907433241813315,0.12463830639680223,TGOLN2/RAB36,2
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,2/62,204/21728,0.11519937221039735,0.18961692520108603,0.12499598501274899,TRAF1/APOL3,2
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,2/62,204/21728,0.11519937221039735,0.18961692520108603,0.12499598501274899,NFKB1/IRAK1,2
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,2/62,204/21728,0.11519937221039735,0.18961692520108603,0.12499598501274899,EDEM1/ELF4,2
ABBUD_LIF_SIGNALING_1_UP,ABBUD_LIF_SIGNALING_1_UP,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,ST3GAL1,1
AMIT_EGF_RESPONSE_480_MCF10A,AMIT_EGF_RESPONSE_480_MCF10A,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,GIT2,1
HAHTOLA_SEZARY_SYNDROM_DN,HAHTOLA_SEZARY_SYNDROM_DN,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,IL2RB,1
HARRIS_BRAIN_CANCER_PROGENITORS,HARRIS_BRAIN_CANCER_PROGENITORS,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,COL6A1,1
LEIN_ASTROCYTE_MARKERS,LEIN_ASTROCYTE_MARKERS,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,ITGB5,1
PID_CXCR3_PATHWAY,PID_CXCR3_PATHWAY,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,PIK3CA,1
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,CHD1L,1
REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,PIK3CA,1
REACTOME_SIGNALING_BY_SCF_KIT,REACTOME_SIGNALING_BY_SCF_KIT,1/62,43/21728,0.11573040961577219,0.18961692520108603,0.12499598501274899,PIK3CA,1
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,2/62,205/21728,0.11612915109541384,0.18996085528778264,0.12522270464717283,NRP2/ELF4,2
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,2/62,205/21728,0.11612915109541384,0.18996085528778264,0.12522270464717283,PXN/PLOD2,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,2/62,207/21728,0.11799454985421047,0.19111356407448238,0.12598257336708582,DNAJC3/AKAP13,2
CHANDRAN_METASTASIS_TOP50_DN,CHANDRAN_METASTASIS_TOP50_DN,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,STAT6,1
KAAB_FAILED_HEART_VENTRICLE_DN,KAAB_FAILED_HEART_VENTRICLE_DN,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,IRAK1,1
KEGG_LYSINE_DEGRADATION,KEGG_LYSINE_DEGRADATION,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,PLOD2,1
NAKAMURA_METASTASIS_MODEL_DN,NAKAMURA_METASTASIS_MODEL_DN,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,EHBP1L1,1
NAKAYAMA_FRA2_TARGETS,NAKAYAMA_FRA2_TARGETS,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,SQSTM1,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,HGF,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,NFKB1,1
PID_ERBB2_ERBB3_PATHWAY,PID_ERBB2_ERBB3_PATHWAY,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,PIK3CA,1
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,PIK3CA,1
REACTOME_DAP12_INTERACTIONS,REACTOME_DAP12_INTERACTIONS,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,PIK3CA,1
REACTOME_INTRA_GOLGI_TRAFFIC,REACTOME_INTRA_GOLGI_TRAFFIC,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,RAB36,1
REACTOME_TNF_SIGNALING,REACTOME_TNF_SIGNALING,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,TRAF1,1
WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,LMNA,1
WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1/62,44/21728,0.11825864178565137,0.19111356407448238,0.12598257336708582,PIK3CA,1
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,2/62,209/21728,0.11986761544865498,0.1930173793003591,0.12723757346366665,MYO1C/PLXNA1,2
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,COL6A1,1
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,CCN1,1
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,LMNA,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,IL2RB,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,PLXNA1,1
NAKAMURA_METASTASIS_MODEL_UP,NAKAMURA_METASTASIS_MODEL_UP,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,AKAP13,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,HEBP1,1
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,GEM,1
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,PIK3CA,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,TRAF1,1
WP_NEPHROTIC_SYNDROME,WP_NEPHROTIC_SYNDROME,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,LMNA,1
ZHAN_V2_LATE_DIFFERENTIATION_GENES,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,IRAK1,1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,1/62,45/21728,0.12077976169937976,0.1930173793003591,0.12723757346366665,GEM,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,2/62,211/21728,0.1217482036849393,0.19441062366198245,0.12815600387888348,HHAT/AKAP13,2
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,2/62,212/21728,0.12269127410140035,0.1945624341518844,0.12825607776047626,SQSTM1/RAB36,2
BIOCARTA_KERATINOCYTE_PATHWAY,BIOCARTA_KERATINOCYTE_PATHWAY,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,NFKB1,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,CCN1,1
JIANG_TIP30_TARGETS_UP,JIANG_TIP30_TARGETS_UP,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,CCN1,1
KLEIN_TARGETS_OF_BCR_ABL1_FUSION,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,IRAK1,1
LUI_THYROID_CANCER_PAX8_PPARG_DN,LUI_THYROID_CANCER_PAX8_PPARG_DN,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,TMEM109,1
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,FBN1,1
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,COL3A1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,GEM,1
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,PIK3CA,1
PID_PS1_PATHWAY,PID_PS1_PATHWAY,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,DKK1,1
PID_RHOA_REG_PATHWAY,PID_RHOA_REG_PATHWAY,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,AKAP13,1
SIG_BCR_SIGNALING_PATHWAY,SIG_BCR_SIGNALING_PATHWAY,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,PIK3CA,1
SILIGAN_BOUND_BY_EWS_FLT1_FUSION,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,GALNT10,1
WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,1/62,46/21728,0.12329378903760069,0.1945624341518844,0.12825607776047626,NFKB1,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,2/62,213/21728,0.12363617171476808,0.1949498256192111,0.12851144725342994,DKK1/COL15A1,2
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,3/62,430/21728,0.12444443049682788,0.19607062972562075,0.12925028432263375,PRRX1/TPP1/IL2RB,3
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,2/62,214/21728,0.12458287887756203,0.19613517394495683,0.12929283204491243,TBC1D2B/IL2RB,2
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,2/62,215/21728,0.1255313780251211,0.19651482591299027,0.12954309963920047,TRAF1/PRRX1,2
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,CCN1,1
KEGG_TYPE_II_DIABETES_MELLITUS,KEGG_TYPE_II_DIABETES_MELLITUS,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,PIK3CA,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,COL3A1,1
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,AKAP13,1
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,PIK3CA,1
TSENG_ADIPOGENIC_POTENTIAL_DN,TSENG_ADIPOGENIC_POTENTIAL_DN,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,COL6A1,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,TRAM2,1
ZHAN_MULTIPLE_MYELOMA_HP_DN,ZHAN_MULTIPLE_MYELOMA_HP_DN,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,ST3GAL1,1
ZHAN_MULTIPLE_MYELOMA_LB_UP,ZHAN_MULTIPLE_MYELOMA_LB_UP,1/62,47/21728,0.12580074342740133,0.19651482591299027,0.12954309963920047,PLXNA1,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,VCL,1
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,PIM1,1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,CTF1,1
ENGELMANN_CANCER_PROGENITORS_UP,ENGELMANN_CANCER_PROGENITORS_UP,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,GEM,1
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,SQSTM1,1
PID_PI3KCI_PATHWAY,PID_PI3KCI_PATHWAY,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,PIK3CA,1
REACTOME_IRS_MEDIATED_SIGNALLING,REACTOME_IRS_MEDIATED_SIGNALLING,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,PIK3CA,1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,IRAK1,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,NFKB1,1
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,ITGB5,1
WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,1/62,48/21728,0.12830064444246125,0.19870427335879723,0.13098638926027234,NFKB1,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,2/62,218/21728,0.12838745296542564,0.19870427335879723,0.13098638926027234,MANBA/GCNT1,2
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,2/62,219/21728,0.1293429460507656,0.19987558176201256,0.13175851889721457,STAT6/TPP1,2
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,2/62,219/21728,0.1293429460507656,0.19987558176201256,0.13175851889721457,ZDHHC7/PIK3CA,2
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,TGOLN2,1
GUILLAUMOND_KLF10_TARGETS_UP,GUILLAUMOND_KLF10_TARGETS_UP,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,IL2RB,1
HENDRICKS_SMARCA4_TARGETS_DN,HENDRICKS_SMARCA4_TARGETS_DN,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,NRP2,1
JIANG_AGING_HYPOTHALAMUS_UP,JIANG_AGING_HYPOTHALAMUS_UP,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,TPP1,1
REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,TGOLN2,1
REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,ST3GAL1,1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,DNAJC3,1
WP_MICROTUBULE_CYTOSKELETON_REGULATION,WP_MICROTUBULE_CYTOSKELETON_REGULATION,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,PIK3CA,1
WP_PHOSPHOINOSITIDES_METABOLISM,WP_PHOSPHOINOSITIDES_METABOLISM,1/62,49/21728,0.13079351160318842,0.20072963031702143,0.13232150999238623,PIK3CA,1
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,2/62,221/21728,0.1312590313252387,0.20129052669693617,0.13269125438847945,FN1/IRAK1,2
BURTON_ADIPOGENESIS_7,BURTON_ADIPOGENESIS_7,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,FBN1,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,ITGB5,1
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,FBN1,1
CHUNG_BLISTER_CYTOTOXICITY_DN,CHUNG_BLISTER_CYTOTOXICITY_DN,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,VCL,1
KENNY_CTNNB1_TARGETS_UP,KENNY_CTNNB1_TARGETS_UP,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,CCN1,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,IL2RB,1
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,RAB36,1
OHGUCHI_LIVER_HNF4A_TARGETS_UP,OHGUCHI_LIVER_HNF4A_TARGETS_UP,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,ANXA13,1
REACTOME_SARS_COV_1_INFECTION,REACTOME_SARS_COV_1_INFECTION,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,ST3GAL1,1
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,PIK3CA,1
REACTOME_SIGNALING_BY_FGFR1,REACTOME_SIGNALING_BY_FGFR1,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,PIK3CA,1
WONG_PROTEASOME_GENE_MODULE,WONG_PROTEASOME_GENE_MODULE,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,SQSTM1,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,NFKB1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,DNAJC3,1
ZHU_CMV_8_HR_DN,ZHU_CMV_8_HR_DN,1/62,50/21728,0.13327936437686816,0.20207843340336,0.13321064459989201,LMNA,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,2/62,225/21728,0.1351111230231198,0.2044502567527969,0.13477415690516067,CCN1/MYO1C,2
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,COL3A1,1
BURTON_ADIPOGENESIS_11,BURTON_ADIPOGENESIS_11,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,COL3A1,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,LMNA,1
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,PIK3CA,1
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,VCL,1
VILIMAS_NOTCH1_TARGETS_UP,VILIMAS_NOTCH1_TARGETS_UP,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,TRAF1,1
WP_SYNAPTIC_SIGNALING_PATHWAYS_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,WP_SYNAPTIC_SIGNALING_PATHWAYS_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,PIK3CA,1
ZHOU_TNF_SIGNALING_30MIN,ZHOU_TNF_SIGNALING_30MIN,1/62,51/21728,0.13575822217780154,0.2044502567527969,0.13477415690516067,CCN1,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/62,227/21728,0.13704686074630865,0.20623656231980028,0.13595169431984327,STAT6/FLII,2
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,PIK3CA,1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,TNIP1,1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,AKAP13,1
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,PIK3CA,1
KEGG_MTOR_SIGNALING_PATHWAY,KEGG_MTOR_SIGNALING_PATHWAY,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,PIK3CA,1
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,FBN1,1
PID_KIT_PATHWAY,PID_KIT_PATHWAY,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,PIK3CA,1
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,PIK3CA,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,ELF4,1
REACTOME_APOPTOTIC_EXECUTION_PHASE,REACTOME_APOPTOTIC_EXECUTION_PHASE,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,LMNA,1
WP_NETRINUNC5B_SIGNALING_PATHWAY,WP_NETRINUNC5B_SIGNALING_PATHWAY,1/62,52/21728,0.1382301043674482,0.2063197106730755,0.13600650593704885,PIK3CA,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,2/62,229/21728,0.13898888270127313,0.20729846700886698,0.13665170473536278,FN1/DKK1,2
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,3/62,453/21728,0.1392221702106638,0.20749259738063375,0.1367796759964416,ST3GAL1/MANBA/APOL3,3
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,2/62,230/21728,0.13996220921967722,0.2075354845104046,0.13680794730726684,TGOLN2/PRRX1,2
JI_RESPONSE_TO_FSH_DN,JI_RESPONSE_TO_FSH_DN,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,FN1,1
KRIEG_HYPOXIA_VIA_KDM3A,KRIEG_HYPOXIA_VIA_KDM3A,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,NRP2,1
PID_NFAT_3PATHWAY,PID_NFAT_3PATHWAY,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,PIM1,1
REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,LMNA,1
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,PLXNA1,1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,PIK3CA,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,PRRX1,1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,TRAF1,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,PIM1,1
WP_CARDIAC_PROGENITOR_DIFFERENTIATION,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,DKK1,1
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,NFKB1,1
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,CCN1,1
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,1/62,53/21728,0.14069503025456853,0.2075354845104046,0.13680794730726684,DKK1,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,3/62,456/21728,0.1411930404406441,0.20811750722826075,0.13719161824192141,SQSTM1/PXN/ELF4,3
BAKKER_FOXO3_TARGETS_UP,BAKKER_FOXO3_TARGETS_UP,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,VCL,1
BROWNE_HCMV_INFECTION_30MIN_UP,BROWNE_HCMV_INFECTION_30MIN_UP,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,COL6A1,1
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,NRP2,1
KEGG_INOSITOL_PHOSPHATE_METABOLISM,KEGG_INOSITOL_PHOSPHATE_METABOLISM,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,PIK3CA,1
KEGG_NON_SMALL_CELL_LUNG_CANCER,KEGG_NON_SMALL_CELL_LUNG_CANCER,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,PIK3CA,1
KYNG_DNA_DAMAGE_BY_UV,KYNG_DNA_DAMAGE_BY_UV,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,ELF4,1
LEE_LIVER_CANCER_MYC_UP,LEE_LIVER_CANCER_MYC_UP,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,CCN1,1
MORI_PLASMA_CELL_UP,MORI_PLASMA_CELL_UP,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,TRAM2,1
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,PIK3CA,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,PXN,1
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,PIK3CA,1
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,1/62,54/21728,0.14315301909536293,0.20916766479293408,0.1378838849215742,PIK3CA,1
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,1/62,55/21728,0.14560409009361353,0.21213282351075338,0.13983852549102715,NFKB1,1
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,1/62,55/21728,0.14560409009361353,0.21213282351075338,0.13983852549102715,CCN1,1
REACTOME_RHOJ_GTPASE_CYCLE,REACTOME_RHOJ_GTPASE_CYCLE,1/62,55/21728,0.14560409009361353,0.21213282351075338,0.13983852549102715,GIT2,1
REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,1/62,55/21728,0.14560409009361353,0.21213282351075338,0.13983852549102715,MYO1C,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,2/62,237/21728,0.14681720765435904,0.21374545716394386,0.1409015779149154,RAB36/APOL3,2
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,2/62,238/21728,0.1478022604330485,0.2144514787260334,0.14136698921983998,CHD1L/HGF,2
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,2/62,238/21728,0.1478022604330485,0.2144514787260334,0.14136698921983998,BNC2/COL3A1,2
CROONQUIST_STROMAL_STIMULATION_UP,CROONQUIST_STROMAL_STIMULATION_UP,1/62,56/21728,0.14804826240082525,0.2144514787260334,0.14136698921983998,COL6A1,1
MCCLUNG_CREB1_TARGETS_DN,MCCLUNG_CREB1_TARGETS_DN,1/62,56/21728,0.14804826240082525,0.2144514787260334,0.14136698921983998,COL6A1,1
OUILLETTE_CLL_13Q14_DELETION_DN,OUILLETTE_CLL_13Q14_DELETION_DN,1/62,56/21728,0.14804826240082525,0.2144514787260334,0.14136698921983998,KLHL21,1
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1/62,56/21728,0.14804826240082525,0.2144514787260334,0.14136698921983998,TGOLN2,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/62,56/21728,0.14804826240082525,0.2144514787260334,0.14136698921983998,FN1,1
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/62,57/21728,0.1504855551163634,0.21735602074237126,0.14328167109730452,DKK1,1
BYSTROEM_CORRELATED_WITH_IL5_DN,BYSTROEM_CORRELATED_WITH_IL5_DN,1/62,57/21728,0.1504855551163634,0.21735602074237126,0.14328167109730452,PIM1,1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,1/62,57/21728,0.1504855551163634,0.21735602074237126,0.14328167109730452,FN1,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/62,57/21728,0.1504855551163634,0.21735602074237126,0.14328167109730452,NFKB1,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,2/62,242/21728,0.15175626070727338,0.21903414386157394,0.1443878943526123,HGF/DKK1,2
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,2/62,243/21728,0.15274813065569814,0.21991920401904497,0.14497132837919677,LMNA/HEBP1,2
JIANG_HYPOXIA_CANCER,JIANG_HYPOXIA_CANCER,1/62,58/21728,0.15291598728759637,0.21991920401904497,0.14497132837919677,FN1,1
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,1/62,58/21728,0.15291598728759637,0.21991920401904497,0.14497132837919677,PDLIM4,1
REACTOME_SIGNALING_BY_ERBB4,REACTOME_SIGNALING_BY_ERBB4,1/62,58/21728,0.15291598728759637,0.21991920401904497,0.14497132837919677,PIK3CA,1
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,1/62,58/21728,0.15291598728759637,0.21991920401904497,0.14497132837919677,NFKB1,1
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,VCL,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,BOYLAN_MULTIPLE_MYELOMA_C_DN,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,PLOD2,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,FLNA,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,FURIN,1
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,AKAP13,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,GIT2,1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,FN1,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,1/62,59/21728,0.1553395779100316,0.22213449236317243,0.1464316523896606,STAT6,1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/62,60/21728,0.15775634592745647,0.22511047376315066,0.14839342730018304,TRAM2,1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,1/62,60/21728,0.15775634592745647,0.22511047376315066,0.14839342730018304,STAT6,1
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1/62,60/21728,0.15775634592745647,0.22511047376315066,0.14839342730018304,LMNA,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,3/62,482/21728,0.1586620128288649,0.22601392957285918,0.14898898778999822,TGOLN2/EDEM1/COL15A1,3
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,2/62,249/21728,0.15872648234913023,0.22601392957285918,0.14898898778999822,FURIN/PLOD2,2
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,2/62,249/21728,0.15872648234913023,0.22601392957285918,0.14898898778999822,NFKB1/FLNA,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,2/62,250/21728,0.15972725593082443,0.2267801662117782,0.14949409303486477,TRAF1/PLXNA1,2
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,3/62,484/21728,0.16003323781726217,0.2267801662117782,0.14949409303486477,GIT2/HGF/GEM,3
CUI_GLUCOSE_DEPRIVATION,CUI_GLUCOSE_DEPRIVATION,1/62,61/21728,0.16016631023207595,0.2267801662117782,0.14949409303486477,DNAJC3,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,1/62,61/21728,0.16016631023207595,0.2267801662117782,0.14949409303486477,SQSTM1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1/62,61/21728,0.16016631023207595,0.2267801662117782,0.14949409303486477,IRAK1,1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,1/62,61/21728,0.16016631023207595,0.2267801662117782,0.14949409303486477,COL3A1,1
WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1/62,61/21728,0.16016631023207595,0.2267801662117782,0.14949409303486477,NFKB1,1
WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,1/62,61/21728,0.16016631023207595,0.2267801662117782,0.14949409303486477,NFKB1,1
DAZARD_UV_RESPONSE_CLUSTER_G1,DAZARD_UV_RESPONSE_CLUSTER_G1,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,STAT6,1
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,TRAF1,1
GEORGES_CELL_CYCLE_MIR192_TARGETS,GEORGES_CELL_CYCLE_MIR192_TARGETS,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,PIM1,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,AKAP13,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,PIK3CA,1
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,NFKB1,1
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,DKK1,1
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1/62,62/21728,0.16256948966465146,0.22889420098340008,0.15088767041910858,PIM1,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,2/62,253/21728,0.1627367912486355,0.22896952726731093,0.15093732570723647,GALNT10/DKK1,2
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,TLN1,1
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,PIK3CA,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,MANBA,1
INGRAM_SHH_TARGETS_DN,INGRAM_SHH_TARGETS_DN,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,HGF,1
LEE_LIVER_CANCER_MYC_DN,LEE_LIVER_CANCER_MYC_DN,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,TBC1D8,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,TPP1,1
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,GEM,1
PID_ENDOTHELIN_PATHWAY,PID_ENDOTHELIN_PATHWAY,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,COL3A1,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,DKK1,1
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,PIK3CA,1
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,ST3GAL1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,IRAK1,1
WORSCHECH_TUMOR_REJECTION_UP,WORSCHECH_TUMOR_REJECTION_UP,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,STAT6,1
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,PIK3CA,1
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,HGF,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,NFKB1,1
WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,1/62,63/21728,0.1649659030146372,0.2293789888496545,0.1512072438791277,ELF4,1
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,1/62,64/21728,0.16735556902031845,0.23190041657636412,0.15286937579063453,PIM1,1
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,1/62,64/21728,0.16735556902031845,0.23190041657636412,0.15286937579063453,COL6A1,1
GOLDRATH_IMMUNE_MEMORY,GOLDRATH_IMMUNE_MEMORY,1/62,64/21728,0.16735556902031845,0.23190041657636412,0.15286937579063453,TRAF1,1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,1/62,64/21728,0.16735556902031845,0.23190041657636412,0.15286937579063453,HGF,1
PID_TCR_PATHWAY,PID_TCR_PATHWAY,1/62,64/21728,0.16735556902031845,0.23190041657636412,0.15286937579063453,FLNA,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,2/62,259/21728,0.168787017646956,0.2337229728187718,0.154070809747647,LMNA/COL3A1,2
KEGG_GLIOMA,KEGG_GLIOMA,1/62,65/21728,0.1697385063689496,0.23423448204000452,0.1544079979964454,PIK3CA,1
LEE_LIVER_CANCER_ACOX1_UP,LEE_LIVER_CANCER_ACOX1_UP,1/62,65/21728,0.1697385063689496,0.23423448204000452,0.1544079979964454,TBC1D8,1
PID_CD8_TCR_DOWNSTREAM_PATHWAY,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1/62,65/21728,0.1697385063689496,0.23423448204000452,0.1544079979964454,IL2RB,1
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1/62,65/21728,0.1697385063689496,0.23423448204000452,0.1544079979964454,HHAT,1
REACTOME_RAB_GERANYLGERANYLATION,REACTOME_RAB_GERANYLGERANYLATION,1/62,65/21728,0.1697385063689496,0.23423448204000452,0.1544079979964454,RAB36,1
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,PANX1,1
BRUNO_HEMATOPOIESIS,BRUNO_HEMATOPOIESIS,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,SQSTM1,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,TBC1D8,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,VCL,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,FLII,1
PID_HDAC_CLASSI_PATHWAY,PID_HDAC_CLASSI_PATHWAY,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,NFKB1,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,FURIN,1
RAMASWAMY_METASTASIS_UP,RAMASWAMY_METASTASIS_UP,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,ELF4,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,DKK1,1
WESTON_VEGFA_TARGETS_3HR,WESTON_VEGFA_TARGETS_3HR,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,PIM1,1
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,NFKB1,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/62,66/21728,0.1721147336968879,0.2355747239443119,0.15529148904982368,PIK3CA,1
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1/62,67/21728,0.1744842695897323,0.23784712087706053,0.15678945919488138,NFKB1,1
MARSON_FOXP3_TARGETS_UP,MARSON_FOXP3_TARGETS_UP,1/62,67/21728,0.1744842695897323,0.23784712087706053,0.15678945919488138,MYO1C,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/62,67/21728,0.1744842695897323,0.23784712087706053,0.15678945919488138,NFKB1,1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1/62,67/21728,0.1744842695897323,0.23784712087706053,0.15678945919488138,PIK3CA,1
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,1/62,67/21728,0.1744842695897323,0.23784712087706053,0.15678945919488138,APOL3,1
ZHANG_RESPONSE_TO_CANTHARIDIN_DN,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,1/62,67/21728,0.1744842695897323,0.23784712087706053,0.15678945919488138,PIK3CA,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,2/62,265/21728,0.17487621611044432,0.23822000461355042,0.15703526515280608,GIT2/TPP1,2
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,GEM,1
JI_RESPONSE_TO_FSH_UP,JI_RESPONSE_TO_FSH_UP,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,COL3A1,1
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,NFKB1,1
WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,PIK3CA,1
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,FN1,1
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,NFKB1,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/62,68/21728,0.1768471325824581,0.2396977402140173,0.15800939241899226,PIK3CA,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,2/62,267/21728,0.1769140875834074,0.2396977402140173,0.15800939241899226,NFKB1/FLNA,2
ENGELMANN_CANCER_PROGENITORS_DN,ENGELMANN_CANCER_PROGENITORS_DN,1/62,69/21728,0.17920334115955328,0.24214716078779125,0.15962405702240087,FN1,1
LEE_AGING_NEOCORTEX_DN,LEE_AGING_NEOCORTEX_DN,1/62,69/21728,0.17920334115955328,0.24214716078779125,0.15962405702240087,COL6A1,1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/62,69/21728,0.17920334115955328,0.24214716078779125,0.15962405702240087,FLII,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/62,69/21728,0.17920334115955328,0.24214716078779125,0.15962405702240087,PXN,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,2/62,270/21728,0.1799781483983752,0.24303089568961803,0.16020661743691472,AKAP13/TNIP1,2
CROONQUIST_NRAS_SIGNALING_DN,CROONQUIST_NRAS_SIGNALING_DN,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,PLOD2,1
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,NFKB1,1
PID_AP1_PATHWAY,PID_AP1_PATHWAY,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,CCN1,1
PID_CDC42_PATHWAY,PID_CDC42_PATHWAY,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,PIK3CA,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,AKAP13,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,PLOD2,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,TPP1,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1/62,70/21728,0.18155291375515414,0.2438481057913018,0.16074532452497664,PXN,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,2/62,272/21728,0.1820255342214922,0.2443197964333838,0.1610562642597382,SQSTM1/PANX1,2
BAE_BRCA1_TARGETS_UP,BAE_BRCA1_TARGETS_UP,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,STAT6,1
BASSO_CD40_SIGNALING_DN,BASSO_CD40_SIGNALING_DN,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,GCNT1,1
BURTON_ADIPOGENESIS_2,BURTON_ADIPOGENESIS_2,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,ST3GAL1,1
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,PLOD2,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,BNC2,1
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,NFKB1,1
LIN_APC_TARGETS,LIN_APC_TARGETS,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,LMNA,1
REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,NFKB1,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,FURIN,1
REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,PIK3CA,1
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,AKAP13,1
WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,1/62,71/21728,0.18389586875317665,0.2448699456858977,0.16141892412066083,NFKB1,1
CROMER_METASTASIS_UP,CROMER_METASTASIS_UP,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,TMEM109,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,IRAK1,1
MATZUK_SPERMATOCYTE,MATZUK_SPERMATOCYTE,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,LMNA,1
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,TGOLN2,1
REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,MYO1C,1
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,PIK3CA,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1/62,72/21728,0.1862322244874569,0.24683744115201797,0.1627159024021883,GEM,1
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,NFKB1,1
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,TMEM109,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,VCL,1
LEE_AGING_CEREBELLUM_DN,LEE_AGING_CEREBELLUM_DN,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,CCN1,1
REACTOME_SIGNALING_BY_FGFR2,REACTOME_SIGNALING_BY_FGFR2,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,PIK3CA,1
WP_FOLATE_METABOLISM,WP_FOLATE_METABOLISM,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,NFKB1,1
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1/62,73/21728,0.18856199924187955,0.24877819178666338,0.16399525041916704,PIK3CA,1
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,2/62,280/21728,0.19025021505528886,0.250692588143627,0.16525722562570366,CHD1L/HGF,2
CAMPS_COLON_CANCER_COPY_NUMBER_DN,CAMPS_COLON_CANCER_COPY_NUMBER_DN,1/62,74/21728,0.19088521125051516,0.250692588143627,0.16525722562570366,AHNAK,1
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,1/62,74/21728,0.19088521125051516,0.250692588143627,0.16525722562570366,PLOD2,1
FOROUTAN_INTEGRATED_TGFB_EMT_DN,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1/62,74/21728,0.19088521125051516,0.250692588143627,0.16525722562570366,TBC1D8,1
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,1/62,74/21728,0.19088521125051516,0.250692588143627,0.16525722562570366,PIK3CA,1
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,1/62,74/21728,0.19088521125051516,0.250692588143627,0.16525722562570366,AKAP13,1
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,1/62,74/21728,0.19088521125051516,0.250692588143627,0.16525722562570366,NFKB1,1
ANDERSEN_LIVER_CANCER_KRT19_DN,ANDERSEN_LIVER_CANCER_KRT19_DN,1/62,75/21728,0.1932018786977523,0.2529096811580206,0.16671873927964106,TNIP1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/62,75/21728,0.1932018786977523,0.2529096811580206,0.16671873927964106,TMEM109,1
OUILLETTE_CLL_13Q14_DELETION_UP,OUILLETTE_CLL_13Q14_DELETION_UP,1/62,75/21728,0.1932018786977523,0.2529096811580206,0.16671873927964106,TGOLN2,1
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1/62,75/21728,0.1932018786977523,0.2529096811580206,0.16671873927964106,FURIN,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/62,75/21728,0.1932018786977523,0.2529096811580206,0.16671873927964106,PIK3CA,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,2/62,285/21728,0.19541708935208815,0.2542793688904207,0.1676216411017736,EDEM1/ITGB5,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,HHAT,1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,AHNAK,1
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,PIK3CA,1
REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,LMNA,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,AHNAK,1
SANA_RESPONSE_TO_IFNG_UP,SANA_RESPONSE_TO_IFNG_UP,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,APOL3,1
WP_16P112_PROXIMAL_DELETION_SYNDROME,WP_16P112_PROXIMAL_DELETION_SYNDROME,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,NFKB1,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,NFKB1,1
WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,1/62,76/21728,0.1955120197184298,0.2542793688904207,0.1676216411017736,CHD1L,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,2/62,286/21728,0.1964527282698435,0.25513146963123107,0.16818334819260808,PXN/EHBP1L1,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,2/62,287/21728,0.19748909286713023,0.25513146963123107,0.16818334819260808,HEBP1/TBC1D8,2
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,LMNA,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,FN1,1
GROSS_HYPOXIA_VIA_HIF1A_UP,GROSS_HYPOXIA_VIA_HIF1A_UP,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,PLXNA1,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,NRP2,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,NRP2,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,IL2RB,1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,PIM1,1
REACTOME_MEIOTIC_SYNAPSIS,REACTOME_MEIOTIC_SYNAPSIS,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,LMNA,1
REACTOME_SENSORY_PROCESSING_OF_SOUND,REACTOME_SENSORY_PROCESSING_OF_SOUND,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,MYO1C,1
WP_JOUBERT_SYNDROME,WP_JOUBERT_SYNDROME,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,FLNA,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1/62,77/21728,0.19781565239797239,0.25513146963123107,0.16818334819260808,FN1,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,2/62,288/21728,0.1985261708377179,0.25588382813932636,0.16867930493646083,LMNA/AHNAK2,2
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,2/62,289/21728,0.1995639499375174,0.25705676522041293,0.16945250820221844,PLXNA1/EDEM1,2
MORI_PRE_BI_LYMPHOCYTE_DN,MORI_PRE_BI_LYMPHOCYTE_DN,1/62,78/21728,0.20011279477251998,0.2571053276387677,0.1694845206784803,NFKB1,1
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,1/62,78/21728,0.20011279477251998,0.2571053276387677,0.1694845206784803,ST3GAL1,1
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1/62,78/21728,0.20011279477251998,0.2571053276387677,0.1694845206784803,PIK3CA,1
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1/62,78/21728,0.20011279477251998,0.2571053276387677,0.1694845206784803,KLHL21,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,2/62,290/21728,0.20060241798433767,0.2575699202198388,0.16979078135241024,ITGB5/IRAK1,2
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/62,79/21728,0.20240346482906046,0.2590558341196372,0.17077029977542266,PLOD2,1
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1/62,79/21728,0.20240346482906046,0.2590558341196372,0.17077029977542266,PIK3CA,1
MEISSNER_NPC_HCP_WITH_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K27ME3,1/62,79/21728,0.20240346482906046,0.2590558341196372,0.17077029977542266,COL15A1,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/62,79/21728,0.20240346482906046,0.2590558341196372,0.17077029977542266,PIM1,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/62,79/21728,0.20240346482906046,0.2590558341196372,0.17077029977542266,COL15A1,1
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,2/62,292/21728,0.20268137249829843,0.2592466125025915,0.17089606139649752,TRAF1/FN1,2
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,2/62,293/21728,0.20372183490835316,0.2602465598956232,0.17155522939650794,ST3GAL1/MANBA,2
WANG_MLL_TARGETS,WANG_MLL_TARGETS,2/62,293/21728,0.20372183490835316,0.2602465598956232,0.17155522939650794,COL6A1/TBC1D8,2
BOYLAN_MULTIPLE_MYELOMA_D_DN,BOYLAN_MULTIPLE_MYELOMA_D_DN,1/62,80/21728,0.20468768050556307,0.2604880538755174,0.17171442287493557,AHNAK,1
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,1/62,80/21728,0.20468768050556307,0.2604880538755174,0.17171442287493557,VCL,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,1/62,80/21728,0.20468768050556307,0.2604880538755174,0.17171442287493557,IRAK1,1
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1/62,80/21728,0.20468768050556307,0.2604880538755174,0.17171442287493557,AKAP13,1
TOOKER_GEMCITABINE_RESISTANCE_UP,TOOKER_GEMCITABINE_RESISTANCE_UP,1/62,80/21728,0.20468768050556307,0.2604880538755174,0.17171442287493557,TPP1,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/62,80/21728,0.20468768050556307,0.2604880538755174,0.17171442287493557,GEM,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,2/62,295/21728,0.20580467034921415,0.26174399288408273,0.17254234123362158,ZDHHC7/PIK3CA,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/62,81/21728,0.2069654596911068,0.2623909923746105,0.17296884503087226,NFKB1,1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1/62,81/21728,0.2069654596911068,0.2623909923746105,0.17296884503087226,PLOD2,1
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1/62,81/21728,0.2069654596911068,0.2623909923746105,0.17296884503087226,NFKB1,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/62,81/21728,0.2069654596911068,0.2623909923746105,0.17296884503087226,TPP1,1
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,1/62,81/21728,0.2069654596911068,0.2623909923746105,0.17296884503087226,TRAM2,1
FOROUTAN_PRODRANK_TGFB_EMT_DN,FOROUTAN_PRODRANK_TGFB_EMT_DN,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,TBC1D8,1
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,NFKB1,1
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,ITGB5,1
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,NFKB1,1
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,FLNA,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,NFKB1,1
REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,PIK3CA,1
REACTOME_SELECTIVE_AUTOPHAGY,REACTOME_SELECTIVE_AUTOPHAGY,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,SQSTM1,1
RIZ_ERYTHROID_DIFFERENTIATION,RIZ_ERYTHROID_DIFFERENTIATION,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,ELF4,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1/62,82/21728,0.20923682022601453,0.26360956937679475,0.1737721342548715,PIK3CA,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,2/62,300/21728,0.21102235422765359,0.26546573996430917,0.17499572687821996,NFKB1/DKK1,2
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,2/62,300/21728,0.21102235422765359,0.26546573996430917,0.17499572687821996,CCN1/GEM,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/62,83/21728,0.21150177990198193,0.26546573996430917,0.17499572687821996,SQSTM1,1
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,1/62,83/21728,0.21150177990198193,0.26546573996430917,0.17499572687821996,CCN1,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/62,83/21728,0.21150177990198193,0.26546573996430917,0.17499572687821996,TBC1D8,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/62,83/21728,0.21150177990198193,0.26546573996430917,0.17499572687821996,PIK3CA,1
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,AHNAK2,1
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,ITGB5,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,PIM1,1
REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,CHD1L,1
REACTOME_PI_METABOLISM,REACTOME_PI_METABOLISM,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,PIK3CA,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,NFKB1,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/62,84/21728,0.21376035646220726,0.2671340603738888,0.17609548816108608,DNAJC3,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,2/62,303/21728,0.21415976502992357,0.267301145930649,0.17620563140766862,ANXA13/TLN1,2
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,2/62,303/21728,0.21415976502992357,0.267301145930649,0.17620563140766862,AHNAK2/FBN1,2
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1/62,85/21728,0.21601256760152276,0.2692796071959503,0.1775098383733899,PIK3CA,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1/62,85/21728,0.21601256760152276,0.2692796071959503,0.1775098383733899,TBC1D8,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,2/62,305/21728,0.2162540150331429,0.26941367074098055,0.1775982134213851,ST3GAL1/EDEM1,2
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/62,86/21728,0.2182584309665233,0.27157449790021326,0.17902263647288308,DNAJC3,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/62,86/21728,0.2182584309665233,0.27157449790021326,0.17902263647288308,COL15A1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,2/62,309/21728,0.2204484531548352,0.2730104023884679,0.17996918855784744,TPP1/TNIP1,2
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,PIK3CA,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,FURIN,1
REACTOME_SIGNALING_BY_FGFR,REACTOME_SIGNALING_BY_FGFR,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,PIK3CA,1
SANA_RESPONSE_TO_IFNG_DN,SANA_RESPONSE_TO_IFNG_DN,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,DKK1,1
TAKAO_RESPONSE_TO_UVB_RADIATION_UP,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,TPP1,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,NFKB1,1
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,1/62,87/21728,0.220497964155696,0.2730104023884679,0.17996918855784744,STAT6,1
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,2/62,311/21728,0.22254846398728997,0.275098307953182,0.18134554149890622,HHAT/LMNA,2
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/62,88/21728,0.22273118471954945,0.275098307953182,0.18134554149890622,TRAM2,1
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,1/62,88/21728,0.22273118471954945,0.275098307953182,0.18134554149890622,DKK1,1
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,1/62,88/21728,0.22273118471954945,0.275098307953182,0.18134554149890622,FBN1,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,FLNA,1
LI_DCP2_BOUND_MRNA,LI_DCP2_BOUND_MRNA,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,FLII,1
REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,MYO1C,1
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,PLOD2,1
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,TGOLN2,1
WNT_SIGNALING,WNT_SIGNALING,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,DKK1,1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1/62,89/21728,0.22495811016074085,0.2766599741096642,0.18237499601243953,PRRX1,1
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,1/62,90/21728,0.22717875793420717,0.27904985406814703,0.18395041128275885,PLXNA1,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/62,90/21728,0.22717875793420717,0.27904985406814703,0.18395041128275885,DKK1,1
LU_IL4_SIGNALING,LU_IL4_SIGNALING,1/62,91/21728,0.22939314544728961,0.2809123607059931,0.18517818064745808,VCL,1
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1/62,91/21728,0.22939314544728961,0.2809123607059931,0.18517818064745808,FLNA,1
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,1/62,91/21728,0.22939314544728961,0.2809123607059931,0.18517818064745808,PIK3CA,1
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,1/62,91/21728,0.22939314544728961,0.2809123607059931,0.18517818064745808,NFKB1,1
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,1/62,91/21728,0.22939314544728961,0.2809123607059931,0.18517818064745808,NFKB1,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/62,319/21728,0.23096509324990433,0.2824132094548156,0.1861675441629526,TRAM2/TPP1,2
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/62,92/21728,0.23160129005986363,0.2824132094548156,0.1861675441629526,PIM1,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,1/62,92/21728,0.23160129005986363,0.2824132094548156,0.1861675441629526,GEM,1
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1/62,92/21728,0.23160129005986363,0.2824132094548156,0.1861675441629526,PDLIM4,1
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,1/62,92/21728,0.23160129005986363,0.2824132094548156,0.1861675441629526,AHNAK2,1
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1/62,92/21728,0.23160129005986363,0.2824132094548156,0.1861675441629526,PDLIM4,1
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,1/62,92/21728,0.23160129005986363,0.2824132094548156,0.1861675441629526,AHNAK2,1
CAMPS_COLON_CANCER_COPY_NUMBER_UP,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1/62,93/21728,0.2338032090844655,0.2845807965383815,0.1875964233746786,FLII,1
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,1/62,93/21728,0.2338032090844655,0.2845807965383815,0.1875964233746786,FN1,1
WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,1/62,93/21728,0.2338032090844655,0.2845807965383815,0.1875964233746786,NFKB1,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/62,94/21728,0.2359989197864193,0.28690623964367107,0.18912936169876823,LMNA,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/62,94/21728,0.2359989197864193,0.28690623964367107,0.18912936169876823,GIT2,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1/62,95/21728,0.23818843938396206,0.28904411341407216,0.19053865381486398,ITGB5,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/62,95/21728,0.23818843938396206,0.28904411341407216,0.19053865381486398,COL6A1,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/62,95/21728,0.23818843938396206,0.28904411341407216,0.19053865381486398,PIK3CA,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1/62,96/21728,0.24037178504837253,0.29116678598273665,0.191937925258056,ANXA13,1
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1/62,96/21728,0.24037178504837253,0.29116678598273665,0.191937925258056,PIK3CA,1
WP_G_PROTEIN_SIGNALING_PATHWAYS,WP_G_PROTEIN_SIGNALING_PATHWAYS,1/62,96/21728,0.24037178504837253,0.29116678598273665,0.191937925258056,AKAP13,1
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,1/62,97/21728,0.24254897390409536,0.2936272776745125,0.19355988797210727,FBN1,1
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,1/62,98/21728,0.24472002302886753,0.2955442294922458,0.19482354774522848,DNAJC3,1
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,1/62,98/21728,0.24472002302886753,0.2955442294922458,0.19482354774522848,ITGB5,1
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1/62,98/21728,0.24472002302886753,0.2955442294922458,0.19482354774522848,COL3A1,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/62,98/21728,0.24472002302886753,0.2955442294922458,0.19482354774522848,NFKB1,1
ROVERSI_GLIOMA_COPY_NUMBER_UP,ROVERSI_GLIOMA_COPY_NUMBER_UP,1/62,99/21728,0.24688494945384265,0.29797991499767934,0.1964291581547954,GALNT10,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/62,100/21728,0.2490437701637167,0.29968664208696055,0.19755423722379944,ELF4,1
BROWNE_HCMV_INFECTION_12HR_DN,BROWNE_HCMV_INFECTION_12HR_DN,1/62,100/21728,0.2490437701637167,0.29968664208696055,0.19755423722379944,TBC1D8,1
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,1/62,100/21728,0.2490437701637167,0.29968664208696055,0.19755423722379944,PIK3CA,1
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,1/62,100/21728,0.2490437701637167,0.29968664208696055,0.19755423722379944,PLOD2,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/62,100/21728,0.2490437701637167,0.29968664208696055,0.19755423722379944,NFKB1,1
KANG_IMMORTALIZED_BY_TERT_DN,KANG_IMMORTALIZED_BY_TERT_DN,1/62,101/21728,0.2511965020968516,0.30155570538118465,0.19878632875394617,ST3GAL1,1
MCCLUNG_CREB1_TARGETS_UP,MCCLUNG_CREB1_TARGETS_UP,1/62,101/21728,0.2511965020968516,0.30155570538118465,0.19878632875394617,LMNA,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/62,101/21728,0.2511965020968516,0.30155570538118465,0.19878632875394617,FLNA,1
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1/62,101/21728,0.2511965020968516,0.30155570538118465,0.19878632875394617,LMNA,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,2/62,339/21728,0.25209369499053624,0.3024523043058789,0.19937736916679263,TRAF1/APOL3,2
BURTON_ADIPOGENESIS_3,BURTON_ADIPOGENESIS_3,1/62,102/21728,0.253343162145402,0.3035893044887128,0.20012688273295917,HGF,1
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,1/62,102/21728,0.253343162145402,0.3035893044887128,0.20012688273295917,NFKB1,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,2/62,341/21728,0.2542112033226825,0.3044481792174031,0.20069305525474934,LMNA/PLOD2,2
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/62,103/21728,0.25548376715543564,0.3054268208655594,0.201338178450667,TRAF1,1
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,1/62,103/21728,0.25548376715543564,0.3054268208655594,0.201338178450667,PLOD2,1
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,1/62,103/21728,0.25548376715543564,0.3054268208655594,0.201338178450667,DKK1,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,2/62,343/21728,0.2563292516326784,0.30625561418346137,0.2018845212258875,CTF1/HGF,2
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1/62,104/21728,0.25761833392705935,0.3074306570944504,0.2026591126603576,MYO1C,1
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1/62,104/21728,0.25761833392705935,0.3074306570944504,0.2026591126603576,FURIN,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,2/62,345/21728,0.258447766278128,0.30823764419181593,0.20319108071658898,BNC2/COL15A1,2
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,AHNAK2,1
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,DKK1,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,PLXNA1,1
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,ITGB5,1
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,PIK3CA,1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,TGOLN2,1
RICKMAN_HEAD_AND_NECK_CANCER_A,RICKMAN_HEAD_AND_NECK_CANCER_A,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,PRRX1,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/62,105/21728,0.25974687921454187,0.30832490913254174,0.20324860599926892,TRAM2,1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1/62,106/21728,0.26186941972643674,0.310478062751674,0.20466797063257783,ITGB5,1
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1/62,106/21728,0.26186941972643674,0.310478062751674,0.20466797063257783,TMEM109,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,2/62,350/21728,0.26374561698707477,0.3118847774027698,0.20559528069869734,BNC2/AHNAK,2
BORCZUK_MALIGNANT_MESOTHELIOMA_DN,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1/62,107/21728,0.2639859721257043,0.3118847774027698,0.20559528069869734,TRAF1,1
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1/62,107/21728,0.2639859721257043,0.3118847774027698,0.20559528069869734,FN1,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/62,107/21728,0.2639859721257043,0.3118847774027698,0.20559528069869734,DKK1,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1/62,107/21728,0.2639859721257043,0.3118847774027698,0.20559528069869734,COL3A1,1
TAVAZOIE_METASTASIS,TAVAZOIE_METASTASIS,1/62,107/21728,0.2639859721257043,0.3118847774027698,0.20559528069869734,VCL,1
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/62,108/21728,0.2660965530298345,0.31364163133920736,0.20675340351961982,COL15A1,1
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,1/62,108/21728,0.2660965530298345,0.31364163133920736,0.20675340351961982,TBC1D8,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1/62,108/21728,0.2660965530298345,0.31364163133920736,0.20675340351961982,FN1,1
REACTOME_AMYLOID_FIBER_FORMATION,REACTOME_AMYLOID_FIBER_FORMATION,1/62,108/21728,0.2660965530298345,0.31364163133920736,0.20675340351961982,FURIN,1
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,1/62,109/21728,0.26820117901096985,0.3159372202400886,0.20826666187219403,SQSTM1,1
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/62,110/21728,0.2702998665960258,0.31785115814798587,0.20952833486787814,DKK1,1
REACTOME_NUCLEOTIDE_EXCISION_REPAIR,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,1/62,110/21728,0.2702998665960258,0.31785115814798587,0.20952833486787814,CHD1L,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1/62,110/21728,0.2702998665960258,0.31785115814798587,0.20952833486787814,NFKB1,1
LIM_MAMMARY_LUMINAL_MATURE_UP,LIM_MAMMARY_LUMINAL_MATURE_UP,1/62,111/21728,0.27239263226681176,0.32012498605188394,0.2110272483129506,EDEM1,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,2/62,359/21728,0.2732844055626643,0.3209855364810745,0.21159452546099924,ST3GAL1/KLHL21,2
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,1/62,112/21728,0.274479492460153,0.32163817054736626,0.21202474358568668,NRP2,1
PASINI_SUZ12_TARGETS_UP,PASINI_SUZ12_TARGETS_UP,1/62,112/21728,0.274479492460153,0.32163817054736626,0.21202474358568668,MANBA,1
ROPERO_HDAC2_TARGETS,ROPERO_HDAC2_TARGETS,1/62,112/21728,0.274479492460153,0.32163817054736626,0.21202474358568668,ST3GAL1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/62,112/21728,0.274479492460153,0.32163817054736626,0.21202474358568668,AHNAK,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,2/62,361/21728,0.2754040938251485,0.32253378159266516,0.21261513278578956,GALNT10/IL2RB,2
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1/62,113/21728,0.27656046356801167,0.3236996234431876,0.21338365885655353,NFKB1,1
BOSCO_TH1_CYTOTOXIC_MODULE,BOSCO_TH1_CYTOTOXIC_MODULE,1/62,114/21728,0.27863556193760575,0.3259388084991063,0.2148597356434414,APOL3,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1/62,115/21728,0.2807048038715315,0.328168544677235,0.2163295837047798,ELF4,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1/62,116/21728,0.2827682056278804,0.32981427810046104,0.21741445558573874,PIM1,1
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,1/62,116/21728,0.2827682056278804,0.32981427810046104,0.21741445558573874,BNC2,1
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,1/62,116/21728,0.2827682056278804,0.32981427810046104,0.21741445558573874,MYO1C,1
RICKMAN_HEAD_AND_NECK_CANCER_C,RICKMAN_HEAD_AND_NECK_CANCER_C,1/62,116/21728,0.2827682056278804,0.32981427810046104,0.21741445558573874,DKK1,1
REACTOME_MEIOSIS,REACTOME_MEIOSIS,1/62,117/21728,0.2848257834203597,0.3318294593177555,0.2187428684421743,LMNA,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/62,117/21728,0.2848257834203597,0.3318294593177555,0.2187428684421743,DKK1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/62,118/21728,0.28687755341841337,0.3338332200565921,0.22006375288861887,HGF,1
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,1/62,118/21728,0.28687755341841337,0.3338332200565921,0.22006375288861887,FURIN,1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1/62,119/21728,0.288923531747338,0.3356317239466767,0.22124933147055176,SQSTM1,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,1/62,119/21728,0.288923531747338,0.3356317239466767,0.22124933147055176,ANXA13,1
WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,1/62,119/21728,0.288923531747338,0.3356317239466767,0.22124933147055176,PIK3CA,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2/62,377/21728,0.29235033792649245,0.33941654928338305,0.22374429847078722,ITGB5/KLHL21,2
CERVERA_SDHB_TARGETS_1_UP,CERVERA_SDHB_TARGETS_1_UP,1/62,121/21728,0.2929981776789672,0.3397765610893844,0.22398161921765433,ANXA13,1
REACTOME_L1CAM_INTERACTIONS,REACTOME_L1CAM_INTERACTIONS,1/62,121/21728,0.2929981776789672,0.3397765610893844,0.22398161921765433,NRP2,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,1/62,122/21728,0.2950268773125998,0.3419320720927136,0.22540253784494044,TMEM109,1
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,1/62,123/21728,0.2970498493391954,0.3432879361691334,0.2262963270760218,DKK1,1
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,1/62,123/21728,0.2970498493391954,0.3432879361691334,0.2262963270760218,SQSTM1,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/62,123/21728,0.2970498493391954,0.3432879361691334,0.2262963270760218,HLCS,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/62,123/21728,0.2970498493391954,0.3432879361691334,0.2262963270760218,PLOD2,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/62,123/21728,0.2970498493391954,0.3432879361691334,0.2262963270760218,ITGB5,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/62,383/21728,0.2986958534390697,0.34482694822129667,0.2273108479433053,BNC2/HHAT,2
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,1/62,124/21728,0.29906710966509076,0.34482694822129667,0.2273108479433053,NFKB1,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/62,124/21728,0.29906710966509076,0.34482694822129667,0.2273108479433053,ST3GAL1,1
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,1/62,124/21728,0.29906710966509076,0.34482694822129667,0.2273108479433053,COL3A1,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,1/62,126/21728,0.3030845586230494,0.3484606468283288,0.22970619179852167,FN1,1
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1/62,126/21728,0.3030845586230494,0.3484606468283288,0.22970619179852167,IL2RB,1
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,1/62,126/21728,0.3030845586230494,0.3484606468283288,0.22970619179852167,FBN1,1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1/62,126/21728,0.3030845586230494,0.3484606468283288,0.22970619179852167,DKK1,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/62,126/21728,0.3030845586230494,0.3484606468283288,0.22970619179852167,PIM1,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1/62,128/21728,0.30707935057047675,0.3528518865492857,0.23260090878523595,LMNA,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,2/62,392/21728,0.3081993391835628,0.353936684039571,0.23331601019664092,MANBA/GCNT1,2
GAL_LEUKEMIC_STEM_CELL_UP,GAL_LEUKEMIC_STEM_CELL_UP,1/62,129/21728,0.3090682894716168,0.35412608110301425,0.233440861248194,COL6A1,1
KEGG_AXON_GUIDANCE,KEGG_AXON_GUIDANCE,1/62,129/21728,0.3090682894716168,0.35412608110301425,0.233440861248194,PLXNA1,1
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,1/62,129/21728,0.3090682894716168,0.35412608110301425,0.233440861248194,PIK3CA,1
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1/62,129/21728,0.3090682894716168,0.35412608110301425,0.233440861248194,FURIN,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1/62,130/21728,0.31105161120191716,0.35599308403768903,0.2346715945838067,HGF,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1/62,130/21728,0.31105161120191716,0.35599308403768903,0.2346715945838067,MYO1C,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1/62,131/21728,0.31302933136607536,0.35784944017530884,0.23589530952228166,PRRX1,1
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,1/62,131/21728,0.31302933136607536,0.35784944017530884,0.23589530952228166,PIK3CA,1
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,1/62,132/21728,0.3150014655261577,0.35969520354065226,0.23711204167689753,GEM,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/62,132/21728,0.3150014655261577,0.35969520354065226,0.23711204167689753,PIK3CA,1
QI_HYPOXIA,QI_HYPOXIA,1/62,133/21728,0.31696802920171707,0.3611209936318543,0.2380519263242317,PLOD2,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1/62,133/21728,0.31696802920171707,0.3611209936318543,0.2380519263242317,NRP2,1
WHITFIELD_CELL_CYCLE_G1_S,WHITFIELD_CELL_CYCLE_G1_S,1/62,133/21728,0.31696802920171707,0.3611209936318543,0.2380519263242317,DNAJC3,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/62,133/21728,0.31696802920171707,0.3611209936318543,0.2380519263242317,FN1,1
YEGNASUBRAMANIAN_PROSTATE_CANCER,YEGNASUBRAMANIAN_PROSTATE_CANCER,1/62,135/21728,0.32088450696558124,0.36537613356805293,0.24085692596826758,GCNT1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,2/62,405/21728,0.3218858416705018,0.36630900081507334,0.24147187455634217,DNAJC3/PRRX1,2
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/62,136/21728,0.32283445188144044,0.3667661870047759,0.2417732529172427,COL3A1,1
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1/62,136/21728,0.32283445188144044,0.3667661870047759,0.2417732529172427,NFKB1,1
REACTOME_HCMV_EARLY_EVENTS,REACTOME_HCMV_EARLY_EVENTS,1/62,136/21728,0.32283445188144044,0.3667661870047759,0.2417732529172427,NFKB1,1
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,1/62,137/21728,0.3247788879681087,0.36835125287025633,0.2428181325816276,PIK3CA,1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1/62,137/21728,0.3247788879681087,0.36835125287025633,0.2428181325816276,PIK3CA,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/62,137/21728,0.3247788879681087,0.36835125287025633,0.2428181325816276,DKK1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/62,408/21728,0.3250360754672077,0.3684352585014208,0.24287350931871415,BNC2/PRRX1,2
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,2/62,409/21728,0.32608539732031006,0.3694165649822432,0.24352038917946342,AHNAK2/NFKB1,2
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,1/62,138/21728,0.3267178305342695,0.3699247467838775,0.24385538398434953,IRAK1,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,2/62,411/21728,0.3281828690448825,0.3713745402240178,0.2448110917036007,TMEM109/AKAP13,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/62,139/21728,0.3286512948467697,0.3714867445121913,0.24488505707092242,KLHL21,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/62,139/21728,0.3286512948467697,0.3714867445121913,0.24488505707092242,MANBA,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,2/62,412/21728,0.32923100642786673,0.37193306284832556,0.24517927131363937,SQSTM1/ST3GAL1,2
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,1/62,140/21728,0.33057929613073367,0.37303732126474265,0.2459072014196797,LMNA,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/62,140/21728,0.33057929613073367,0.37303732126474265,0.2459072014196797,NFKB1,1
REACTOME_MITOTIC_PROPHASE,REACTOME_MITOTIC_PROPHASE,1/62,141/21728,0.3325018495696762,0.37499648056849133,0.247198684480642,LMNA,1
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1/62,143/21728,0.3363306734391752,0.3784660598208168,0.249485840417615,IRAK1,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/62,143/21728,0.3363306734391752,0.3784660598208168,0.249485840417615,CCN1,1
REACTOME_REPRODUCTION,REACTOME_REPRODUCTION,1/62,143/21728,0.3363306734391752,0.3784660598208168,0.249485840417615,LMNA,1
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,1/62,143/21728,0.3363306734391752,0.3784660598208168,0.249485840417615,DKK1,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,1/62,144/21728,0.3382369740297133,0.38018591717753253,0.2506195749940834,TNIP1,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,1/62,144/21728,0.3382369740297133,0.38018591717753253,0.2506195749940834,PIM1,1
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,1/62,145/21728,0.3401378870954176,0.38104533899553467,0.2511861081586134,FBN1,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/62,145/21728,0.3401378870954176,0.38104533899553467,0.2511861081586134,NFKB1,1
KIM_ALL_DISORDERS_DURATION_CORR_DN,KIM_ALL_DISORDERS_DURATION_CORR_DN,1/62,145/21728,0.3401378870954176,0.38104533899553467,0.2511861081586134,KLHL21,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/62,145/21728,0.3401378870954176,0.38104533899553467,0.2511861081586134,TGOLN2,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/62,145/21728,0.3401378870954176,0.38104533899553467,0.2511861081586134,GEM,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/62,145/21728,0.3401378870954176,0.38104533899553467,0.2511861081586134,DKK1,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/62,146/21728,0.3420334276134217,0.3818930390445086,0.25174491430160134,PIM1,1
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/62,146/21728,0.3420334276134217,0.3818930390445086,0.25174491430160134,TMEM109,1
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,1/62,146/21728,0.3420334276134217,0.3818930390445086,0.25174491430160134,TNIP1,1
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1/62,146/21728,0.3420334276134217,0.3818930390445086,0.25174491430160134,MYO1C,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,1/62,146/21728,0.3420334276134217,0.3818930390445086,0.25174491430160134,GCNT1,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/62,146/21728,0.3420334276134217,0.3818930390445086,0.25174491430160134,TRAM2,1
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,2/62,425/21728,0.3428175309072903,0.3825562241738591,0.25218208771531997,PLOD2/APOL3,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,1/62,147/21728,0.3439236105199164,0.3835777740388424,0.2528554961227067,CHD1L,1
GOZGIT_ESR1_TARGETS_UP,GOZGIT_ESR1_TARGETS_UP,1/62,149/21728,0.34768796303907945,0.3871323639372594,0.2551986913052982,PIM1,1
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,1/62,149/21728,0.34768796303907945,0.3871323639372594,0.2551986913052982,AKAP13,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,1/62,149/21728,0.34768796303907945,0.3871323639372594,0.2551986913052982,HHAT,1
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,1/62,150/21728,0.34956216232039794,0.3887888726305366,0.25629066627313807,FURIN,1
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,1/62,150/21728,0.34956216232039794,0.3887888726305366,0.25629066627313807,HHAT,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,2/62,433/21728,0.3511386133952892,0.38979013198202084,0.2569506991196747,PLOD2/PANX1,2
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/62,151/21728,0.35143106332772656,0.38979013198202084,0.2569506991196747,DKK1,1
REACTOME_AUTOPHAGY,REACTOME_AUTOPHAGY,1/62,151/21728,0.35143106332772656,0.38979013198202084,0.2569506991196747,SQSTM1,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/62,151/21728,0.35143106332772656,0.38979013198202084,0.2569506991196747,SQSTM1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,1/62,151/21728,0.35143106332772656,0.38979013198202084,0.2569506991196747,NRP2,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/62,434/21728,0.3521764267328005,0.3904016366867188,0.2573538046590278,SQSTM1/PIM1,2
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/62,152/21728,0.3532946807941808,0.39099499326616705,0.2577449469056035,FLII,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/62,152/21728,0.3532946807941808,0.39099499326616705,0.2577449469056035,SQSTM1,1
REACTOME_HIV_LIFE_CYCLE,REACTOME_HIV_LIFE_CYCLE,1/62,152/21728,0.3532946807941808,0.39099499326616705,0.2577449469056035,FURIN,1
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,1/62,153/21728,0.3551530294125883,0.3928355663431158,0.2589582576082065,TGOLN2,1
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/62,155/21728,0.35885397867578417,0.396275633971283,0.26122595940348264,KLHL21,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/62,155/21728,0.35885397867578417,0.396275633971283,0.26122595940348264,GIT2,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,1/62,155/21728,0.35885397867578417,0.396275633971283,0.26122595940348264,DKK1,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/62,156/21728,0.3606966085057617,0.39809192337553073,0.26242326224399326,PIK3CA,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1/62,157/21728,0.36253402785828515,0.3996813501648601,0.2634710166410609,NFKB1,1
REACTOME_INFLUENZA_INFECTION,REACTOME_INFLUENZA_INFECTION,1/62,157/21728,0.36253402785828515,0.3996813501648601,0.2634710166410609,DNAJC3,1
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,1/62,158/21728,0.3643662512263621,0.4012615749684951,0.26451270506450975,TMEM109,1
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1/62,158/21728,0.3643662512263621,0.4012615749684951,0.26451270506450975,NFKB1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/62,159/21728,0.3661932930633566,0.4028326438728668,0.2655483578946386,MYO1C,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1/62,159/21728,0.3661932930633566,0.4028326438728668,0.2655483578946386,ELF4,1
REACTOME_HCMV_INFECTION,REACTOME_HCMV_INFECTION,1/62,160/21728,0.3680151677830966,0.40461558337682535,0.2667236763915455,NFKB1,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,1/62,161/21728,0.3698318897599814,0.40639091326984306,0.2678939786125365,HGF,1
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1/62,162/21728,0.37164347332908576,0.4079359892733882,0.26891249685281426,PLOD2,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/62,162/21728,0.37164347332908576,0.4079359892733882,0.26891249685281426,NFKB1,1
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,1/62,163/21728,0.3734499327862686,0.40969534611012676,0.2700722695923196,COL6A1,1
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,1/62,164/21728,0.37525128238827377,0.41122308287865295,0.27107935776242686,ITGB5,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,1/62,164/21728,0.37525128238827377,0.41122308287865295,0.27107935776242686,GIT2,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1/62,165/21728,0.3770475363528414,0.41296659942401576,0.2722286885394265,ITGB5,1
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,2/62,459/21728,0.37793468997928825,0.4137130556247704,0.27272075446647,COL3A1/ST3GAL1,2
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1/62,166/21728,0.37883870885880633,0.4140268779054418,0.2729276269545133,PANX1,1
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,1/62,166/21728,0.37883870885880633,0.4140268779054418,0.2729276269545133,PLOD2,1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1/62,166/21728,0.37883870885880633,0.4140268779054418,0.2729276269545133,NFKB1,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/62,167/21728,0.3806248140462076,0.4155274692680248,0.2739168208003094,GEM,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,1/62,167/21728,0.3806248140462076,0.4155274692680248,0.2739168208003094,ITGB5,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/62,168/21728,0.3824058660163916,0.41701929670730614,0.27490023744438935,PRRX1,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1/62,168/21728,0.3824058660163916,0.41701929670730614,0.27490023744438935,LMNA,1
DARWICHE_PAPILLOMA_RISK_LOW_DN,DARWICHE_PAPILLOMA_RISK_LOW_DN,1/62,169/21728,0.38418187883211463,0.4185024040120274,0.275877905752409,IRAK1,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/62,169/21728,0.38418187883211463,0.4185024040120274,0.275877905752409,HEBP1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,2/62,466/21728,0.3850764701505379,0.41924992312926534,0.2763706723568454,CCN1/TRAM2,2
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/62,170/21728,0.3859528665176475,0.419449853739879,0.27650246715090904,NRP2,1
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,1/62,170/21728,0.3859528665176475,0.419449853739879,0.27650246715090904,DKK1,1
TIEN_INTESTINE_PROBIOTICS_6HR_DN,TIEN_INTESTINE_PROBIOTICS_6HR_DN,1/62,170/21728,0.3859528665176475,0.419449853739879,0.27650246715090904,PLXNA1,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,2/62,467/21728,0.3860940005597693,0.419449853739879,0.27650246715090904,FLII/TBC1D8,2
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1/62,171/21728,0.38771884305888105,0.42098775619777046,0.27751625657067636,TGOLN2,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,2/62,472/21728,0.39117115421059445,0.42411986354685555,0.2795809501250591,TRAM2/PLOD2,2
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,1/62,173/21728,0.39123581846071764,0.42411986354685555,0.2795809501250591,COL3A1,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,HOLLERN_SQUAMOUS_BREAST_TUMOR,1/62,173/21728,0.39123581846071764,0.42411986354685555,0.2795809501250591,PIM1,1
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,1/62,174/21728,0.39298684510212023,0.4255594899598848,0.28052995571280465,PLOD2,1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1/62,174/21728,0.39298684510212023,0.4255594899598848,0.28052995571280465,TNIP1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1/62,175/21728,0.3947329161610267,0.42722034820655497,0.2816247979178923,AHNAK2,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,2/62,476/21728,0.3952200246209907,0.42751757502012544,0.2818207306295689,CCN1/EHBP1L1,2
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1/62,177/21728,0.3982102466756846,0.4305206965671561,0.28380039639772764,FLNA,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,2/62,481/21728,0.4002646130983323,0.4325093456250508,0.2851113191836162,ITGB5/DKK1,2
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,1/62,179/21728,0.4016679199163061,0.43332753612418656,0.28565067255230464,DKK1,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/62,179/21728,0.4016679199163061,0.43332753612418656,0.28565067255230464,ELF4,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/62,179/21728,0.4016679199163061,0.43332753612418656,0.28565067255230464,LMNA,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,2/62,484/21728,0.40328237387533983,0.434485819868583,0.2864142162992648,FBN1/TPP1,2
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,1/62,180/21728,0.4033894192418057,0.434485819868583,0.2864142162992648,GEM,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/62,180/21728,0.4033894192418057,0.434485819868583,0.2864142162992648,VCL,1
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1/62,182/21728,0.4068178113418224,0.4372422203096937,0.2882312428535179,IRAK1,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1/62,182/21728,0.4068178113418224,0.4372422203096937,0.2882312428535179,IRAK1,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/62,182/21728,0.4068178113418224,0.4372422203096937,0.2882312428535179,TNIP1,1
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,1/62,182/21728,0.4068178113418224,0.4372422203096937,0.2882312428535179,ST3GAL1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1/62,184/21728,0.4102268183244764,0.44067077334161586,0.29049135419610544,COL3A1,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1/62,186/21728,0.4136165480119389,0.4438381304533446,0.2925792844884452,HGF,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1/62,186/21728,0.4136165480119389,0.4438381304533446,0.2925792844884452,IL2RB,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/62,187/21728,0.41530421740304746,0.4451742596776406,0.29346006445214357,HLCS,1
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1/62,187/21728,0.41530421740304746,0.4451742596776406,0.29346006445214357,LMNA,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/62,189/21728,0.4186652320250207,0.4485380441077432,0.29567748015891826,HLCS,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,1/62,190/21728,0.42033860384425337,0.450091150045044,0.29670129175303733,PLOD2,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/62,191/21728,0.4220072363338838,0.45139742663677523,0.29756239278138374,HGF,1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1/62,191/21728,0.4220072363338838,0.45139742663677523,0.29756239278138374,COL3A1,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/62,193/21728,0.42533033610142224,0.4547102211668765,0.29974619580949274,COL15A1,1
KONDO_PROSTATE_CANCER_WITH_H3K27ME3,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1/62,194/21728,0.4269848296775407,0.4562365784977227,0.30075237465058635,ANXA13,1
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,1/62,196/21728,0.430279769690027,0.4595132147645087,0.302912342054662,NFKB1,1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1/62,198/21728,0.43355606706542715,0.46227599731618413,0.304733575713295,HEBP1,1
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,1/62,198/21728,0.43355606706542715,0.46227599731618413,0.304733575713295,LMNA,1
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1/62,198/21728,0.43355606706542715,0.46227599731618413,0.304733575713295,AKAP13,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,1/62,199/21728,0.4351872572113603,0.4637694711383776,0.3057180776574008,BNC2,1
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,1/62,200/21728,0.43681382556348525,0.4647643664906041,0.30637391533857966,PLOD2,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1/62,200/21728,0.43681382556348525,0.4647643664906041,0.30637391533857966,FURIN,1
LEE_DIFFERENTIATING_T_LYMPHOCYTE,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1/62,200/21728,0.43681382556348525,0.4647643664906041,0.30637391533857966,AKAP13,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1/62,203/21728,0.4416659284931196,0.468935012204832,0.3091232161651608,COL6A1,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1/62,203/21728,0.4416659284931196,0.468935012204832,0.3091232161651608,FLII,1
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,1/62,203/21728,0.4416659284931196,0.468935012204832,0.3091232161651608,FLNA,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,1/62,203/21728,0.4416659284931196,0.468935012204832,0.3091232161651608,HGF,1
PROVENZANI_METASTASIS_UP,PROVENZANI_METASTASIS_UP,1/62,204/21728,0.44327413812998007,0.47039428582147674,0.31008517324215795,VCL,1
LINSLEY_MIR16_TARGETS,LINSLEY_MIR16_TARGETS,1/62,206/21728,0.44647689689048553,0.473543234867505,0.31216096888827893,TMEM109,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/62,207/21728,0.4480714713906616,0.47473396547551927,0.3129459016946502,KLHL21,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,1/62,207/21728,0.4480714713906616,0.47473396547551927,0.3129459016946502,HEBP1,1
MIKKELSEN_MEF_ICP_WITH_H3K27ME3,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,1/62,208/21728,0.4496615261638497,0.4759174069656315,0.3137260294949753,DKK1,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/62,208/21728,0.4496615261638497,0.4759174069656315,0.3137260294949753,LMNA,1
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,1/62,209/21728,0.45124707381151885,0.4770935956430772,0.3145013762217627,AHNAK,1
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,1/62,209/21728,0.45124707381151885,0.4770935956430772,0.3145013762217627,COL3A1,1
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/62,210/21728,0.45282812690058816,0.47851375594747025,0.31543754969855214,AHNAK,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/62,211/21728,0.4544046979635199,0.47967589312833264,0.31620363364115267,TBC1D8,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/62,211/21728,0.4544046979635199,0.47967589312833264,0.31620363364115267,PIK3CA,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/62,215/21728,0.4606664114023027,0.48603084412240843,0.3203928343592313,SQSTM1,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,1/62,216/21728,0.46222075912196325,0.4869047996614608,0.3209689481916086,TBC1D8,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/62,216/21728,0.46222075912196325,0.4869047996614608,0.3209689481916086,PIK3CA,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/62,216/21728,0.46222075912196325,0.4869047996614608,0.3209689481916086,PIK3CA,1
REACTOME_KERATINIZATION,REACTOME_KERATINIZATION,1/62,217/21728,0.46377069929184234,0.488281866549025,0.3218767143725916,FURIN,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/62,219/21728,0.46685740612393134,0.4912746344776935,0.32384955500779206,NFKB1,1
BIDUS_METASTASIS_UP,BIDUS_METASTASIS_UP,1/62,220/21728,0.46839419727276743,0.4923767632773292,0.3245760812647457,PLOD2,1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1/62,220/21728,0.46839419727276743,0.4923767632773292,0.3245760812647457,FLII,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/62,221/21728,0.46992662984525624,0.49372970195752247,0.32546794206679835,COL3A1,1
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,1/62,223/21728,0.4729784678658727,0.49641767206371196,0.32723985916096954,GEM,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1/62,223/21728,0.4729784678658727,0.49641767206371196,0.32723985916096954,FURIN,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/62,224/21728,0.47449789753303473,0.4972342551231593,0.32777815290110957,FN1,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/62,224/21728,0.47449789753303473,0.4972342551231593,0.32777815290110957,SQSTM1,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,1/62,224/21728,0.47449789753303473,0.4972342551231593,0.32777815290110957,PIM1,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/62,228/21728,0.48053263492191534,0.5030341630920362,0.33160146777020283,PLOD2,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,1/62,228/21728,0.48053263492191534,0.5030341630920362,0.33160146777020283,COL15A1,1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1/62,232/21728,0.4864991759875069,0.5090152584955091,0.3355442218815222,DKK1,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/62,233/21728,0.48798024460905387,0.5102995073562455,0.3363908021705919,CCN1,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,1/62,234/21728,0.4894571101514701,0.511312412058545,0.33705851166358003,FURIN,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,1/62,234/21728,0.4894571101514701,0.511312412058545,0.33705851166358003,KLHL21,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1/62,235/21728,0.4909297843475531,0.5125847047780367,0.33789721043231474,IL2RB,1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1/62,236/21728,0.4923982788978929,0.5127874415851762,0.33803085507864505,CHD1L,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/62,236/21728,0.4923982788978929,0.5127874415851762,0.33803085507864505,FURIN,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/62,236/21728,0.4923982788978929,0.5127874415851762,0.33803085507864505,GIT2,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,1/62,236/21728,0.4923982788978929,0.5127874415851762,0.33803085507864505,IL2RB,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/62,236/21728,0.4923982788978929,0.5127874415851762,0.33803085507864505,LMNA,1
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,1/62,238/21728,0.4953227757031863,0.5155661793661721,0.33986260646718475,PLOD2,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/62,239/21728,0.4967788011990636,0.5168143474728625,0.340685402226539,PLOD2,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/62,241/21728,0.4996784642405,0.5195623101043338,0.3424968665540759,PXN,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,1/62,242/21728,0.5011221248360738,0.5207942743647626,0.3433089806945699,CHD1L,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/62,243/21728,0.5025616867954965,0.5220207092578931,0.3441174498613296,PLOD2,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/62,245/21728,0.5054285605586177,0.5244570726374105,0.34572350712730837,SQSTM1,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/62,245/21728,0.5054285605586177,0.5244570726374105,0.34572350712730837,FURIN,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,1/62,246/21728,0.5068558951601803,0.5256670417846818,0.3465211220302915,HLCS,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1/62,247/21728,0.5082791767214904,0.5268715628869853,0.3473151455674383,CHD1L,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1/62,248/21728,0.5096984165633633,0.5280706560893342,0.3481055910183955,CCN1,1
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,1/62,250/21728,0.5125248162166607,0.5304526390061324,0.3496758005376827,TRAM2,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/62,250/21728,0.5125248162166607,0.5304526390061324,0.3496758005376827,HGF,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,1/62,254/21728,0.5181296095645653,0.5359777760637047,0.3533179856860248,PRRX1,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/62,256/21728,0.520908181673549,0.5385751600859099,0.35503018819098386,PDLIM4,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/62,259/21728,0.5250465081350032,0.5425750253557403,0.3576669100911546,AHNAK,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/62,262/21728,0.5291496599746354,0.5465344537315022,0.36027697588243845,FLII,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/62,263/21728,0.5305096115763113,0.5476579468915024,0.36101758558297226,COL15A1,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/62,265/21728,0.5332179313067171,0.5490452803424334,0.3619321195100273,PDLIM4,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/62,265/21728,0.5332179313067171,0.5490452803424334,0.3619321195100273,COL15A1,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/62,265/21728,0.5332179313067171,0.5490452803424334,0.3619321195100273,AKAP13,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/62,265/21728,0.5332179313067171,0.5490452803424334,0.3619321195100273,MYO1C,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/62,265/21728,0.5332179313067171,0.5490452803424334,0.3619321195100273,TRAF1,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/62,268/21728,0.5372516138269205,0.5529157273758385,0.36448352856207833,KLHL21,1
REACTOME_CHROMATIN_MODIFYING_ENZYMES,REACTOME_CHROMATIN_MODIFYING_ENZYMES,1/62,272/21728,0.5425765520444554,0.5581104410600431,0.367907897737603,NFKB1,1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,1/62,280/21728,0.5530462061420872,0.5685891501062235,0.3748154908097948,FN1,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,1/62,283/21728,0.5569112367471167,0.5722703821936664,0.37724216886262413,FBN1,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,1/62,284/21728,0.5581922581190764,0.5732939373841662,0.37791689918596294,MYO1C,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1/62,290/21728,0.5658022178837607,0.580517114932242,0.3826784371741263,COL3A1,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,1/62,290/21728,0.5658022178837607,0.580517114932242,0.3826784371741263,DKK1,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/62,296/21728,0.573283177447512,0.5875933535529262,0.387343112627753,FLNA,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,1/62,296/21728,0.573283177447512,0.5875933535529262,0.387343112627753,ST3GAL1,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,1/62,297/21728,0.5745176139442576,0.5885587776251763,0.38797952276222786,TNIP1,1
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,1/62,298/21728,0.5757485368099875,0.5895196214054427,0.38861291355595784,ELF4,1
MUELLER_PLURINET,MUELLER_PLURINET,1/62,299/21728,0.5769759558822124,0.5901757108464725,0.3890454094729284,PXN,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,1/62,299/21728,0.5769759558822124,0.5901757108464725,0.3890454094729284,FN1,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/62,308/21728,0.587866666664443,0.6010100270979977,0.396187419767436,KLHL21,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,1/62,310/21728,0.5902491018672124,0.6031392549298279,0.3975910124576663,TPP1,1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1/62,311/21728,0.5914352329571475,0.6040445120354216,0.39818776036655407,FLNA,1
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,1/62,314/21728,0.5949733939956909,0.6070418198373886,0.40016359369839366,AHNAK,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/62,314/21728,0.5949733939956909,0.6070418198373886,0.40016359369839366,HEBP1,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,1/62,322/21728,0.6042617736625245,0.6158939658606887,0.40599895206888553,FLNA,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/62,322/21728,0.6042617736625245,0.6158939658606887,0.40599895206888553,PANX1,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/62,329/21728,0.612216966975017,0.623686348128473,0.41113571133298954,DKK1,1
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,1/62,330/21728,0.6133405030303256,0.6245147227211615,0.4116817780834276,CHD1L,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/62,331/21728,0.6144608361835232,0.6253389996971415,0.4122251436739554,HEBP1,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,1/62,335/21728,0.6189103190312786,0.6295488179428375,0.41500026713821037,MYO1C,1
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,1/62,342/21728,0.6265756603760615,0.6370238649199776,0.4199278381286868,TRAM2,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,1/62,345/21728,0.6298141803844877,0.6399929954210047,0.4218850969082693,PIM1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1/62,347/21728,0.6319578255230718,0.6418471201173247,0.42310734087466223,TBC1D8,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1/62,354/21728,0.6393648450905512,0.6490424159042327,0.4278504991311778,NFKB1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,1/62,360/21728,0.6455968384191488,0.655038244528153,0.43180296542088153,AHNAK2,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,1/62,368/21728,0.6537416043275593,0.6629677963241176,0.43703014720539307,HEBP1,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1/62,375/21728,0.660717007744502,0.6697040904694902,0.44147073035029705,CCN1,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/62,377/21728,0.6626844593958227,0.6713600867595142,0.4425623675405399,GIT2,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,1/62,378/21728,0.6636639715272197,0.6720140466596709,0.44299345965846254,PANX1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1/62,385/21728,0.6704426344151615,0.6785365092773165,0.4472930844875058,TNIP1,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,1/62,387/21728,0.6723545827221499,0.6801294220397011,0.4483431368473493,CTF1,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/62,403/21728,0.6872623564950519,0.6948602317929872,0.45805372609561784,PRRX1,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1/62,407/21728,0.6908837754276949,0.6981708468912717,0.4602360924364353,DNAJC3,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,1/62,410/21728,0.6935727331571485,0.7005363148153527,0.4617954152282854,SQSTM1,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,1/62,411/21728,0.6944639279476661,0.7010845072908701,0.4621567851765703,PANX1,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/62,412/21728,0.6953525725255734,0.7016295766907992,0.4625160963850618,HHAT,1
REACTOME_M_PHASE,REACTOME_M_PHASE,1/62,415/21728,0.6980032766673899,0.7039511742630519,0.4640464997234726,LMNA,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1/62,421/21728,0.7032367920475912,0.7088739607213194,0.46729161374325745,GIT2,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,1/62,427/21728,0.7083810499717388,0.713701889105227,0.47047419706633153,ST3GAL1,1
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,1/62,428/21728,0.7092298540138847,0.7141994325705385,0.4708021790514172,TGOLN2,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,1/62,431/21728,0.711761708428926,0.7163904739164579,0.4722465193757126,HLCS,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,1/62,436/21728,0.7159333486795071,0.7202289487715842,0.47477685228219946,KLHL21,1
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,1/62,437/21728,0.7167605200293977,0.7207007327831825,0.4750878535663964,COL15A1,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/62,445/21728,0.7232931332798471,0.7269059860934327,0.47917837317030726,COL6A1,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1/62,449/21728,0.7265036213476734,0.7297679910891258,0.48106501452982037,MANBA,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/62,452/21728,0.7288874094914523,0.7317971396690629,0.48240263470912376,TPP1,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,1/62,453/21728,0.729677453701432,0.7322249560335568,0.48268465240257485,APOL3,1
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,1/62,454/21728,0.7304652326847698,0.7326500738593006,0.4829648912120533,TMEM109,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1/62,459/21728,0.7343703721878297,0.7361998947891945,0.48530494267782004,PLOD2,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,1/62,463/21728,0.7374543566495007,0.7389233892324678,0.4871002775101546,HEBP1,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,1/62,467/21728,0.7405031066688021,0.7416088853248531,0.488870563727799,FN1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1/62,470/21728,0.7427667849808797,0.7435058564087214,0.49012105214763474,RAB36,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,1/62,493/21728,0.7594880812303632,0.7598657481031778,0.5009055365752874,MYO1C,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,1/62,496/21728,0.7615887087223053,0.7615887087223053,0.5020413168306502,AKAP13,1
